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Abstract 
Cardiovascular disease is the highest cause of morbidity worldwide, encompassing blood 
vessel disorders such as coronary artery and peripheral arterial disease. For small diameter 
applications (less than 6 mm) a tissue engineered commercial product is yet to be produced. 
Previously, a process for the production of acellular porcine carotid arteries was developed 
which showed excellent potential for clinical translation as vascular bypass grafts. Medical 
products, however, need to be sterilised to a sterility assurance level of 10-6 before they can 
be used clinically.  
The aim of this thesis was firstly to produce acellular vascular grafts from porcine carotid 
arteries using previously developed decellularisation technology. Secondly, to develop robust 
methods capable of evaluating the effects of different sterilisation methods on the biological 
and mechanical characteristics of acellular vascular grafts and finally to determine the 
compatibility of the main stream industrially available sterilisation processes (Gamma and E-
Beam irradiation and ethylene oxide treatment) with acellular vascular grafts.  
Decellularisation of porcine carotid arteries was evaluated by determination of DNA content 
and histology. Biocompatibility was assessed using contact cytotoxicity. Acellular arteries 
were then subjected to 30 kGy (25 kGy min) E-Beam or Gamma irradiation or ethylene oxide 
treatment. The effects of sterilisation were determined using histology, 
immunohistochemistry, second harmonic generation multiphoton imaging, differential 
scanning calorimetry, denatured collagen content and determination of mechanical properties 
compared to non-sterilised acellular arteries. Mechanical properties were assessed using 
uniaxial tensile testing at a low strain rate to failure and burst pressure and compliance 
testing 
Histologically, the architecture of the arteries was retained post decellularisation and DNA 
content was reduced by greater than 95 %. The arteries were not cytotoxic. Stress strain 
mechanics were also retained but compliance testing showed a significant reduction.  
Post sterilisation with both Gamma irradiation and E-beam irradiation, there was a 
significantly increased stiffness of the elastin and collagen modulus of the acellular arteries. 
Ethylene oxide treatment significantly increased the elastin and collagen modulus. E-Beam 
irradiation and ethylene oxide treatment reduced compliance excessively. Histology showed 
the architecture of gamma and E-beam sterilised arteries to be consistent with acellular 
arteries and that ethylene oxide treated arteries exhibited some layer separation.  Multiphoton 
imaging showed damage to all sterilised samples with Gamma sterilised acellular arteries the 
least affected. There were no significant differences in denaturation temperature.  
- v - 
These results were in partial agreement with previously reported data on the effects of 
Gamma and E-beam sterilisation on tendons. Gamma, E-beam [30 kGy] irradiation and 
ethylene oxide treatment caused detrimental effects to the mechanical properties of acellular 
porcine carotid arteries. E-beam irradiation and ethylene oxide treatment caused severe 
reduction in the compliance of acellular porcine carotid arteries. Compliance mismatch is a 
known failure mechanism of vascular grafts, therefore E-Beam irradiation and ethylene oxide 
treatment were not compatible with acellular vascular grafts. Gamma irradiation caused the 
least damaging effects and is the most likely candidate of the three that could potentially be 
optimised for sterilising acellular vascular grafts.  
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Chapter 1 Vascular Disease and Small Diameter Vascular Grafts 
1.1 Introduction 
Cardiovascular disease (CVD) is the highest cause of morbidity worldwide (W.H.O., 2011), 
CVD encompasses a range of heart and blood vessel disorders such as coronary artery 
disease (CAD) and peripheral arterial disease (PAD). Both are characterised by reduced 
blood supply caused primarily by severely stenotic arteries. Vascular grafts are used to 
replace damaged arteries and reinstate normal blood flow and function to the vascular 
system. There has been moderate success in bypass surgery of large diameter blood vessels 
with synthetic grafts, however this does not translate to small diameter blood vessels <6mm. 
The gold standard for coronary artery bypass surgery (CABG) or peripheral arterial disease is 
an autograft of either vein or artery, commonly the saphenous vein (SV). If insufficient native 
artery is available due to previous surgery or disease, then Dacron or expanded 
polytetrafluroethylene (ePTFE) synthetic grafts are used; both of these are associated with 
low patency rates due to early occlusion and increased risk of infection (Teebken & Haverich, 
2002; van Det et al., 2009). This has led to intensive research in tissue engineered small and 
medium diameter vascular grafts. 
Acellular allogeneic and xenogeneic (porcine and bovine) vascular grafts have been 
developed using patented platform decellularisation technology (Ingham et al., 2010). The 
process removes the native cells and cellular debris including the genetic material whilst also 
maintaining the mechanical integrity. These scaffolds have the potential for clinical use in-vivo 
(Wilshaw et al. 2012). The initial clinical use of acellular artery technology will be either a 
peripheral artery bypass or arteriovenous graft to build confidence in the technology. 
All medical devices must be supplied sterile.  Sterilisation is vitally important for the safety of 
the patient and the success of the arterial graft. Current sterilisation techniques such as 
peracetic acid (PAA) treatment require that the tissue is aseptically transferred following 
chemical sterilisation and this is not ideal for a manufacturing process, a process that can 
sterilise the product in its final packaging is preferable (terminal sterilisation). Moreover, it has 
been shown that PAA treatment has an adverse effect on the basement membrane of porcine 
common femoral arteries, in particular the expression of collagen IV as determined by 
immunohistochemistry and increased thrombogenicity (Personal communication; Dr S.P. 
Wilshaw). 
The choice of sterilisation technique implemented should not alter the mechanical properties 
out of a preferential range, reduce biocompatibility or increase thrombogenicity. Ideally for a 
commercial product a terminal sterilisation process is required so that there is no risk of 
contamination post sterilisation. The two main terminal sterilisation processes currently used 
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for tissue grafts are ethylene oxide and Gamma radiation, followed by two newer processes: 
E-Beam radiation and supercritical carbon dioxide. The four processes sterilise via different 
mechanisms and will be discussed in detail in Sections 1.5.6 and 1.5.7, however they all 
result in breaking chemical bonds, producing crosslinking and chain scission of polymers via 
the formation of free radicals. It is therefore necessary to optimise one of these methods in 
order to reduce the amount of graft damage. The aim of this study was to develop robust 
methods for the assessment of the effects of different sterilisation methods on acellular 
vascular grafts and to produce a terminally sterilised acellular vascular product. 
1.2 The vascular system 
The cardiovascular system is a closed loop system of tubular vessels called veins and 
arteries carrying blood to and from the heart respectively. The heart being the driving force of 
the system pumping the flow of blood around the body (Figure 1.1) (Johnson & Byrne, 1998). 
 
Figure 1.1 : Schematic of the cardiovascular system 
Adapted from Kaulitzki (2011) 
The heart can be considered as two pumps; the left and right heart, each consisting of a 
ventricle and atrium (Figure 1.2). The right heart circulates blood around the pulmonary 
system at pressures of 10/24 mmHg (diastolic/systolic) and the left heart circulates blood 
around the systemic system at pressures of 80/120 mmHg. The flow of blood between the 
atria and ventricles is controlled by atrio-ventricular valves and the flow between the 
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ventricles and exit vessels (pulmonary artery, aorta) is controlled by the semi-lunar valves 
(Johnson & Byrne, 1998). 
 
Figure 1.2 : Anatomy and circulation of the heart. 
RA-right atrium; LA-left atrium; RV-right ventricle; LV-left ventricle; AO-aorta; PA-pulmonary artery; AV-atrio-
ventricular valves; SL-semi-lunar valves; IVS-inter-ventricular septum. Adapted from Preventing-a-Heart-
attack.com (2011) 
The aorta and large arteries are under the highest pressure, peaking at around 120 mmHg in 
normal healthy adults. They have a lower distensibility than veins and undergo 
vasoconstriction to maintain an overall small cross-sectional area that helps propagate the 
flow at high velocities (approximately 30 cm/s) around the body. As the arteries branch into 
smaller arteries and arterioles, the cross sectional area increases. The reduction in the radius 
increases the resistance and the distensibility increases reducing the pulsatility. This leads to 
a quick reduction in blood velocity and pressure (Klabunde, 2005).  
 
Figure 1.3 : Relationship between average blood pressure, total cross-sectional area and velocity 
between arteries to veins. 
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As the blood flows into the capillaries, the pressure ranges from around 10-25 mmHg. The 
pulsatility is reduced and the velocity drops to its lowest (approximately 0.05 cm/s). This is 
because of the increased resistance created by the small lumen radii of capillaries although 
the total cross sectional area of the capillaries is larger than that of the arteries or veins. This 
allows high rates of gas and molecule exchange. As the flow now proceeds into the venules 
and veins their ability to distend allows the low pressure to drive large volumes of blood at 
increasing velocities around the body (Figure 1.3) (Carlson et al., 2008; Jan, 2010). 
1.2.1 Physiology of Blood Vessels 
Veins and arteries have three distinct layers (Figure 1.4); the tunica intima (1), tunica media 
(2) and tunica adventitia (3).In comparison to veins, arteries have much thicker media layers, 
which are rich in elastin and collagen, this provides higher strength and elasticity to resist high 
blood pressures. In addition the smooth muscle content and the small lumen diameter of 
arteries help to propagate the strength of the pulse and maintain pressure. Veins have a 
larger luminal diameter for transporting high blood volumes under low pressure; they also 
incorporate one way valves in order to maintain unidirectional blood flow, towards the heart 
without backflow. Capillaries are generally single cell-thick layers of endothelial cells and the 
main location of nutrient transfer to tissues. 
 
Figure 1.4 : Image depicting the relative layers in arteries and veins. 
Haematoxylin and eosin stained arteries (left) and veins (right). (1) tunica intima, (2) tunica media, and (3) 
tunica adventitia (4) internal elastic lamina. Image adapted from www.vascularconcepts.com (2011)  
The tunica adventitia is the external layer of the vessels; its main function is to provide an 
anchorage to nearby tissues and organs. Its primary constituents are extracellular matrix 
(ECM) proteins including; elastin fibres, collagen type I and III, proteoglycans, glycoproteins, 
and hyaluronan and fibro-elastic connective tissue (Stenmark et al., 2006). Most of which are 
produced by a heterogeneous population of myofibroblastic cells. The tunica adventitia is 
entwined with a network of smaller thin walled blood vessels called the vasa-vasorum that 
provides a supply of oxygen and nutrients to the wall of the vessel more readily than diffusion 
from the vessel lumen. This also makes the adventitial layer a key area of vascular 
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inflammation. In between the adventitia and the media layers there is an intervening layer of 
elastic connective tissue called the external elastic lamina (Wagenseil & Mecham, 2009). 
Studies have also shown that the adventitia may contribute to sensing and detecting injury of 
the blood vessel (Schulze-Bauer et al., 2002), and within developing vessels may also 
stimulate progenitor cells to differentiate into smooth muscle cells (SMC), that can then 
replenish the media, and endothelial cells (Hu et al., 2004). 
The tunica media is the thickest layer of blood vessels and contains predominately smooth 
muscle cells, elastin fibres and collagen types I and III. The smooth muscle cells are highly 
organised along the circumferential orientation and are responsible for propagating the pulse 
of the blood by contracting and reducing the lumen size. The elastin fibres contribute largely 
to the compliance of the vessels. Between the media and intima layers there is an intervening 
layer of connective tissue called the internal elastic lamina (Dingemans et al., 2000). 
The tunica intima is a single-cell-thick layer of endothelial cells (EC), making it the thinnest of 
the three layers. The cells are orientated longitudinally along the direction of flow, and are 
stimulated by blood flow-induced shear. This layer rests upon the basement membrane which 
incorporates the basal lamina, a layer of ECM with high concentrations of collagen type IV 
and anchoring fibrils of collagen type VII extending from the lamina (Davis, 1993). The 
basement membrane provides simultaneous flexibility and stability for the endothelial cells, 
allowing them to withstand blood flow-induced deformation of the vessel, as well as acting as 
a mechanical barrier. In capillaries, the EC layer also contains pericytes and multi-potent 
stem cells (Bou-Gharios et al., 2004). The outer surface of the EC layer is a charged surface 
due to the expression of glycoproteins collectively called glycocalyx. This creates a highly 
negatively charged surface which aids in restricting the movement of blood cells and plasma 
proteins through the EC layer (Liu & Yang, 2009). The EC layer helps prevent thrombosis and 
coagulation by controlling blood-wall interactions and plays an important role in inflammation 
(Sumpio et al., 2002). 
1.2.2 Extracellular Matrix and its Components 
There are three main structural components of the extracellular matrix: elastin, collagen and 
glycosaminoglycans (GAG). The combination of these three constituents dictates the vessel 
strength, elasticity and reaction to haemodynamic forces. 
Elastin is primarily responsible for the elasticity and compliance of a particular tissue, it is very 
stable, highly insoluble and particularly difficult to synthesise, it has a compact branched 
three-dimensional structure with cross-links existing between molecules forming an elastin 
fibre (Debelle & Tamburro, 1999); tissues and organs undergoing large amounts of reversible 
deformation have particularly high elastin content. In relation to blood vessels elastin aids in 
recoiling the vessel back to its original diameter (Figure 1.5)(Cooper, 2000). 
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Figure 1.5 : The formational changes of elastin in stretched or relaxed states.  
Adapted from Bruce Alberts et al. (2004) 
Collagen provides the majority of the tensile stiffness and is the main load carrying 
component in the blood vessels. It is responsible for the structural integrity and, therefore, its 
ultimate tensile strength (UTS) (Meyers et al., 2008). Collagen has a triple helix structure 
(Figure 1.6). Each protein strand is made up of amino acids, and demonstrates an α-helical 
left handed twist of 0.87 nm per turn. The combination of these form an overall right handed 
helical twist of 8.6 nm, with an average length of one triple helix being about 300 nm. The 
tensile stiffness and strength of a tissue increases with its collagen content, but the tensile 
strength and stiffness are also highly dependent on collagen fibre orientation and amount of 
cross-linking between individual fibres. Cross-linking occurs between the glycine residues and 
hydroxyl groups forming strong covalent bonds (Fung, 1993). Fibre-forming collagens form 
fibrils which vary in length, they have a staggered formation allowing the head of one fibre to 
bond with the tail of another (Figure 1.6) (Cooper, 2000). 
 
 
 
  
 
Figure 1.6 : Collagen helix structure.  
Image adapted from Fung (1993) 
Glycosaminoglycans (GAGs) are long un-branched polysaccharides, usually attached to a 
protein core (Figure 1.7) in the form of proteoglycans. GAGs account for about 2-5 % of dry 
weight in blood vessels. Although GAGs represent only a small percentage of the mass of 
blood vessels they have a large effect on viscoelasticity, compressibility, wall permeability, 
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haemostasis and thrombosis (Wight, 1989). GAGs are highly negatively charged and draw 
large influxes of positive ions, creating a large osmotic gradient. This gradient allows GAGs to 
attract and contain large volumes of water, it is this property that affects the compressibility of 
a vessel and gives it the ability to endure compressive forces.  
 
Figure 1.7 : Location and orientation of GAGs in relation to a protein core.  
Image adapted from Fung (1993) 
1.3 Vascular disease, risk, incidence and therapies 
Ischemic heart disease (coronary artery disease) is the world’s leading cause of death 
(Finegold et al., 2013). The major underlying condition leading to vascular diseases such as 
coronary artery disease, cerebrovascular disease and peripheral vascular disease are 
stenotic blood vessels caused by atherosclerosis and hypertension. A stenosis is the 
narrowing of a blood vessel (Figure 1.8), which leads to reduced blood flow downstream, 
when flow is reduced by 70 % it is known as ischemia (Hertzer et al., 1984). The lack of blood 
supply reduces the nutrient exchange to the surrounding tissues. In the absence of oxygen 
and glucose cellular metabolism slows down and waste by-products build up. This cessation 
of metabolic activity leads to cell necrosis (premature cell death) and the release of cytokines 
into the intracellular space inciting an inflammatory response. This inflammatory response 
prevents the influx of phagocytes to remove cellular components by phagocytosis leading to 
the build up of decomposing tissue. 
 
 
Figure 1.8 : Stenotic artery.  
Image adapted from www.mayfieldclinic.com (2011) 
In ischemic heart disease the afflicted arteries are the coronary arteries (Figure 1.9), when 
the surrounding heart tissue is denied oxygen the cells begin to die of necrosis; this is known 
GAGs 
Protein core 
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as myocardial infarction (Heart attack). The affected area conducts electrical impulses at a 
slower rate than healthy heart tissue and causes arrhythmias such as ventricular fibrillation 
and ventricular tachycardia. The dead cells are not replaced and collagen scarring occurs; 
damage to the myocardium in this way is one form cardiomyopathy. Myocardial scarring also 
increases the risk of a ventricular aneurysm forming. 
 
Figure 1.9 : Vasculature of the heart. 
Image adapted from Gray et al. (1973) 
In cerebrovascular disease the afflicted arteries are the small arteries in the brain (Figure 
1.10), when the blood flow is reduced in these arteries an ischemic stroke occurs. The lack of 
oxygen and subsequent necrosis of brain cells prevents the brain from functioning correctly 
and reduces the electrical output causing muscular paralysis and lack of conscious control. 
 
Figure 1.10 : Vasculature of the brain. 
Image adapted from Gray et al. (1973) 
In peripheral vascular disease the afflicted arteries are large arteries not within the coronary, 
aortic arch or cerebral vasculature; usually this disease is concerned with the lower 
extremities affecting the femoral, popliteal or tibial artery of the leg. The popliteal artery is the 
continuation of the femoral artery that runs through the popliteal fossa and then divides into 
the anterior and posterior tibial arteries (Figure 1.11). Necrosis of tissues in the lower 
Small arteries 
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extremities leads to (in increasing order) claudication (limping), resting pain, lschemic 
ulceration and finally sever ulceration and gangrene. 
 
 
 
 
Figure 1.11 : Images depicting the femoral, popliteal and tibial arteries of the leg.  
Image adapted from Gray et al. (1973) 
1.3.1 Atherosclerosis, Thrombosis and Hypertension 
As mentioned previously the main cause of vascular disease is atherosclerosis. 
Atherosclerosis is characterised by the formation of plaques in the blood vessel wall. It is 
initiated predominantly as a result of the subendothelial deposition of low density lipoproteins 
(LDL). The lesions develop and grow into the luminal area (Figure 1.12), reducing blood flow 
and altering the haemodynamics of the vessel. 
 
Figure 1.12 : Build up of plaque within a blood vessel lumen.  
Image adopted from www.vwmin.org (2011) 
As the lesion continues to develop there is an increasing risk of rupture or erosion of the 
lesion, this leads to blood clotting and the development of a thrombus, and parts of this blood 
clot can break away causing an embolus (Figure 1.13). When embolus travels through the 
blood stream it can cause acute occlusion in the smaller diameter vessels of the heart or 
brain triggering a myocardial infarction or stroke. 
Tibial Artery Fibular Artery Popliteal Artery 
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Figure 1.13 : Thrombosis and embolus development.  
Image adopted from www.veininfo.co.uk (2011) 
Laminar flow (Particulates flow in parallel layers) and high shear stress prevent the deposition 
of LDL in the blood vessel wall. In areas of non-laminar flow and low shear stress such as 
stagnation and recirculation points found in arterial branching, bifurcations and curvatures 
there is increased deposition of LDL (Figure 1.14) (Zarins et al., 1983). 
 
Figure 1.14 : Aortic arch and carotid and subclavian bifurcations.  
Image adopted from hms.harvard.edu (2011) 
The endothelial cells experiencing laminar flow have an ellipsoid morphology aligned with 
direction of blood flow, in areas of low shear or turbulent flow the ellipsoid morphology is 
reduced into random polygons of no particular orientation (Figure 1.15). These areas of 
altered morphology have increased permeability to macromolecules. Due to the altered 
heamodynamics, a larger concentration of circulating LDL accumulates, leading to increased 
passive diffusion across the endothelium (Lusis, 2000). LDLs are retained in the 
subendothelial matrix by interactions between apolipoprotein B and proteoglycans in the 
intramural space. Lipoprotein(a) is also retained in the subendothelial matrix via 
apolipoprotein B and contributes to the development of lesions by inhibiting transforming 
growth factor β (TGF-β, inhibits the proliferation of SMC), allowing the proliferation of SMCs 
(Grainger et al., 1994). 
Thrombus 
Embolus 
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Figure 1.15 : Endothelial cells subjected to either turbulent or laminar flow.  
Image adopted from hms.harvard.edu (2011) 
When LDLs accumulate in the intramural space between the endothelium and the media they 
can undergo many modifications including oxidation, lipolysis, proteolysis and aggregation, 
one of the most significant being oxidation. Cellular processes create reactive oxygen species 
such as hydroperoxyeicosatetraenoic acid (HPETE) that migrate across cell membranes and 
oxidise the LDL (Cyrus et al., 1999). The build-up of oxidised LDL activates the endothelial 
cells and initiates chronic inflammation (Mestas & Ley, 2008). Activated ECs express growth 
factors and adhesion molecules such as P-selectin, vascular cell adhesion molecule-1 and 
intracellular adhesion moeclule-1 (Dong et al., 1998; Collins et al., 2000).These molecules 
and factors help the recruitment of monocytes by increasing the adhesion potential to the 
endothelium when rolling. Following monocyte adherence, monocytes transmigrate to the 
intramural space. Once monocytes enter the intramural space they differentiate into 
macrophages, aided by growth factors such as macrophage colony-stimulating factor (M-
CSF)(Smith et al., 1995). Macrophages engulf highly oxidised LDL and form ‘foam cells’ 
(Figure 1.16), which can be visualised as fatty streaks. LDLs reach a highly oxidised state 
through reactive oxygen species from cellular waste as well as enzymatic pathways such as 
myeloperoxidase, sphingomyelinase, secretory phospholipase and NADPH oxidase  (Li & 
Glass, 2002; Saha et al., 2009). Two scavenger receptors SR-A and CD36 on the surface of 
macrophages have been shown to be important in the development of lesions (Suzuki et al., 
1997; Febbraio et al., 2000).The scavenger receptors aid in the transport of highly oxidised 
LDL into the macrophage. Normally, excess cholesterol is transported to the liver via the 
reverse cholesterol transport chain and removed from the body in biliary excretion, however 
in the presence of excess highly oxidised LDL, cholesterol and fatty acids build up within the 
macrophage (Li & Glass, 2002). The macrophages eventually die from necrosis (Hegyi et al., 
1996) leaving cellular debris, that increases the inflammation response further. The 
extracellular lipid accumulation and cell debris develops into a necrotic core. As the lesion 
becomes larger, SMCs migrate from the media into the intramural space and produce a 
fibrous cap around the lesion. The SMC migration and proliferation is propagated by an influx 
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of activated T-cells producing cytokines such as IFN- γ and TNF-α, these also further 
exaggerate the inflammatory  response (Collins et al., 2000). As the plaque grows in size it 
bulges into the lumen leading to reduced blood flow and ultimately occlusion of the vessel. 
 
Figure 1.16 : Formation of foam cells. 
Image adopted from Rader & Daugherty (2008) 
A symptom of atherosclerosis is hypertension. Hypertension is characterised by high blood 
pressure and affects the pulmonary and systemic systems differently. The common significant 
change is an increase in wall thickness (Figure 1.17) due to the increased smooth muscle 
mass, proteoglycans and collagen in the vessel wall as well as reduced lumen diameter. This 
is a combination of hypertrophy (increase in cell size) and hyperplasia (increase in cell 
number) (Humphrey & Taylor, 2008). 
 
 
Figure 1.17 : Haematoxylin and eosin stained arteries showing normal (A)and hypertension (B)states.  
Adapted from Laing & McPherson (2009) 
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1.3.2 Incidence and Risk of Cardiovascular Disease 
Cardiovascular diseases account for roughly 25 % of all deaths in the age range 5 to 70 with 
ischemic heart disease being the number one cause of morbidity in the world accounting for 
approximately 11 % of all deaths with strokes following shortly behind with approximately 9% 
(W.H.O., 2011).There is a higher incidence of all forms of heart disease in males than in 
females (Figure 1.18). 
 
Figure 1.18 : Chart of death incidences per 100 000 worldwide from cardiovascular diseases.  
Adapted from W.H.O. (2011). 
As well as gender there are a number of other genetic and environmental factors that 
contribute to an increased risk of the development of atherosclerosis (Table 1.1). 
Table 1.1 : Genetic and environmental factors that increase the risk of atherosclerosis. 
Genetic Environmental 
Elevated levels of LDL/VLDL Depression and other behavioural traits 
Reduced levels of HDL High-fat diet 
Elevated levels of lipoprotein Smoking 
Elevated blood pressure Low antioxidant levels 
Elevated levels of homocysteine Lack of exercise 
Family history Infectious agents 
Diabetes and obesity  
Gender  
Systemic inflammation  
Metabolic syndrome  
Age  
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1.3.3 Therapies 
Atherosclerosis is initially treated by increased regular exercise and cessation of smoking, 
both of which should reduce the amount of LDL in the blood stream. If problems persist 
pharmacological methods are employed and at the extremities of functional disability surgical 
intervention is required. Pharmacological therapies include statins, antioxidants, blood 
thinners and dietary supplements as well as emerging methods utilising antibodies and 
receptor proteins. Surgical methods available include endarterectomy, which involves the 
surgical removal of plaque; angioplasty, where a balloon is inflated within the vessel lumen 
and used to expand the narrowed artery; insertion of a stent (a metal frame to prevent closure 
of the artery) and ultimately a bypass or replacement graft. For large diameter vessels there 
are number of clinical products on the market, both synthetic and natural grafts, which are 
used routinely. Dacron, polyethylene terephthalate (PET) and polytetrafluoro ethylene (PTFE) 
are synthetic options often used with good patency rates in large diameter vessels. However, 
for small diameter vessels (< 6mm) these same materials experience early failure and rapid 
occlusion due to increased thrombogenicity and compliance mismatch (Tilanus et al., 1985; 
Hoenig et al., 2005). For small diameter vascular graft (SDVG) surgery the main categories 
are coronary artery, below the knee femoropopliteal bypass as well as arteriovenous shunts 
for kidney dialysis in established renal failure (ERF)(Figure 1.19). 
 
Figure 1.19 : Number of bypass/replacement grafts performed on coronary arteries, iliac and femoral 
arteries and arteriovenous shunts in the UK 2010-2011.  
Adapted from H.S.C.I.C. (2011) 
The gold standard for small diameter vascular grafts is autologous vascular tissue, usually 
saphenous vein (Figure 1.20). Despite this, the procedure is associated with low patency 
rates and approximately 40 % of patients do not have adequate tissue for the procedure due 
to vascular disease, size mismatch or previous operations (DeWeese et al., 1966; Veith et al., 
1979). 
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Figure 1.20 : Image depicting the greater saphenous vein and its tributaries of the leg.  
Adapted from Gray et al. (1973) 
Coronary artery bypass grafts (CABG) are most likely to consist of a mammary anastomosis 
from the left subclavian artery to the left anterior descending coronary artery (1), 
accompanied by a replacement bypass graft from the aortic arch to the right anterior 
descending coronary artery (2) (Figure 1.21). A mammary anastomosis is the most common 
form of CABG followed by saphenous vein bypass, it is also quite likely that multiple coronary 
arteries will be bypassed (H.S.C.I.C., 2011).  
 
Figure 1.21 : Diagram of routine CABG surgery 
(1) bypass originating from subclavian artery , (2) bypass originating from aortic arch, (3). Aorta, (4) coronary 
artery, (5). vena cava, (6). Auricle. Image adapted from www.nhs.uk (2011). 
A femoropopliteal bypass graft can either be above or below the knee depending on the 
location of the stenotic artery. Above the knee the bypass begins and ends in the femoral 
artery and below the knee begins in the femoral artery ending in the popliteal artery. Below 
the knee femoropopliteal bypass grafts are generally SDVGs. 
 
Figure 1.22 : Image depicting femoropopliteal bypass graft surgery.  
Image adapted from www.shinonglobal.com (2011) 
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People suffering from established renal failure require repeated kidney dialysis (filtration) of 
the blood.  The blood is accessed via an arterio-venous fistula (Figure 1.23) which over time 
becomes stenotic and occludes. Established renal failure requiring vascular access has risen 
over the past decade and plateaued by 2010 at about 107 per million population. A SDVG 
could be a potential solution to providing accesses to the patient’s blood (L'Heureux et al., 
2007a; McAllister et al., 2009).  
 
Figure 1.23 : Two versions of arteriovenous graft in forearm.  
Image adapted from www.intechopen.com (2011) 
1.4 Small Diameter Vascular Grafts 
The final stage of therapy for ischemia is a small diameter vascular graft classed as less than 
6 mm internal diameter and that the gold standard for this therapy is the use of autologous 
saphenous vein. A blood vessel is considered patent when it is less than 30 % occluded, 
although some authors have reported their own conditions for patency in publications. Even 
as the gold standard the primary patency rates using saphenous vein are low and there is an 
indication that arterial autografts supersede venous autografts.  A study of randomised 
controlled trials reported venous grafts for above-knee femoropopliteal bypass had primary 
patency rates of 80 and 74 % at 2 and 5 years respectively (Klinkert et al., 2004) and in 
CABG the internal mammary artery has been shown to have an 85 % patency rate vs 61 % 
for autologous saphenous vein at 10 years (Goldman et al., 2004). Although veins undergo 
structural changes including increasing SMC’s in a process called arterialisation, an intact 
arterial structure appears to be superior to a venous structure. Further to this 40 % of patients 
do not have adequate tissue for the procedure due to vascular disease, size mismatch or 
previous procedures. Encompassing these problems creates a market for another source of 
small diameter vascular graft. To date there is still no comparative alternative to the 
autografts and this is reflected by the number of surgeries being performed with alternative 
- 17 - 
grafts compared to autografts. In the UK there are over 37,000 coronary artery replacements 
or bypass grafts each year and nearly all of these surgeries are autografts with saphenous 
vein or thoracic arteries, less than one percent are prosthetic grafts (Table 1.2). 
Table 1.2 : Number and type of coronary artery bypass/replacement procedures.  
Data also includes mean age of patient, adapted from H.S.C.I.C. (2011). 
Procedure description All procedures # Mean age 
Connection of thoracic artery to coronary artery  17,641 67 
Saphenous vein graft replacement 17,640 68 
Other autograft replacement of coronary artery 1,494 65 
Other replacement of coronary artery 284 68 
Prosthetic replacement of coronary artery 18 69 
Allograft replacement of coronary artery 13 64 
Other bypass of coronary artery 6 57 
Aside from graft infection, the significant causes for graft failure have been identified: lack of 
comparable mechanical properties to the native artery such as compliance and strength 
(Tiwari et al., 2003), anastomotic neointimal hyperplasia and lack of an anti-thrombogenic 
endothelial layer. The ideal graft should have mechanical properties that match the native 
artery as well as be non thrombogenic and promote neointimal growth (combination of ECs 
and basement membrane). One factor that has been reported to promote neointimal growth is 
the porosity of the graft material and it has been suggested that the pore size should range 
from large (20-60 µm) at the luminal surface to small (5 µm)  on the adventitial surface in 
order to promote the growth of the vasa vasorum (Sarazin et al., 2004). It is generally thought 
that compliance should be close to that of the surrounding native artery at physiological 
pressures (Zilla & Greisler, 1999; Greenwald & Berry, 2000) which ranges from approximately 
5.9 % diameter change per 100 mmHg for host arteries to 4.4 % diameter change per 100 
mmHg for saphenous vein (Walden et al., 1980). Burst pressure also should be  similar to 
native arteries ranging from approximately 5000 mmHg for carotid arteries to approximately 
2000 mmHg for saphenous vein (Teebken & Haverich, 2002). Ideally vascular grafts should 
also have a long shelf life, and be easily sterilised with the need for minimal preparation time 
prior to operation (Zhang et al., 2007).  
1.4.1 Synthetic SDVG 
The advantages of synthetic grafts are that they can be produced cheaply and have 
consistent microstructures, porosity and strength (Pankajakshan & Agrawal, 2010). 
Unfortunately they lack growth and regenerative potential and have also been reported to 
have a higher potential for infection compared to biological grafts . 
1.4.1.1 PET and ePTFE (Dacron and Terylene, Teflon and Gore-Tex) 
The two most commonly used synthetic materials over the past 50 years are 
polyethyleneterephthalate (PET) (Dacron or Terylene) and expanded polytetrafluoroethylene 
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(ePTFE), (Teflon or Gore-Tex) (Chlupác et al., 2009). When PET or ePTFE have been used 
as SDVGs the patency rates have been found to be significantly lower when compared to 
autografts. There are two main failure modes; Early failure has been reported to develop as a 
result of thrombosis and long term failure from anastomotic intimal hyperplasia. Both modes 
of failure have been recognised to be influenced greatly by the lack of an endothelial layer 
and smooth muscle cell proliferation. Where as in some animal models complete 
endothelialisation of the grafts occurs, in humans the healing process develops a thrombotic 
acellular fibrous lining along the length of the graft and in some cases islands of endothelial 
cells are observed in the mid region, but in general cellular infiltration is limited to a few 
millimetres of outgrowth at the anastomoses (Berger et al., 1972; Sauvage et al., 1974). A 
study of randomised controlled trials of bypasses using PET and PTFE showed no statistical 
difference in patency rates at approximately 60 and 40 % at 2 and 5 years respectively (Roll 
et al., 2008), this is substantially lower than autograft saphenous vein (Figure 1.24). 
Compliance mismatch has been postulated as another reason for failure in SDVG’s. The 
compliance of Dacron and ePTFE are 0.019 and 0.016 % diameter change per mmHg which 
are both low in comparison to host arteries and saphenous vein (Walden et al., 1980). In 
summary PTFE and Dacron are suitable conduits for large diameter grafts but in small 
diameter grafts have suboptimal patency rates in comparison to autografts. A large mismatch 
in mechanical properties compared to native artery tissue and lack of endothelialisation are 
the key reasons for failure. 
 
Figure 1.24 : Primary patency rates of synthetic and autograft saphenous vein at 2 and 5 years. ASV – 
Autograft saphenous vein. 
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1.4.1.2 Polyurethanes 
Over the last ten years polyurethane (PU) has been investigated as an alternative material to 
PET and PTFE due to its increased elasticity and potentially improved biocompatibility (Tiwari 
et al., 2002). The composition of PU can be easily configured to provide polymers of varying 
compliance making it ideal to address the precedence of compliance mismatch in earlier 
synthetic vascular grafts. Unfortunately first generation PU suffered from inconsistent 
biodegradability from oxidative and hydrolytic stresses, leading to aneurysm formation and 
increased thrombogenicity as well as increased infection rates (Brothers et al., 1990). Newer 
generations of PU have been modified either chemically or used in combination with other 
materials in attempts to stabilise their structure to these stresses. In short and long term 
animal models results showed modified PUs developed a layer of complete endothelialisation 
compared to PTFE which became calcified, thrombogenic and developed increased intimal 
hyperplasia (Jeschke et al., 1999; Soldani et al., 2010). Findings like this gave rise to a series 
of clinical trials as kidney dialysis access grafts all achieving subpar patency rates compared 
to PTFE. An ester modified PU arterial graft “Vectra” achieved a primary graft patency of 42 
% at 1 year, a PU arterial graft coated with gelatine and reinforced with knitted polyester 
achieved primary patency rates of 53.2 % at 1 year (Nakagawa et al., 1995) and a PU arterial 
graft “Myolink” went into phase one clinical trials (Tiwari et al., 2002) but has not yet published 
its findings (Desai et al., 2011). To date there has been several clinical trials using PU arterial 
grafts none of which have shown any clear superiority to PTFE or PET synthetic grafts. 
Promising work has been carried forward into improving mechanical properties and 
addressing compliance mismatch issues but PU still suffer from thrombogenic surfaces that 
lack the promotion of a functioning endothelial layer. 
1.4.2 Regenerative Scaffolds 
New approaches in the research and development of vascular grafts aim to develop scaffolds 
which are biodegradable with a view to regeneration in vivo or by seeding of autologous cells 
prior to implantation. In this approach, ideally the scaffold material should degrade at a rate 
that is inversely proportional to the regeneration of an ECM (Figure 1.25) by either seeded 
cells or host cells, thus scaffold materials should attract and promote the growth of cells and 
not induce an immune response. Likewise degradation products of such scaffolds should be 
bio absorbable and non-cytotoxic or -immunogenic (Berglund et al., 2003).  
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Figure 1.25 : Diagram showing how tissue regeneration should take over support from scaffold.  
As a scaffold material degrades over time, so does its load bearing capacity. As the tissue regenerates 
around the scaffold it produces structural proteins such as collagen; this increases its load bearing capacity. 
Image adopted from Berglund et al. (2003) 
1.4.2.1 Biodegradable synthetics 
For biodegradable synthetic scaffolds, degradation rates should be controllable, and the 
scaffold needs to be designed to promote cell growth, without any residual material left after 
regeneration of the ECM. A wide range of synthetic scaffolds have beein investigated 
singularly or as copolymers. These include scaffolds fabricated from polyglycolic acid (PGA), 
polylactic acid (PLA) and poly-L-lactic acid (PLLA), polyє-caprolactone (PCL), polyethylene 
glycol (PEG), polylactic acid-colysine, polyhydroxyalkanoate (PHA), poly-4-hydroxybutyrate 
(P4HB), and polydioxanone (PDS). PGA is the most commonly used biodegradable polymer 
scaffold when its used on its own PGA degrades in the body within two weeks, so is only 
feasible when used as a copolymer (Kannan et al., 2005). There have been animal studies 
using SDVGs such as a PGA-PLA co-polymer and a polydioxanone composite implanted in a 
rabbit aorta model that showed 100 % patency at 1 year (Greisler et al., 1988) and a 
polydioxanone-polypropylene composite implanted in a canine aorto-iliac model that showed 
86% patency at 1 year (Greisler et al., 1991), despite these early results there have been no 
resulting clinical trials. In addition to this biodegradable polymers can require a lengthy 
conditioning times in order to obtain adequate mechanical properties. PGA scaffolds were 
seeded with bovine SMC and EC and subjected to pulsatile conditions in a bioreactor, the 
burst pressure increased from 570 mmHg after 3 weeks to 2150 mmHg after 8 weeks 
(Niklason et al., 2001). Mechanical properties of some polymers have been modified to attain 
UTS and compliance to reach ranges of approximately 1.5 to 7 MPa and 0.012 to 0.056 % 
diameter change per mmHg (Barnes et al., 2007). Poor mechanics, lengthy preconditioning 
times adding to the lack of “off the shelf” availability and limited animal model and clinical 
trials data, highlight the infancy of biodegradable polymers compared to autologous tissue 
and non-biodegradable synthetic materials.   
1.4.2.2 Natural scaffolds 
Natural scaffolds have the advantage that the material is readily accepted by the body and 
potentially remodelled easily in vivo. Natural scaffolds can be fabricated from natural proteins, 
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produced by cells in vitro or generated through the decellularisation of natural human or 
animal tissues.  
1.4.2.3 Collagen scaffolds 
Scaffolds made from collagen have been investigated extensively, since collagen is the major 
structural component of tissues and has low immunogenicity. Early collagen scaffolds were 
shown to support good growth of EC and SMCs, and cells cultured on collagen scaffolds 
were shown to produce ECM proteins; von Willebrand factor (vWF, a protein involved in 
homeostasis primarily preventing blood coagulation) and prostacyclin (PGI2, lipid preventing 
platelet clotting) but lacked sufficient burst pressures (~20-80 mmHg) and were devoid of 
elastin (Weinberg & Bell, 1986). L'Heureux et al. (1993) developed a novel method of 
contracting a collagen gel around central mandrel with cultured human SMCs, followed by 
embedding fibroblasts which increased burst pressures. Tranquillo et al. (1996) used a 
magnetic field to align SMCs embedded in a collagen gel in the circumferential direction to 
better emulate natural cell alignment. Significant improvements to mechanics were made 
when incorporating biodegradable polymers in the scaffolds such as PGA or PLA, in addition  
polymer and SMC embedded collagen scaffolds have shown elastin deposition (Park et al., 
2009). A 2 mm diameter and 1 cm length scaffold comprised of two layers of collagen Type I 
of different pore sizes was seeded with SMCs and ECs. They were implanted into rat vena 
cava and the grafts were harvested at 6 and 12 weeks. After 12 weeks the original collagen 
had been completely degraded and regenerated with neovascular tissue. The implanted 
grafts were shown to have a UTS and modulus close to that of arteries and showed no signs 
of occlusion (Wu et al., 2007). Tillman et al. (2009) developed SDVG using PCL and collagen 
to increase the mechanical properties of the collagen, the implants were used as aorta-iliac 
bypass grafts in rats and were patent at explantation after one month, however, tensile 
properties of the graft reduced over the month with degradation of the scaffold. Scaffolds 
fabricated from collagen alone or with support structures in general, exhibit very low burst 
pressures, scaffolds with increased burst pressures are those that have been seeded with 
cells and conditioned for long periods. This makes collagen an impractical protein for the 
production of arterial scaffolds despite its natural biocompatibility and the reason no long term 
animal or clinical studies have been conducted. 
1.4.2.4 Elastin 
The mechanical properties of elastin make it a vital component of blood vessels, so using it 
as a scaffold has potential benefits. However, scaffolds made of elastin alone have 
demonstrated very small burst pressures (162±36 mmHg). Elastin-only scaffolds are difficult 
to use due to the high insolubility of the protein and have demonstrated weak mechanical 
properties. However, elastin is a necessity within a natural scaffold to achieve compliance 
similar to native arteries.  
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1.4.2.5 Fibrin 
Fibrin is the body’s natural ECM protein involved in wound healing and is easily extracted in 
the form of fibrinogen from blood. Fibrinogen can then be formed into an autologous scaffold 
(Fussenegger et al., 2003). Scaffolds based on SMC embedded fibrin gels have been shown 
to promote increased collagen synthesis compared to scaffolds based on SMC embedded 
collagen gels (Grassl et al., 2002). A 4 mm SDVG was developed (Swartz et al., 2005) from 
fibrin matrix embedded with SMC and ECs. The grafts were implanted as interpositional 
grafts in jugular veins of lambs and explanted after 15 weeks. After the 15 week period 
mechanical properties were low, the tissue was showing good regeneration and remained 
patent. Fibrin-based scaffolds have shown good remodelling of the ECM and production of 
elastin and collagen, but their burst pressures have been reported as far too low, even when 
incorporated with other biodegradable polymers (460 mmHg)(Tschoeke et al., 2009). 
However a fibrin scaffold reinforced with a polylactide mesh, seeded with autologous ECs, 
SMCs and fibroblasts remained patent for six months in sheep carotid arteries (Koch et al., 
2010) after which the polymer mesh was almost completely degraded. 
1.4.2.6 Autologous synthesised ECM scaffolds 
As mentioned previously L’Heureux et al. (1993) developed a novel technique of culturing 
sheets of SMCs and fibroblasts in vitro. Following one month in culture, the seeded SMCs 
and fibroblasts had developed their own ECM. The sheet of SMCs was wrapped around a 
tubular support, then the fibroblast sheet was wrapped around the SMC sheet, after 
maturation of the cells, ECs were seeded on the luminal surface creating a three tiered blood 
vessel. The burst pressure of the vessel was in excess of 2000 mmHg, similar to that of 
native veins, and the endothelium produced vWF and PGI2. They also demonstrated good 
suturability, but they only had a patency rate of 50 % when implanted as femoral arteries in 
the canine model. Further trials as arteriovenous access grafts showed early favourable 
results. One patient died on day 39 due to unrelated cause, a second graft lasted 13 months, 
and a third one failed after 12 weeks, due to low postoperative flow rate. These grafts have 
shown good burst pressures of 3340 ± 849 mmHg and compliance (3.1 to 15.0 % per 100 
mmHg, 2.3 to 6.2 % per 100 mmHg) and developed a working confluent endothelial layer 
(L'Heureux et al., 2007b; McAllister et al., 2009). However, the production of this type of graft 
required a long culture period of over three months, an approach that is not practical nor 
economically viable.  
1.4.2.7 Allogeneic grafts 
Allogeneic grafts that have been investigated for use as SDVG replacements include 
gluteraldehyde treated human umbilical vein and cryopreserved veins. The umbilical vein 
graft is now in its third decade of clinical use and has shown patency rates at 5 years 
comparable with that of saphenous veins (Dardik et al., 1988), initially there were concerns 
- 23 - 
over the glutarladehyde treatment causing increased calcification and aneurism formation, 
though in the second decade of its use aneurysm formation was not to be seen (Dardik et al., 
2002). This was attributed to improved production methods as well as previous aneurysm 
formation being caused by patient related diseases. Despite its clinical success the product 
was taken off the market in 2004 due to changes in FDA regulations on the implantation of 
tissue with respect to source identification and testing, and the consequent affects this had on 
tissue procurement and processing (Dardik 2006). Nevertheless, glutaraladehyde treated 
tissues prevent the ingress of cells and the potential for regeneration of the tissue by host 
cells. Limited clinical trials have been carried out with cryopreserved allograft veins. 
Cryopreserved cadaver femoral veins from Synergraft, (CryoLife, Marietta, GA) were used in 
a clinical trial before being stopped by the FDA, limited results showed no benefit of using the 
graft and that it was potentially aneurismal (Madden et al., 2005).  Cryopreserved saphenous 
vein allografts were intended to reduce antigenicity but have historically underperformed 
(Martin et al., 1994) and no change has been seen in recent studies, achieving  primary 
patency rates of 56 %, 32 % and 17 % at 1,3 and 5 years respectively for infrapopliteal 
bypasses (Randon et al., 2010). Using the L'Heureux et al. (1993) method of fusing sheets of 
fibrolasts and SMCs to form a blood vessel, an allogeneic renal access graft was implanted 
into 3 human patients. The luminal side was partially “devitalised” by dehydration bringing into 
question whether this is an allogeneic graft or decellularised graft. The study reports that host 
immune responses were minimal to the graft and panel reactive antibodies weren’t elevated 
compared to normal allografts that increase levels as much as 80 % at 3 months. It was 
suggested the lack of host response was due to the graft being constructed from cultured 
fibroblasts that don’t express MHCII antigens and no xeneogenic cells present in the tissue. 
Although the paper questions the need for complete decellularisation on this basis. Grafts 
failed at 3 and 5 and 11 months. And in addition it was not a sufficiently large enough trial to 
evaluate patency (Wystrychowski et al., 2014) 
1.4.2.8 Decellularised natural scaffold  
A decellularised natural scaffold is an allogeneic or xenogeneic tissue devoid of all native 
cells, antigens and cellular debris including the genetic material, leaving only the structural 
materials of ECM matrix providing a natural histo-architecture retaining similar mechanical 
integrity to the desired tissue.  
The main cause of failure in allogeneic grafts is typically acute rejection initialising a few days 
post-surgery. The response is primarily governed by the adaptive immune system; firstly 
alloantigens must be presented to CD4+ T-lymphocytes in the appropriate context, secondly 
activation of lymphocytes and in turn an exponential proliferation and differentiation of 
lymphocytes. It is this activation, proliferation and differentiation that cause a time delay in the 
response. Alloantigen recognition is enabled through three pathways (Figure 1.26) direct, 
indirect and semi direct (Ponticelli, 2012). Recognition in the direct pathway is facilitated by 
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donor antigen presenting cells (APC). The donor APCs migrate to secondary lymphoid tissue 
and present donor MHCs/peptides to CD4+ and CD8+ T-cells. The indirect pathway is 
facilitated by recipient APCs engulfing donor MHCs that were shed during apoptosis or 
necrosis of donor cells. Epitopes of the donor MHC are presented on recipient APC MHCs. 
The recipient APCs then migrate to the secondary lymphoid tissue and present donor 
peptides on recipient APC MHCs to CD4+ T-cells. The semi direct pathway is facilitated by 
transfer of intact donor MHCs/peptides to recipient APCs via cell-cell contact or exosomes. 
Recipient APCs then migrate to the secondary lymphoid tissue and present donor 
MHC/peptides and recipient MHC with donor peptides to CD4+ and CD8+ T-cells. Once 
CD4+ T-cells become activated using interleukin 2 they then help activate the clonal 
expansion of CD8+ T-cells specific to donor epitopes and B-cells specific to donor antigens. 
Cytotoxic CD8+ T cells, helper CD4+ T-cells and alloreactive antibodies then migrate to the 
donor site causing a considerable inflammatory response. The cell-mediated effector cells 
combined with activation of elements from the innate immune response result in necrosis and 
failure of the donor graft (Sagoo et al., 2012). Donor APCs eventually subside and chronic 
rejection can occur through indirect or semi-direct pathways. 
 
Figure 1.26 : Antigen recognition in acute rejection, depicting the direct, indirect and semi-direct  
pathway.  
The direct pathway is an immune response initiated by the graft APC’s and MHC/antigen complexes. The 
semi-indirect pathway is an immune response initiated by host APC’s and graft MHC/antigen complexes. The 
indirect pathway is an immune response initiated by the host APC’s and MHC’s which form complexes with 
the donor antigens. Image adapted from Sagoo et al. (2012). 
The main cause of failure in xenogeneic grafts is the result of a mixture of intense hyperacute 
and the aforementioned acute rejection. The hyperacute rejection is governed by the humoral 
immune system; complement activation is mediated by xenoreactive natural antibodies 
(XNAs). The intense inflammatory response is due to a high content of IgG and IgM 
antibodies specific to the galactosyl-α(1,3)galactose (αGal) epitope. The anti-αGal antibodies 
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are the major initiator in the complement activation pathway. The αGal epitope is expressed 
on membrane glycoproteins and glycolipids on xenogeneic cells but is not expressed in 
humans or old world monkeys (Galili & Swanson, 1991). The high antibody titres are thought 
to be due to constant exposure to intestinal bacteria expressing the αGal epitope. Tissues 
and organ grafts require a blood supply to maintain cells, the antibodies bind to αGal epitopes 
on the endothelial cells activating the complement activation process; this causes thrombosis 
of the vasculature leading to oxygen depleted cells and necrosis in the graft ultimately 
resulting in failure (McPherson et al., 2000). Following the hyperacute rejection response, 
acute vascular rejection may develop within days or weeks, similar to that of the acute 
rejection in allogeneic grafts, the complete mechanism is not understood however the 
synthesis of XNAs has an important role (Parker et al., 1996).  It is therefore essential to 
remove donor cells from allogeneic and xenogeneic grafts to avoid graft rejection response. 
In particular for vascular grafts it is also important to remove all nuclear material in the 
decellularisation process. Firstly as an indicator that the cellular remnants are being removed 
and secondly because DNA is a contributing factor to calcification (Shanahan, 2013). 
Glutaraldehyde fixation is used on porcine bioprosthetic heart valves (and other xenografts) in 
order to reduce the immunogenicity of the grafts; the main cause of failure of glutarladehyde 
fixed grafts is calcification (Schoen, 1987). Fixation causes rupture of the donor cells but 
cellular debris is retained in the graft (Courtman et al., 1994) these cell remnants (Valente et 
al., 1985) and cell membranes (Maranto & Schoen, 1988) have been linked to increased 
calcium deposition caused by the release of phosphate from the phospholipid bilayer and 
other cell debris including DNA and RNA (Neven & D'Haese, 2011). Decellularised scaffolds 
have been shown to have less calcification formation compared to fresh and gluteraldheyde 
fixed tissues (Vesely et al., 1995), but incomplete decellularisation can lead to rapid failure of 
grafts with increased calcification. SynerGrafts model 500 and 700 decellularised porcine 
heart valves failed rapidly in clinical trials and the product withdrawn. Of the four implanted, 
one lasted 1 year post operatively, the explant had been encapsulated and showed signs of 
calcification. The valve was shown to have incomplete decellularisation causing activation of 
the hyperacute response, they postulate that the calcification was nucleated by the collagen 
matrix itself but it may also have been compounded by the presence of foreign nuclear 
material (Simon et al., 2003). 
The removal of αGal epitopes and xenoreactive species in xenogeneic grafts and alloreactive 
species in allogeneic grafts as well as the complete removal of foreign DNA should allow 
tolerance of the scaffold with minimal calcification; this is the basic premise of decellularised 
scaffolds. Therefore decellularisation technique itself is crucial to the success of the implant; 
whilst causing minimal damage to the ECM matrix the process must remove all immunogenic, 
calcific and thrombogenic material of the donor (Wilshaw et al., 2012).This also subsequently 
makes it difficult to assess the constituents of the graft.  Varying types of chemical and 
enzymatic agents have been used alongside physical conditions to achieve decellularisation ( 
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Table 1.3).  
 
 
 
Table 1.3:Physical, Chemical and Enzymatic Methods of Decellularisation. 
 Extra cellular matrix (ECM), glycosaminoglycan (GAG), sodium dodecyl sulphate (SDS), adapted from 
Gilbert et al. (2006). 
Method Mode of action Effects on ECM 
Physical   
Snap Freezing Intracellular ice crystals disrupt cell 
membrane 
ECM can be disrupted or fractured 
during rapid freezing 
Mechanical agitation Can cause cell lysis, but more 
commonly used to facilitate 
chemical exposure and cellular 
removal 
Aggressive agitation or sonication 
can disrupt ECM as the cellular 
material is removed 
Chemical 
  
Acid Solubilises cytoplasmic components 
of cells: disrupts nucleic acids 
Removes GAGs 
Non-Ionic detergents 
Triton X-100 
Disrupts lipid-lipid and lipid protein 
interactions, while leaving protein-
protein interactions intact 
Mixed results: efficiency dependant 
on tissue, removes GAGs 
Ionic detergents: 
Sodium dodecyl 
sulphate 
(SDS) 
 
Sodium deoxycholate 
Triton X-200 
Solubilises cytoplasmic and nuclear 
cell membranes, tends to denature 
proteins 
Removes nuclear remnants and 
cytoplasmic proteins: tends to 
disrupt native tissue structure 
 
 
More disruptive to tissue than SDS 
Yielded efficient cell removal when 
used with zwitterionic detergents 
Zwitterionic 
detergents 
CHAPS 
Exhibit properties of non-ionic and 
ionic detergents 
Efficient cell removal with ECM 
disruption similar to that of Triton X-
100 
Hypertonic and 
hypotonic solutions 
Cell lysis by osmotic shock Efficient for cell lysis, but does not 
effectively remove cellular remnants 
EDTA / EGTA Chelating agents that bind divalent 
metallic ions thereby disrupting cell 
adhesion to ECM 
No isolated exposure, typically used 
with enzymatic methods 
Enzymatic 
  
Trypsin Cleaves peptide bonds on C-side of 
Arg and Lys 
Prolonged exposure can disrupt 
ECM. Removes laminin, fibronectin, 
elastin and GAGs 
Nucleases Catalyse hydrolysis of interior and 
terminal bonds of ribonucleotide 
and deoxyribonucleotide chains 
Difficult to remove from the tissue 
and could invoke an immune 
response 
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These agents and conditions need to be optimised specifically to the properties of a particular 
tissue (Badylak et al., 2009).  The small intestinal submucosa (SIS) was one of the early 
decellularised scaffolds that has been used as a vascular graft (Lantz et al., 1993). Lantz et 
al. (1990) used SIS in the replacement of 36 canine carotid and femoral arteries, and overall 
graft patency over 82 weeks was 75 %.  Of those that remained patent no infections, thrombi 
or intimal hyperplasia were observed, although 4 grafts showed aneurismal dilation. Huynh et 
al. (1999) developed acellular 4 mm SDVGs made from the intestinal collagen layer of the 
SIS material impregnated with a thin layer of type I bovine collagen, they were also treated 
with heparin and cross-linked. Eighteen grafts were implanted into rabbit carotid arteries and 
all grafts remained patent at explant periods of 28, 53 and 90 days. Remodelling of the 
arteries was demonstrated and burst pressures were lower than adequate 931±284 mmHg.  
Zhao et al. (2010) also developed SDVGs by seeding decellularised ovine carotid arteries 
with mesenchymal stem cells and ECs then implanting them into ovine carotid arteries. The 
implants attained burst pressures of 1800 mmHg, all the grafts were patent after 5 months 
and had developed an endothelium layer as well as smooth muscle, collagen and elastin. 
Schaner et al. (2004) decellularised human saphenous vein, the grafts of 7mm diameter were 
implanted as canine carotid interposition grafts and explanted after 2 weeks. The grafts 
showed an intact basement membrane, burst pressures of 2380 ± 620 mmHg and were all 
patent at explantation. A decellularised bovine ureter scaffold was also developed for use as 
a haemodialysis access graft which has been shown to be less immunogenic than 
cryopreserved allografts (Madden et al., 2002). Assessment of explants of failed bovine 
ureters produced by their proprietary Synergraft™ technique showed that the implants 
contained residual cells and residual αGAL epitope leading to graft failure, aneurismal dilation 
and thrombosis (Spark et al., 2008), and had a primary patency rate of 14 % at 1 year (Das et 
al., 2011). A clinical study of decellularised cross-linked Artergraft Bovine Carotid Arteries™ 
showed primary patency rates of 60.5 %, compared to 10.1 % in PTFE, however secondary 
patency rates were not significantly different  (Kennealey et al., 2011). Decellularised 
scaffolds have been shown to mimic native mechanical properties but limited clinical trials 
have been conducted. Decellularisation methods are still under optimisation to achieve 
complete decellularisation including calcification factors and immunogenic epitopes whilst 
maintaining a functional histo-architecture, some success has been shown in progressing 
from synthetic grafts but not to the desired level of competing with autografts. 
1.4.2.9 Overview of Small Diameter Vascular grafts 
Autologous vein remains the gold standard for SDVG replacement, usually the saphenous 
vein, studies have highlighted that preferentially an arterial autograft would be superior to 
venous autograft but are not as abundant or replaceable as veins. The long history using 
standard synthetic replacements such as Dacron and ePTFE may be improving surgeon 
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experience and increasing patency rates but are still a long stretch from meeting the same 
standard as autografts. PU replacements are yet to be seen as a practical alternative and 
have shown substandard results to date. In the field of biodegradable synthetics a large 
range of polymer compositions are being tuned to reach desired mechanical properties and 
porosities although to attain this, long preconditioning times have been needed in some 
cases making them an unrealistic off the shelf product. Similar to biodegradable scaffolds 
natural scaffolds of collagen, elastin and fibrin require composite scaffolds in order to attain 
desired characteristics and the development of a potential off the shelf product seems 
unlikely in the near future. The allogenic glutaralaldehyde treated scaffolds experienced over 
thirty years of clinical use and patency rates comparable to saphenous vein but there have 
been concerns over aneurismal formation from the grafts and increased calcification 
commonly associated with gluteraladheyhe fixed tissues. The use of cryopreservation is also 
providing a limited increase to the potential of allogeneic grafts and has not sufficiently 
reduced antigenicity. Decellularised scaffolds have shown the ability to retain natural 
architecture and mechanics. Clinically trialled products being used have received mixed views 
and failed grafts contain residual cells and immunogenic agents suggesting that complete 
decellularisation is not being fully achieved. A competent clinical solution has not yet been 
developed and ASV remains the gold standard for SDVG.  
1.4.3 Mechanical Concepts and their role in Vascular Grafts 
Determination of the mechanical properties of vascular grafts is an important aspect to be 
considered. In order for a graft to be suitable for use it should have adequate strength to 
resist extremes of physiological pressure it should also have a compliance similar to that of 
analogous tissue. Compliance mismatch has been attributed to failure in vascular grafts. A 
graft that is too compliant is likely to stimulate aneurysm formation and an artery that it is non-
compliant promotes intimal hyperplasia leading to occlusion of the graft. Too weak a material 
and the graft may rupture. 
1.4.4 Compliance 
Compliance in its simplest form is the relative change in volume to change in pressure. A 
compliant vessel subjected to the equal pressure will dilate more and accommodate an 
increased volume compared to a non compliant vessel. This relationship is described as: 
Equation 1-1              𝑪 = ∆𝑽/∆𝑷 
Veins for example are more distensible than arteries and therefore under the same pressure 
expand more and allow a larger volume of blood to pass through the vessel (Figure 1.27). 
The relationship between pressure, lumen size, wall thickness and wall stress can be 
described by an adaption of Laplace law (Westerhof et al., 2010): 
Equation 1-2               𝝉 = 𝑷𝒓/𝒘 
Where r is the lumen radius and w the wall thickness. This relationship demonstrates how a 
vessel will increase its wall thickness when subjected to increased pressure and lumen radius 
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to maintain wall normal shear stress and is postulated as one of the causes contributing to 
intimal thickening. 
 
Figure 1.27 : Relationship between vein and artery wall thickness, volume and pressure. 
Image adopted from www.columbia.edu (2011) 
 
In clinical applications often the dynamic compliance is calculated in the physiological ranges 
using systolic and diastolic diameters and pressures, described as: 
Equation 1-3      𝑪 =  
(𝑫𝒔 −  𝑫𝒅)
𝑫𝒅(𝑷𝒔 − 𝑷𝒅)
   
The value is converted to a percentage and presented as percentage compliance per 
millimetre of mercury (% mmHg-1 ) (Schmitz-Rixen et al., 1993). In static compliance it is 
possible to calculate the circumferential (CC),  longitudinal (LC),  cross-sectional (XC) and 
volumetric compliance (VC)(Salacinski et al., 2001) as well as the physiological compliance. 
These can be calculated incrementally, cumulatively or over the physiological range as 
described below, where D = diameter, L = length, A = area, V = volume and 2 and 1 
represent final and initial respectively: 
Equation 1-4 𝐶𝐶 =
(𝐷2 − 𝐷1)
𝐷1(𝑃2 − 𝑃1)
 
Equation 1-5 𝐿𝐶 =
(𝐿2 − 𝐿1)
𝐿1(𝑃2 − 𝑃1)
 
Equation 1-6 𝑋𝐶 =
(𝐴2 − 𝐴1)
𝐴1(𝑃2 − 𝑃1)
 
Equation 1-7 𝑉𝐶 =
(𝑉2 − 𝑉1)
𝑉1(𝑃2 − 𝑃1)
 
There have been many studies into the effects of compliance mismatch in reference to 
vascular grafts and its contribution to graft failure. It is now widely accepted that non-
compliant (stiffer) grafts in comparison to the host artery at the site of implant contribute to the 
increase in intimal hyperplasia/thickening and grafts that are excessively compliant can 
become aneurysmal. Intimal hyperplasia is an increase in thickness of the intima causing 
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reduced lumen diameter; it is characterised by the migration of smooth muscle cells into the 
tunica media and the subsequent generation of extra cellular matrix (Newby & Zaltsman, 
2000; Mitra et al., 2006). 
Generally vascular bypass graft surgery utilises end to side attachment (Figure 1.28 at the 
anastomoses compared to end to end and this should be taken into consideration when 
comparing models on intimal hyperplasia formation. End to end anastomoses experience far 
less intimal hyperplasia than end to side anastomoses, so end to end models can provide 
conflicting results. A computational model of end to end and end to side anastomosis which 
simulated grafts of decreasing compliance has shown how peak stresses occur at suture 
penetrations and the suture line. In end to end anastomoses there is no significant difference 
in stress regardless of graft compliance. In models of end to side anastomoses, decreasing 
graft compliance from native arteries to the compliance of Dacron increases mean stress by 
40 % providing evidence that excessive stress at sutures could be a signal transduction 
mechanism that is increased in end to side anastomoses (Ballyk et al., 1998).  
Animal models using the end to side technique of implanting various vascular graft materials 
have shown that intimal hyperplasia occurs preferentially to the toe and heel regions of the 
distal anastomosis and the bed of the host artery opposing the outflow of the graft. The 
amount of intimal hyperplasia was constant on the host bed irrespective of material, the heel 
and in particular the toe region was significantly larger in less compliant grafts. This supports 
that the less compliant grafts contribute to the pathogenesis of distal anastomosis intimal 
hyperplasia, but also that a second model, haemodynamics has more influence on bed 
formation of intimal hyperplasia (Sottiurai et al., 1989; Bassiouny et al., 1992; Trubel et al., 
1994). On the bed floor of the host artery opposite the graft outflow, a stagnation point occurs 
creating areas of low shear stress. It is at these areas of low shear stress and long particle 
residence times that create conditions suitable for intimal hyperplasia (Morinaga et al., 1985); 
The importance of compliance as a factor was further confirmed, as one of the animal models 
used solely autograft tissue and simulated compliance by wrapping an external mesh around 
the graft, this provided end to side anastomosis and varying levels of graft compliance whilst 
eliminating an immunogenic/foreign body response as a dominating factor of intimal 
hyperplasia (Trubel et al., 1994). It is also important to note that that compliance mismatch 
alone is not sufficient to initiate intimal hyperplasia and surgical healing at an anastomosis is 
required this was identified in an end to end simulation where external occlusion was induced 
in an animal model (Okuhn et al., 1989). 
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Figure 1.28 : End to side anastomosis.  
Image adapted from Ballyk et al. (1998) 
The majority of aneurysm formation in relation to bypass grafts is pseudo aneurysms forming 
at the anastomosis due to pooling of blood from poor suture technique, however less 
compliant arteries have not been considered for implantation due to the likelihood of 
aneurysm formation so minimal literature is available to review this. Late onset of true 
aneurysms occurred in a small number of Dacron grafts where the material has stretched due 
to material fatigue and degradation (Khaira & Vohra, 2002; Van Damme et al., 2005). The 
relationship of increased compliance and true aneurysm formation is supported by literature 
investigating aneurysm formation by enzymatic removal of collagen from arteries, this results 
in an increase in artery compliance and aneurysm simulation (Hamilton et al., 1988). 
1.4.5 Stress Strain 
When subjected to stress-strain analysis there is a non-linear elasticity in blood vessels 
(Figure 1.29). The non-linearity is due firstly to the elastin bearing the load and causing large 
deformations (elastin phase). Subsequently, as the weight bearing is transferred to the 
collagen in the transition phase, the collagen begins to un-crimp, eventually bearing the entire 
load. At this point the strength of the collagen can be observed with small deformations with 
increased load (collagen phase). If the collagen is stretched further, failure will occur. If the 
tissue is unloaded [before it fails] it will return to its original dimension, showing elastic 
mechanical properties. However, unloading does not follow the same path as loading. This is 
called hysteresis and is a result of the viscoelastic properties. Blood vessels are highly 
anisotropic, demonstrating different stress-strain behaviour when loaded along perpendicular 
axes (Meyers et al. 2008).  
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Figure 1.29 : Stress-Strain behaviour of an artery during loading and unloading.  
Image adapted from Fung (1993) 
1.5 Sterilisation of Medical Devices 
Although there is a large emerging research focus on SDVG there is very little investigation 
and mention of the sterilisation process that must inevitably be carried out. For any medical 
device or tissue engineered implant intended for clinical use, sterilisation is essential. 
Microorganisms such as viruses and bacteria can be present in the implant or contaminate 
the implant during processing/production and they have the potential to infect the recipient, 
with potentially life threatening consequences as well as cause failure of the implant. Terminal 
sterilisation is the process of killing or inactivating all types of microorganisms prior to storage, 
transfer or use of an implant  in order to prevent infection or transmission of diseases (Nather 
et al., 2007). 
1.5.1 Micro-Organisms 
Microorganisms can be subdivided into unicellular forms and noncellular forms. Unicellular 
microorganisms may be eukaryotes or prokaryotes. Eukaryotes have a cell nucleus whereas 
prokaryotes do not. Examples of eukaryotic microorganisms are fungi and protozoa, 
prokaryotes are microorganisms such as bacteria and archaea. Noncellular microorganisms 
such as viruses rely on the host cell to survive 
1.5.1.1 Gram positive and Gram negative bacteria 
Bacteria may be categorised into two groups Gram positive and Gram negative bacteria. 
They are distinguished using a staining method (Gram stain). In general Gram-positive 
bacteria have a much denser cell wall rich in peptidoglycans compared to Gram negative 
bacteria. It is this compositional difference that allows the differentiation of Gram-positive and 
negative bacteria in the Gram stain. Also specific to Gram positive bacteria are teichoic and 
teichuronic acids present in some cell walls. In general Gram negative bacteria have a thin 
layer of peptioglycans in the cell wall, far less dense than Gram positive bacteria, this layer is 
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connected by lipoproteins to an external outer membrane, the space between the two layers 
is called the periplasm. The outer membrane is similar in structure to that of the cytoplasmic 
membrane but additionally contains lipopolysaccharides, these are part of endotoxins and a 
play a role in bacterial infection. 
1.5.1.2 Mycobacteria 
Mycobacteria typically stain Gram positive and are then further differentiated using an acid-
fast stain. Their cell wall has a unique hydrophobic structure creating a strong permeability 
barrier. This barrier effectively gives a higher resistance to biocides and antibiotics. 
1.5.1.3 Viruses 
Viruses are non-cellular micro-organisms. They are small (less than 5 µm), obligate 
intracellular parasites. Viruses cannot survive on their own and require the use of prokaryotic 
and eukaryotic host cells in order to replicate. There are many different virus structures, and 
for the purpose of this discussion of biocides they will be classed into two categories, 
enveloped and non-enveloped viruses. Common to all viruses is a central nucleocapsid made 
up of single or double stranded RNA or DNA encircled by a protein capsid built of units called 
capsomers. Non-enveloped viruses are limited to this structure and are considered 
hydrophilic. Enveloped viruses have an additional external lipid bi-layer membrane, providing 
protection and aiding attachment to target cells.  
Although there are many differences between viruses, there a several common stages  
followed by viruses during the course of viral replication: attachment to the host cell, 
penetration, synthesis of biological molecules, assembly and release. Firstly in order to enter 
a cell the virus must attach to the cell surface, this is assisted by specific proteins on the 
capsid or lipid bilayer membrane. These proteins interact with specific receptors on the target 
cell surface, so the type and number of these receptors determines the sensitivity of the cell 
to infection by a particular virus. Once the virus is attached it must penetrate the membrane 
of the target cell. There are varying mechanisms by which viruses do this, the virus can inject 
or release the nucleocapsid/nucleic acid into the cell or another method is to be endocytosed 
or fused into the cell, common in enveloped viruses. 
Now within the host cell the virus replicates its nucleic acid using the cells biochemical 
pathways and synthesises specific viral proteins to allow the virus to replicate itself. Viral 
replication continues until the cell bursts or lyses to release its viral particles or alternatively 
the virus uses the host own cell membrane to form its own viral envelope in a process called 
budding, this process eventually results in cell death of the host cell. Some viruses have the 
capacity for latency by incorporating their genetic information into the host genome. The 
genetic information may then be replicated as the host cell divides. The virus may reactivate 
at a later stage. 
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1.5.1.4 Prions 
Prions are proteins which have no cellular component and have no recognisable form of 
associated nucleic acid. Prions are abnormal forms of normal cellular proteins. The normal 
and abnormal forms have the same primary structure but they differ in their secondary or 
tertiary structure. It is this change in conformation of the protein that prevents the abnormal 
form from being degraded in the body and this can lead to accumulation of the protein 
causing cellular and tissue pathology.  Prions in particular affect neural tissues and can 
accumulate to form amyloid deposits on the brain. Although prions are very resistant to 
sterilisation they are a very rare cause of disease. 
1.5.2 Microbial Susceptibility To Sterilisation 
Due to the different composition and structure of microorganisms, they have different 
susceptibility to sterilisation processes and antibiotics. A general guide to the order of 
sterilisation resistance is as follows, starting with the most resistant; prions, bacterial spores, 
mycobacteria, small non-enveloped viruses, Gram negative bacteria, large non-enveloped 
viruses, Gram positive bacteria, enveloped viruses (Table 1.4) 
Table 1.4 : Micro-organisms in order of sterilization resistance.  
Adapted from McDonnell (2007) 
Resistance Microorganism Examples 
 Prions Scrapie, Creutzfeldt-Jakob disease, chronic 
wasting disease 
 Bacterial Spores Bacillus, Geobacilus, Clostridium 
 Protozoal oocysts Cryptosporidium 
 Helminth eggs Ascaris, Enterobius 
 Mycobacteria Mycobacterium tuberculosis, M. terrae, M. 
chelonae 
 Small, nonenveloped viruses Poliovirus, parvoviruses, papillomaviruses 
 Protozoal cysts Giardia, Acanthamoeba 
 Fungal spores Aspergillus, Penicillum 
 Gram-negative bacteria Pseudomonas, Providencia, Escherichia 
 Vegetative fungi and algae Aspergillus, Trichophyton, Candida, 
Chlamydomonas 
 Vegetative helminthes and protozoa Ascaris, Cryptosporidium, Giardia 
 Large, nonenveloped viruses Adenoviruses, Rotaviruses 
 Gram-positive bacteria Staphylococcus, Streptococcus, 
Enterococcus 
 Enveloped viruses Human immunodeficiency virus, Hepatitis B 
virus, Herpes simplex virus 
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1.5.3 Sterility Assurance and Biological Indicator Organisms 
In healthcare applications products that interact with broken/damaged skin, normally sterile 
tissue or are implanted surgically require a sterility assurance level (SAL) of 10-6 (ANSI, 
2011). This is the probability that from a bio burden of 106 colony forming units (CFU) a 
sterilization technique can reduce the bio burden to less than one in a million (6 log 
reduction). 
The bacteria which are most resistant to a particular sterilisation process are used as an 
indicator of sterilisation efficacy. Sporulating bacteria are generally more resistant such as 
Bacillus atrophaeous and Bacillus pumilus spores. A list of standard indicator organisms  for a 
particular sterilisation process is shown in (Table 1.5). 
Table 1.5 : Sterilisation processes and their indicator organism. 
(Parisi & Antoine, 1974; Europe, 2004; F.D.A, 2007) 
Sterilisation method Indicator organism 
Steam Geobacillus stearothermophilus  
Dry Heat Bacillus atrophaeus 
ethylene Oxide  Bacillus atrophaeus  
Liquid Hydrogen Peroxide  Bacillus atrophaeus 
Gaseous Hydrogen Peroxide  Geobacillus stearothermophilus  
Liquid and Gaseous Peracetic Acid  Geobacillus stearothermophilus  
Irradiation Bacillus pumilus  
1.5.4 Viral Clearance and Porcine Model Viruses 
For any product using animal tissue or their derivatives there is a risk of zoonotic 
contaminants, it is therefore required that the sterilisation process is assessed and validated 
against model viruses endogenous to the particular tissue (EMA, 1996; ICH, 1997; ISO, 
22442-3:2007).  
For porcine tissue the following viruses (Table 1.6) are often investigated 
Encephalomyocarditis (EMC), porcine parvovirus (PPV), porcine reovirus, porcine 
pseudorabies virus (PRV) and murine leukemia retrovirus (LRV). Murine leukemia retrovirus 
is often used as a representation of porcine endogenous retroviruses due to the lack of robust 
assays to detect porcine endogenous retroviruses (Hodde & Hiles, 2002). 
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Table 1.6 : Common model viruses used for porcine tissue. 
Virus Host  Genome Envelope Size Family 
Pseudorabies (PRV) Porcine dsDNA   120-200 nm Herpesviridae 
Parvovirus (PPV) Porcine ssDNA 𝒙 18-24 nm Parvoviridae 
Endogenous retrovirus 
(PERV) 
Porcine ssRNA   80-100 nm Retroviridae 
Leukemia retrovirus 
(LRV) 
Porcine ssRNA   80-110 nm Retroviridae 
Encephalomyocarditis 
(EMC) 
Porcine ssRNA 𝒙 20-30 nm Picornaviridae 
Reovirus Porcine dsRNA 𝒙 60-80 nm Reoviridae 
 
It is accepted that for viral clearance a 6 log reduction must be achieved for sterility and that 
the log reduction effect of individual steps of a process is cumulative. Since various 
microorganisms are more or less susceptible to sterilisation, a common method of 
measurement must be applied to compare the efficacy of the process. These are commonly 
suspension tests and the most widely used is the determination of the D-value (also known as 
Time-Kill). A basic D-value test involves subjecting a known concentration of the indicator 
organism to the sterilisation process for a length of time, over which at intervals, samples are 
removed to determine the population density of microorganisms remaining. This data can 
then be used to calculate the reduction in the population density of the microorganisms . A D-
value is the time it takes to reduce the population by 90% (1 log unit) under a given set of 
conditions. 
1.5.5 Sterilisation Techniques for Soft Tissues 
The two main branches of sterilisation are chemical and physical sterilisation. Physical 
sterilisation incorporates thermal treatments such as moist heat, dry heat and tyndallisation 
and non-thermal techniques such as filtration, osmotic pressure, ionising and non-ionising 
radiation. Chemical sterilisation includes various treatments or process with chemicals such 
as aldehydes, halogens, alcohols, phenolics, heavy metals, quaternary ammonium 
compounds and oxides/peroxides. The type of sterilisation technique implemented is 
dependent on the application, more vigorous techniques may be applicable for sterilisation of 
equipment but not for use on heat or pressure sensitive tissues and medical devices, 
therefore the choice of technique is a balance between microbial killing efficacy and 
compatibility with the product. A list of some of the desired properties is shown below (Table 
1.7). 
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Table 1.7 : Desired attributes for a sterilisation process 
Desired attributes for a sterilisation process 
 Activity against a wide range if not all microorganism 
Rapid activity 
Efficacy in the presence of contaminating organic or inorganic materials which can inhibit activity 
No residual cytotoxic, mutagenic or carcinogenic effect 
Minimal alteration to mechanical or biological structures 
 
1.5.6 Chemical Sterilisation Methods 
1.5.6.1 Ethylene oxide 
There has been a long practice of ethylene oxide (EO) sterilisation in industry as a result of its 
bactericidal and virucidal ability (Phillips & Kaye, 1949; Jordy et al., 1975), because of this 
popularity it has since made its transition into sterilisation of tissue engineered products. The 
majority of recent studies are on the effects on bone and tendon allografts, though there are 
also studies on its effects on dura mater, fascia lata, aortic wall and sub intestinal 
submucosa.  
EO is highly reactive and combusts spontaneously in just 3 % air, it also has a high diffusivity 
allowing deep penetration. Its mechanism of action is direct alkylation; it replaces hydrogen 
atoms within a susceptible functional group with a hydroxyethyl radical. This process results 
in cross-linking between functional proteins, enzymes and nucleic acids, leading to damage 
of virus and cell structures and function, eventually causing inactivation. 
Bactericidal ability at low temperatures (30 - 40 oC) has been demonstrated by inactivation of 
Bacillus subtilis (Ijiri et al., 1994), Bacillus atrophaeus (Bacillus subtilis var. niger) strips 
sandwiched between freeze-dried skin, dura mater, amnion, cortical and cancellous bone 
(Kearney et al., 1989; Kearney et al., 1993). 
Few studies have investigated virucidal ability but it has been demonstrated at low 
temperatures (~30 oC) by spiking non freeze-dried musculoskeletal tissues with HIV-1, bovine 
viral diarrhea, reovirus type 3, duck hepatitis B, poliomyelitis, canine parvovirus, all achieving 
complete inactivation (Moore et al., 2004). 
It is also well known that EO leaves toxic residuals in the material being sterilised, such as 
ethylene chlorohydrin (ECH) in the presence of chloride ions, and ethylene glycol (EG) 
formed by its reaction with water; both are considered mutagenic and carcinogenic 
(Vangsness et al., 2003). The maximum dose of EO and ECH due to a permanently 
implanted medical device is described in ISO 10993-7:2008, a maximum dose for EG is not 
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set, as sufficient control of EO residues will prevent formation of EG (ISO, 10993-7:2008 ). 
Various methodologies have been introduced to reduce toxic residues. Pre sterilisation, a 
defatting treatment such as a chloroform and methanol wash (Arizono et al., 1994) or 
irrigation with deionised water (Prolo et al., 1980) followed by a prolonged freeze drying 
period. Post sterilisation, prolonged aeration (Kakiuchi et al., 1996) and rinsing with saline 
solution (500 ml for 10 minutes) is used before implantation (Kaku et al., 2002).  
The extent of EO residuals on cytotoxicity has been investigated in various studies. Arizono 
et al. (1994) measured mean concentration of EO residuals by gas chromatography in human 
femoral head chips subjected to either defatting, freeze drying and EO sterilisation or 
defatting and EO sterilisation. The process including freeze drying had a mean concentration 
of 2.61 ± 1.3 ug/g of EO and the process without freeze drying had a mean concentration of 
18.1 ± 3.8 ug/g of EO. Cytotoxicity was determined by quantification of fibroblasts grown in 
medium shaken with each type of bone chips. Fibroblast growth was inhibited by both groups 
compared to non EO sterilised bone chips. Fibroblast number reduced by 22 % when 
incubated with the freeze dried group compared to 43 % reduction when incubated with the 
non-freeze dried group. This is an indication of the impact of freeze drying on EO sterilised 
products. Jackson et al. (1990) found that 6.4 % of patients with freeze dried EO sterilised 
bone-patellar tendon-bone allografts developed a chronic inflammatory intraarticular reaction 
that subsided when the grafts were explanted. It was not determined if the inflammatory 
response was a result of allosensitisation or EO residuals. In response, Lomas et al. (2001) 
found that microparticles from EO sterilised mineralised and demineralised bone matrices 
incited an inflammatory response in-vitro and not ECH residuals. Similarly EO and Gamma 
sterilised chitosan membranes showed no cytotoxic effect on Vero cells in-vitro (Marreco et 
al., 2004). 
The effects on mechanical properties by EO sterilisation and the difference in the effects 
between hard and soft tissues is still in contention. Smith et al. (1996) showed that repetitive 
freeze thaw cycles significantly decreased the collagen modulus in tendons (possibly due to 
autolysis), but subsequent freeze-drying and freeze-drying then EO sterilisation did not further 
alter properties and that no step significantly altered the UTS. It is important to note that 
immediate freezing after dissection has been shown not to significantly affect the mechanical 
properties of tendon (Ker, 1981). Similarly Bechtold et al. (1994) found no significant 
differences in UTS between frozen, frozen/freeze-dried and frozen/freeze-dried/EO sterilised 
tendon however, a significant decrease in collagen modulus was found after freeze-drying 
tendon from a frozen state, and then a return to non-significantly different levels collagen 
modulus after EO sterilisation. This could suggest that the freeze drying process was 
damaging collagen and then the EO sterilisation process was causing cross-linking to mask 
the damage. Olde Damink et al. (1995) showed that EO reacted with the amino-groups in 
dermal sheep collagen, increasing the pH and decreasing the helical stability of the collagen 
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as shown by the resulting decrease in shrinkage temperature, however no significant 
differences were found in tensile strength before or after EO sterilisation. 
Due to the prevalence of negative publications on EO sterilisation on tissue regarding 
cytotoxicity and mechanics, tissue banks have decreased EO sterilisation and leaned towards 
ionising radiation. However modern techniques and improved equipment can reduce residual 
levels and potentially reduce or eliminate cytotoxic effects. The effects of EO sterilisation on 
mechanical properties for different tissues must be investigated individually as different 
tissues have different structures and different susceptibilities to EO, in addition the necessity 
to use a freeze-drying process may cause differing levels of damage to a particular tissues 
structure. This may be of particular concern to vascular tissues where compliance is a 
significant factor in graft failure.  
1.5.6.2 Hydrogen peroxide 
Hydrogen peroxide (H2O2) is a powerful oxidising agent, it is a broad spectrum biocide. Liquid 
H2O2 at low concentrations is effective against bacteria or fungi but higher concentrations are 
required to be effective against bacterial spores. To increase efficacy it is often used in 
combination with peracetic acid. Gas or plasma H2O2 has rapid activity against bacterial 
spores and is less damaging to surfaces. Liquid H2O2 can be made into a gas by vaporisation 
and distributed using a vacuum, increasing penetration can be achieved by the pumping of air 
or nitrogen into sterilisation chambers. During the process ozone and other free radicals are 
produced such as .OH and .OOH these complement the biocidal activity. Advantages of H2O2 
are that it has shorter cycle times compared to EO and breaks down in the environment to 
water and oxygen (McDonnell, 2007). 
1.5.6.3 Peracetic Acid 
Liquid PAA is a broad spectrum rapid biocide, it acts as a sterilant during quick cycle times at 
temperatures between 40 – 60 oC. PAA is  an oxidising agent. It causes oxidation of key 
cellular components by breaking down peptide bonds, free radicals are also produced to 
complement biocidal activity. It effects bacterial cell walls and membrane permeability, 
denatures proteins and enzymes in particular sulfhydryl and sulphur bonds and nucleic acids 
making it effective against viruses. Gaseous PAA is more effective at low concentrations than 
its liquid form. Sterilisation cycles with PAA are usually performed in a vacuumed process 
with controlled humidity and temperature. Humidity ranges are around 30 – 80 % and the 
temperature range is around 40 – 50 oC. PAA breaks down into water and acetic acid and 
requires constant aeration to remove the build-up of toxic residues (McDonnell, 2007). 
1.5.6.4 Electrolyzed Water 
Electrolyzed water is a developing technology; it is the process of electrolysis of water by 
applying a voltage between an anode and cathode separated by an ion permeable barrier. 
This creates two solutions: a reduced alkaline solution at the cathode and an oxidised acidic 
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solution at the anode. The acidic solution has a high oxidising potential (~1,100 mV) which is 
highly biocidal. It has good activity against biofilms but is slower on bacterial spores and it 
has been shown to have no effect against prions. The primary mechanism of action is due to 
chlorine in particular hypochlorous acid, again complementary radicals increase the biocidal 
action. This process causes damage to cell walls, membranes, intracellular components and 
damages the surface of spores and viruses (McDonnell, 2007). 
1.5.6.5 Ozone 
Ozone is used in a low temperature process at about 30 – 35 oC, where either air or high 
concentrations of pure oxygen are passed through a high energy source causing ionisation. 
Ozone is a broad spectrum biocide, the process requires high humidity between 70 – 95 % to 
be effective and is distributed using a vacuum. Ozone breaks down in the environment to 
oxygen and water with no toxic residues (McDonnell, 2007). 
1.5.7 Physical Sterilisation Methods 
1.5.7.1 Radiation  
Depending on the mechanism utilised, electron excitation from either the atomic nucleus or 
from orbitals surrounding the target atoms in a compound, causes energy in the form of 
particles or electromagnetic waves to be released. High energy or ionizing radiation such as 
Gamma irradiation, X-rays and electron beams are required for a sterilisation process as they 
produce greater specimen penetration and higher microbial killing efficacy. Gamma and X-ray 
radiation are forms of electromagnetic radiation and electron beams produce beta-particle 
radiation 
1.5.7.2 Gamma Radiation 
Gamma radiation produces high energy photons, it releases electrons from the atomic 
nucleus giving rise to the formation of isotopes. Isotopes decay to stable non-radioactive 
elements after a period of time measured as the half-life. The decay causes the release of 
energy in the form of alpha or beta particles or as waves of Gamma irradiation. Different 
isotopes release Gamma radiation at different wavelengths causing different levels of 
sterilisation efficacy. Gamma radiation is a rapid biocide. The process mainly affects nucleic 
acids, it also produces free radicals to compliment effectiveness. 
It is generally accepted that a dose of 25 kGγ is sufficient to sterilise a product. Standards 
developed by the British Standards Institute (BSI) and published by the International 
Standard Organisation (ISO) provide four methods for selecting a radiation sterilisation dose 
(RSD) for health care products (ISO, 11137-2:2012):  
1. VDmax 25 - a dose of 25 kGγ for a bioburden of less than 1000 cfu/product,  
2. VDmax 15 - a dose of 15 kGγ for a bioburden of 1.5 cfu/product,  
3. Methods 1 – specific dose based on product bioburdens 
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4. Method 2 – specific dose based on product bioburdens 
Regarding Gamma irradiation and tissue grafts there are controversial arguments for and 
against using higher or lower doses than those recommended by the standard. The 
arguments relate to the source of the tissue, the conditions in which the tissue is being 
sterilised and the effects of the process on the tissue structure. 
For tissues sterilised in liquid mediums containing radical scavengers at room temperature it 
has been found that viral and bacterial inactivation is possible at RSD of 25 kGγ for a wide 
range of viruses and bacteria including Echovirus I1, Influenza virus A, Poliovirus III Leon 
(Sullivan et al., 1971), HIV (Spire et al., 1985) and Bacillius pumillus. Controversially, other 
literature has indicated that higher doses are required for viral inactivation. The effectiveness 
of Gamma irradiation has been shown to be reduced in freeze dried or frozen conditions, due 
to pathogens becoming more resistant in the absence of water. Freezing at -80 oC is common 
practice in tissue banks, Fideler et al. (1994) found that when cadaveric frozen bone patellar 
ligament bone allografts maintained at a temperature of -70 oC using dry ice were irradiated 
at 30 kGγ HIV was inactivated to undetectable levels and that at 25 kGγ the virus was still 
detectable. Campbell & Li (1999) found that in dry ice conditions that 35 kGγ was required to 
inactivate HIV and 89 kGγ was required to achieve a SAL of 10-6 for the bioburden of bone 
grafts. In a study by Hiemstra et al. (1991) the inactivation of HIV in plasma was investigated 
at -80 oC and 15 oC. The results showed that 25 kGγ was sufficient to inactivate the virus to 
SAL at 15 oC but at -80 oC doses in excess of 50 kGγ were required (Table 1.8).  
Table 1.8 : Effects of radiation dose on HIV with varying temperatures and materials 
Dose  Temp Material Inactivation Author 
20 kGγ - 70 oC bone-patellar ligament-bone HIV DNA still present Fideler et al. (1994) 
25 kGγ - 70 oC bone-patellar ligament-bone HIV DNA still present Fideler et al. (1994) 
30 kGγ - 70 oC bone-patellar ligament-bone No HIV DNA present Fideler et al. (1994) 
40 kGγ - 70 oC bone-patellar ligament-bone No HIV DNA present Fideler et al. (1994) 
50 kGγ - 80 oC Plasma 5-6 log10 reduction Hiemstra et al. (1991) 
25 kGγ 15 oC Plasma 5-6 log10 reduction Hiemstra et al. (1991) 
25 kGγ 37 oC  T-Lymphocytes No HIV DNA present Spire et al. 1985 
Collagen has been shown to be susceptible to alteration by Gamma irradiation even at levels 
as low as 10 kGγ (Cheung et al. 1990). Gamma irradiation causes peptide fragmentation via 
chain scission resulting in shorter collagen chains and reduced number of alpha chains. It has 
also been reported that the damage via chain scission is masked when performing stress 
strain analysis due to the increased levels of collagen cross-linking. Gouk et al. (2008) carried 
out 2-30 kGγ radiation on freeze dried acellular cadaver dermis (AlloDerm). After rehydration 
mechanical testing showed reduced ultimate tensile strength and Young’s modulus, in tissues 
subjected to doses greater than 15 kGγ. This was reversed in lower doses all doses showed 
large reductions in extensibility. One explanation for the flip in behaviour over a certain dose 
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is that in lower doses cross-linking is having a more prominent effect and that as dosage 
increases the effects from chain scission outweigh the cross linking effect. Sun & Leung 
(2008) also carried out 2-30 kGγ radiation on freeze dried acellular cadaver dermis and found 
that after rehydration collagen denaturation temperature decreased with increasing dose 
determined by differential scanning calorimetry. Effects caused by Gamma radiation on 
tendon mechanical properties has been shown to be less deleterious than its effects on 
dermis. Smith et al. (1996) Gamma (25 kGγ) irradiated frozen tendon (maintained 
temperature with dry ice) and found no significant differences in ultimate tensile stress, strain 
or Young’s modulus. This highlights that different tissues containing different amounts and 
structures of collagen are susceptible to varying effects from radiation. 
One proposed way in which to reduce the adverse effects of Gamma irradiation on collagen 
structure is to introduce radioprotectants. Radioprotectants and radical scavengers act as 
antioxidants to combine with free radicals to prevent protein fragmentation and chain 
scission. Some of the radioprotectants that have been used are ascorbic acid (Lee & Song, 
2002) riboflavin (Seto et al., 2009) and L-tyrosine. A solution of propylene glycol, dimethyl 
sulfoxide, mannitol and trehalose was used as a radioprotectant or semitendinosus tendons 
irradiated at a dose of 50kGγ at -50 oC, and the irradiated tendons showed no significant 
structural differences from untreated controls. Inactivation of Sindbis virus, porcine parvovirus 
and Clostridium sordellii was also demonstrated (Grieb et al., 2006). 
The majority of the literature on tissue irradiation is concerned with sterilisation of bone and 
tendon allografts. The structure and density of these tissues may require higher RSD’s 
compared to softer lighter tissues such as arteries and dermis. Also due to tissue banking 
storage procedures irradiation is usually performed on frozen tissue and at low temperatures, 
also creating another tissue specific variant that should be investigated.  It is also apparent 
that lower RSDs could be effective if there were a lower bioburden identified for a particular 
tissue. This method is not as easy to implement in a research environment due the sample 
size required for validation with ISO standards. Taking this into consideration a RSD of 25 
kGy at room temperature might be predicted to achieve sterilisation of vascular tissues. The 
use of irradiation causes damage to collagen structure but to different extents depending on 
tissue and dosage, therefore the effects of radiation should be investigated per tissue. 
Damaging effects may also be reduced by using certain radioprotectants or as discussed 
below for E-Beam, the use of an oxygen depleted atmosphere to prevent free radical 
formation as well as the possibility of using a fractionated dose. 
1.5.7.3 E-Beam Radiation 
Electron beam irradiation is an alternative to Gamma irradiation, with shorter exposure times 
and greater control over application, but with limitations of reduced penetration depth 
(Hogstrom & Almond, 2006) and a short lived but rapid increase in temperature up to 40 oC 
above ambient. It is thought that with reduced exposure time required with E-Beam, that there 
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will be reduced structural damage to collagen in tissues. However there have been reports to 
suggest that E-Beam causes similar damage to collagen in tendons as that caused by 
Gamma irradiation determined by stress-strain parameters (Seto et al., 2009) or increased 
damage to collagen in sub intestinal submucosa compared to EO or Gamma irradiation  
(Grimes et al., 2005). More recent work by Hoburg et al. (2010) showed that no significant 
difference was caused to the mechanical properties determined by stress-strain parameters 
of bone patellar tendon grafts, when subjected to 10, 25 and 34 kGγ of E-Beam irradiation 
with the exception of a significant reduction in failure load when subjected to 34 kGγ. The 
bone patellar tendon grafts were deep frozen at -70 oC and irradiated under these conditions 
with the use of dry ice. A novel technique of protecting the tissue from increased radical 
formation in the presence of oxygen was used, by surrounding the tissue in CO2 gas, based 
on findings from the lacquer and coatings industry (Klose, 2007; Baulmann, 1985; Scherzer & 
Beckert, 1997). Further research by Hoburg et al. (2011) investigated the use of a 
fractionated dose of E-Beam. Evidence from radiotherapy had shown that a fractionated 
dosage was as effective at microbe elimination as continuous dosage (Gerbi et al., 2009). 
The dosage was applied at 3.4 kGγ 10 times for a period of 30s and the total process took 
around 12 minutes. The results from this showed no difference in mechanical properties 
compared to non-irradiated specimens of bone patellar tendon bone and less deleterious 
effects than a single dose of Gamma or E-Beam radiation. This suggests a fractionated dose 
reduced total damage caused to the collagen structures. There is little research into the 
differences in effects between Gamma and E-Beam irradiation on tissues. E-Beam appears 
to have some distinct benefits over Gamma irradiation such as shorter exposure time, tighter 
control over ambient temperature conditions, reduced cost and use of fractionated dose. One 
of the major causes for concern in the use of E-Beam is whether the rapid increase in 
temperature will have a substantial effect on the collagen in arterial tissues or whether it will 
be negligible as it is only for a short exposure time. The concept of using a fractionated dose 
is extremely appealing as this, in theory, should reduce the amount of radiation damage while 
maintaining sterilisation. Again the use of an oxygen depleted atmosphere to prevent radical 
formation is an appealing concept, however the extent to which the radicals contribute to 
sterilisation is undetermined and a higher radiation dose may be required and this has yet to 
be investigated in the literature. There is also an increased cost and complexity in 
implementing an oxygen depleted atmosphere into a sterilisation procedure. 
1.5.7.4 Plasma 
Plasma is a state in which atoms in a gas are excited to the extent at which the orbital 
electrons are released giving rise to a mixture of charged nuclei and free electrons and other 
reactive agents such as free radicals. These species are highly reactive and causes essential 
structural degradation and disruption to functions needed for bacterial and virus survival. 
Also, as isotopes are formed just like in radiation techniques, as they return to their natural 
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states photons or heat are released complementing efficacy. Plasmas which have potential 
for use in tissue sterilisation include oxygen, hydrogen peroxide, peracetic acid, aldehydes 
and halogens. Plasmas are generated via heat at very high temperatures (~3000 oC) or 
electromagnetic radiation from microwaves or high-energy radio frequencies at low 
temperatures (30-50 oC) in a gas vacuum (0.001 to 0.15 kPa). Improvements in technology 
allow plasmas to be produced at room temperature using a process called dielectric barrier 
discharge. Dielectric barrier discharge works by passing the gas through a pair of electrodes 
barriered by a dielectric material which prevents arcing (breakdown of plasma) (McDonnell, 
2007). 
1.5.7.5 Supercritical Carbon Dioxide 
When a liquid is heated to slightly above the critical temperature for the transition phase 
between liquid and a gas the substance exhibits properties of both a liquid and a gas. CO2 is 
becoming an increasingly popular choice as a super critical fluid for use as a sterilisation 
method. This is attributed to the ability of CO2 to easily attain a super critical state at low 
pressures (7.49 MPa) and low temperatures (31.1 oC) (Figure 1.30) as well as high 
penetration ability, non-toxicity and its easy removal by out gassing and depressurisation 
(White et al., 2006). 
 
Figure 1.30 : a graph showing the temperature and pressure at which carbon dioxide change phase to 
a supercritical fluid.   
Adopted from (White et al., 2006) 
Unfortunately SCCO2 has shown poor inactivation of bacterial spores and viruses unless 
used in high temperature and pressure conditions which are detrimental to natural tissues 
(Kamihira et al., 1987; Ishikawa et al., 1997; Ballestra & Cuq, 1998; Spilimbergo & Bertucco, 
2003). This has made it difficult to achieve SAL’s of 10-6. As a result,  most SCCO2 methods 
are classed as high level disinfectants (Spilimbergo & Bertucco, 2003). Those methods that 
have shown effectiveness as a terminal sterilisation process are those which have used 
SCCO2 in combination with PAA or H2O2 which could cause damaging effects to the ECM or 
leave toxic residuals.  
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White et al. (2006) found that by itself SCCO2 was incapable of inactivating B.subtilis 
endospores or B.stearothermophilus endospores, but when combined with either 5 % PAA or 
trifluoroacetic acid (TFA) for a period of one hour at 60 oC and 10.34 MPa, that greater than 
6.4 log reduction in CFU’s was possible, achieving a SAL of 10-6 with a D-value of 3.25. A 
mixture analysis also showed that within the dynamic equilibrium of PAA to AA and H2O2 that 
it was the PAA that was responsible for the inactivation of bacterial endospores.  
Zhang et al. (2006a) also found that SCCO2 by itself was not effective at inactivating 
B.atrophaeus spores, but by using SCCO2 with 30% H2O2 (200ppm) at a pressure of 27.5 
MPa and temperature of 60 oC for a period of 4 hours it was possible to inactivate B. pumilus 
achieving a 6.28 log reduction meeting the industry requirements of a SAL of 10-6. No 
analysis of  the effects on tissue were performed. Further work by the group (Zhang et al., 
2006b) used  a similar process on B.atrophaeus spores at a lower temperature of 40 oC in 
attempts to provide evidence for the mechanism of inactivation. This study showed that there 
was damage to the permeability barrier and internal structures of the spores. 
Studies on the virucidal effects of SCCO2 using any of the aforementioned additives is rare, 
Qiu et al. (2009) used a SCCO2 method with added PAA (final concentration ~55 ppm) to 
sterilise acellular porcine dermal matrix for no longer than one and a half hours at 
temperature and pressure of 35 – 41°C and 9.41-10.03 MPa respectively. The study 
investigated inactivation of the viruses; Encephalomyocarditis virus (EMC), porcine parvovirus 
(PPV), porcine pseudorabies virus (PRV), and murine leukemia retrovirus (LRV) as well as B. 
atrophaeus spores. For the spores, a 6 fold log reduction was achieved after 52 minutes 
reaching sufficient SAL’s with a calculated D-Value of 6.3 minutes, EMC was completely 
inactivated with a log reduction of 6.44, showing that the process was capable of inactivating 
viruses as well as bacterial spores. The effects of the process on the mechanical properties of 
the matrix were investigated using a SCCO2 run time of 1.5 hours by susceptibility to 
enzymatic digestion and tensile testing. The enzymatic digestion showed that the treated 
samples were less susceptible to digestion but were not statistically significant from controls. 
For the tensile tests, the maximum load and stress of the treated matrix was increased 
compared to the control and the elasticity decreased, but only the elasticity was significantly 
different. Together, the data showed that there was some change in the matrix architecture. 
SCCO2 has shown potential for use as a terminal sterilisation process. It has been shown that 
with the addition of additives SCCO2 can sterilise to industry standards at acceptable 
temperatures and pressures. The effect of different additives on the possible damage to 
collagen and the basement membrane would need to be assessed for the process to be used 
as an industrial terminal sterilisation method for vascular scaffolds. 
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1.6 Summary 
Cardiovascular disease is the highest cause of morbidity worldwide, encompassing blood 
vessel disorders such as coronary artery and peripheral arterial disease. Due to lack of 
autograft tissue and low patency rates of synthetic alternatives there is a huge clinical need 
for an off the shelf small diameter (less than 6 mm) vascular graft. Advances in synthetic 
materials are promising but are yet to establish a graft with desired mechanical and biological 
properties. A large focus has been directed at the tissue engineering approach, but similarly 
there is yet no commercial product available that has comparable clinical outcome to 
autograft tissue.  Previously, a process for the production of acellular porcine carotid arteries 
has been developed which shows excellent potential for clinical translation as vascular 
bypass grafts.  
Medical products need to be sterilised to a sterility assurance level of 10-6 before they can be 
used clinically. Terminal sterilisation whereby the product is sterilised in its final packaging is 
desirable for an implantable product. The primary source of literature related to the 
sterilisation of grafts comes from tissue banks. The sterilisation processes currently used are 
Gamma and E-Beam irradiation and ethylene oxide treatment. There is much contention on 
the effects of each of these processes on the mechanical and biological effects on 
proteinaceous materials and grafts. It is therefore necessary to assess the effects of 
sterilisation processes on the mechanical and biological properties of the specific type of graft 
under research and development.  .  
1.7 General Aims and objectives 
It was the aim of this thesis to develop a range of robust test methods that enable evaluation 
of the effects of sterilisation methods on the mechanical and biological properties of acellular 
vascular grafts. Then using these test methods, determine the compatibility of terminal 
sterilisation processes, Gamma and E-Beam irradiation and Ethylene oxide treatment with 
acellular vascular grafts.  
1.8 Experimental Approach 
1.8.1 Porcine Scaffold 
In the search for a small diameter vascular graft porcine vessels are being investigated. Pigs 
have similar physiological and genomic features to humans and have similar flow rates in the 
vascular system (Rothschild et al., 2011) as well as a high availability through the meat 
industry. The left and right porcine carotid artery (Figure 1.31) have an internal diameter of ~ 
6 mm at the proximal end narrowing to ~ 3 mm at the distal end with a length of ~ 150 mm 
depending on age and weight. This makes the porcine carotid arteries a suitable candidate 
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for a small diameter vascular graft model with future potential as a coronary artery bypass 
graft. The free graft length in CABG range 8-24 cm with an average 17.7 cm (Mills & Everson, 
1989). Therefore in this study acellular vascular grafts will be derived from porcine carotid 
arteries.  
 
Figure 1.31 : Porcine cardiovascular system identifying vasculature. 
1.8.2 Sterilisation 
In order to translate the acellular vascular grafts into a clinical product they must first be 
sterilised in accordance with the medical device directive. As a medical device, to be deemed 
sterile a SAL of 10-6 must be achieved. It is also beneficial to have the product terminally 
sterilised i.e. sterilised whilst in its final packaging to prevent contamination post sterilisation. 
The three highly profiled and industry available sterilisation methods currently being used are 
Gamma and E-Beam irradiation and ethylene oxide treatment. The effects of each 
sterilisation method on the biomechanical and biological properties of acellular porcine grafts 
must be investigated to determine a compatible method 
1.8.3 Assessment  Methods 
Once mechanical and biological quality checks have been passed acellular arteries will be 
sterilised using Gamma or E-Beam irradiation or ethylene oxide. After which a range of 
methods will be used to assess and build up an overall picture of the effect of each 
sterilisation process. These methods have been categorised into three categories:  
 Histological evaluation 
 Mechanical evaluation 
 Biological evaluation 
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Histological evaluation involves haematoxylin and eosin staining, immunohistochemical 
labelling of collagen IV and multiphoton imaging of acellular sterilised porcine carotid arteries. 
Mechanical evaluation involves determination of mechanical properties via uniaxial tensile 
testing at low strain rate to failure and burst pressure and compliance testing of acellular 
sterilised porcine carotid arteries. 
Biological evaluation involves determination of biocompatibility, denatured collagen content 
and denaturation temperature (differential scanning calorimetry) of acellular sterilised porcine 
carotid arteries. 
Although all assessments will be carried out to enhance the understanding of the effects 
caused by the particular sterilisation process, a success failure criteria can be applied for 
some methods.  
 
 
 
 
•Histological Evaluation
•Mechanical Evaluation
•Biological Evaluation
Native 
Artery
•Histological Evaluation
•Mechanical Evaluation
•Biological Evaluation
Acellular 
Artery
•Histological Evaluation
•Mechanical Evaluation
•Biological Evaluation
Sterilised 
Artery
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Chapter 2 : General Materials and Methods 
2.1 Equipment 
A list of equipment used throughout this project and the manufacturer is presented in 
Appendix A; Table  A-1. 
2.2 Chemicals and Reagents 
A list of reagents used throughout this project and their supplier is presented in Appendix A; 
Table  A-2. 
2.3 Consumables 
A list of consumables used throughout this project and their supplier is presented in Appendix 
A; Table  A-3. 
2.4 Cell Lines 
Mammalian cell lines used in biocompatibility assays are listed in Table 2.1. 
Table 2.1 : Cell lines, Cell lines with type species and NCTC catalogue number. 
Cell lines Type Species Cat No. 
 BHK Fibroblast Hamster 93120840 
 L929 Fibroblast Murine 85103115 
2.5 Antibodies 
Monoclonal antibody CIV22 (DAKO, M0785) with specificity to collagen IV epitope was used 
in immunohistochemical labelling. The isotype control protein used to detect background 
staining of the Fc receptor was Mouse, IgG1 (Dako, X0931) and was used in equal 
concentration to the primary antibody (1.6 mg.L-1). An antigen retrieval step of incubation with 
citrate buffer was used to enable antibody binding to the epitope. 
 
- 50 - 
2.6 Methods 
2.6.1 Glassware Disinfection 
Glassware was disinfected by immersion in a 1 % (v/v) solution of Neutracon© followed by 
rinsing in distilled water. 
2.6.2 Equipment and Reagent Sterilisation 
All equipment or solutions prior to contact with tissue were sterilised by either dry heat, moist 
heat (autoclave) or filter sterilisation. Dry heat sterilisation was carried out in a hot air oven at 
a temperature of 180 °C for 4 hours. Autoclave sterilisation was carried out for 20 minutes at 
121 °C and 15 psi (0.1034MPa). Filtered solutions were passed through a 0.2 µm pore size 
filter in a class II safety cabinet. 
2.6.3 Measurement of Ph. 
A Jenway 3020 pH meter was used to determine the pH of solutions. Solutions of pH 4, 7 and 
10 made from buffer tablets (Merck Chemicals Ltd.) dissolved in de-ionised water were used 
to calibrate the pH meter. The pH of solutions was altered using varying molarities of 
hydrochloric acid and sodium hydroxide added drop-wise whilst stirring. Temperature 
compensation was employed.  
2.6.4 Aseptic Technique and Cabinets 
All work requiring aseptic technique was carried out in Class II safety cabinets 
2.6.5 Microbiological Plating Technique 
Plating techniques for detection of single colonies of microorganisms in sterility checks used 
the pattern shown in Figure 2.1 . A microbiological loop was heated to red hot in a blue 
Bunsen flame and allowed to cool, the loop was then submersed in the suspension in 
question and streaked. 
 
Figure 2.1 Streaking pattern, streaking pattern used during sterility checks of suspensions.  
Streaks began from the initial inoculation point (A) which was streaked using a microbiological loop in 
multiple lines circumferentially; the final line was streaked to the centre of the plate. 
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2.6.6 Histological Analysis 
2.6.6.1 Tissue fixation and embedding 
Reagents: 
Zinc fixative solution  
Trizma base (12.1 g) was dissolved into 1000 ml of distilled water using a magnetic 
stirrer and stirrer bar. Calcium acetate (0.5 g) was added and dissolved. The pH was 
adjusted to 7.0-7.4 by adding 6 M hydrochloric acid or 6 M sodium hydroxide drop 
wise. Zinc acetate (5.0 g) was dissolved into the solution followed by zinc chloride 
(5.0 g). 
Method: 
Approximately 3.0 mm length of tissue was dissected and placed into individual plastic 
cassettes and labelled using a pencil. Cassettes were submerged in zinc fixative for 16-24 
hours at room temperature. The cassettes were placed into a metal holding basket and 
placed in the tissue processor and run on program three (Table 2.2). 
Table 2.2 : Tissue processing steps. 
Station Number Contents Time 
1 N/A 0 Hours 
2 70% Alcohol 1 Hour 
3 90% Alcohol 1 Hour 
4 100% Alcohol 1 Hour 
5 100% Alcohol 1 Hour 
6 100% Alcohol 1 Hour 
7 Xylene 1 Hour 
8 Xylene 1 Hour 
9 Xylene 1 Hour 
10 Molten Wax 1 Hour 
11 Molten Wax 1 Hour 
 
The program was completed after eleven hours. Upon completion the histology cassettes 
were removed and transferred to fresh molten wax. The individual specimens were orientated 
with the circumference face down into metal moulds filled with molten wax. The cassette base 
was placed on top of the mould and additional wax was used to fill the cassette. The 
cassettes were then left to cool and harden at room temperature. Once hard, the excess wax 
was removed and the block stored at room temperature. 
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2.6.6.2 Sectioning of paraffin wax embedded tissue samples 
Method: 
The hotplate and water bath were turned on and set to 55-60 °C and 45-50 °C, respectively. 
A paraffin wax block to section was selected; the angle of the blade of the microtome was set 
to 2.5 ° and the section thickness to 5 µm. The handle of the microtome was turned in a 
clockwise direction smoothly cutting the wax block into thin sections. The sections were 
removed using two sets of fine tip forceps and floated on the surface of the water bath until 
any wrinkles in the wax disappeared. The floating sections were then removed onto 
Superfrost or Superfrost plus slides. They were removed in a vertical motion to allow as much 
water as possible to run off the slide. The slides were labelled and recorded accordingly 
before being placed onto the hotplate. Samples were left on the hot plate for a minimum of 60 
minutes and stored at room temperature until stained. 
2.6.6.3 Haematoxylin and eosin staining 
Method: 
Slides plus sections to be stained were placed into a slide holder and then immersed in a 
series of reagents for different periods of time (Table 2.3). Sections were dewaxed, 
rehydrated, stained then dehydrated. 
Table 2.3 : Haematoxylin and Eosin staining procedure. 
Step Solution Time 
1 Histo-clear III 10 Minutes 
2 Histo-clear III 10 Minutes 
3 100% Ethanol 3 Minutes 
4 100% Ethanol 2 Minutes 
5 100% Ethanol 2 Minutes 
6 70% Ethanol 2 Minutes 
7 Running tap water 3 Minutes 
8 Haematoxylin 1 Minute 
9 Running tap water Until water ran clear 
10 Eosin 1 Minute 
11 70% Ethanol 5 Seconds 
12 100% Ethanol 1 Minute 
13 100% Ethanol 2 Minutes 
14 100% Ethanol 3 Minutes 
15 Histo-clear III 10 Minutes 
16 Histo-clear III 10 Minutes 
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Sections were then mounted using DPX mountant and left to for a minimum of four hours 
inside a fume hood. Sections were then viewed using an upright microscope under normal 
Koehler illumination and images captured with a digital camera and Image Pro Plus V5.1. 
2.6.6.4 DAPI staining  
Reagents: 
Dulbecco’s phosphate buffered saline (DPBS) 
Five Oxoid Dulbecco’s PBS tablets were dissolved in 500 ml distilled water. The pH 
was adjusted to 7.2 – 7.4 using 6 M hydrochloric acid or 6 M sodium hydroxide drop 
wise whilst using a magnetic stirrer. The solution was sterilised by autoclaving. 
Dye buffer (10 mM Tris, 1 mM Na2EDTA, 1 mM NaCl)   
Trizma base (1.211 g), disodium ethylenediaminetetraacetic acid (0.3724 g) and 
sodium chloride (0.058 g) were dissolved in 1000 ml of distilled water. The solution 
was sterilised by autoclaving. The pH was adjusted immediately before use to 7.4 
using 6 M hydrochloric acid or 6 M sodium hydroxide drop wise whilst using a 
magnetic stirrer.  
DAPI dye solution (1 mg.ml-1) 
DAPI (10 mg) was added to 10 ml of nuclease free water and stored at – 20 °C in a 
foil wrapped container.  
Working dye solution (0.1 µg.ml-1) 
DAPI dye solution (20 µl) was added to 200 ml of dye buffer in a dark bottle and 
mixed by inversion.   
Method: 
Slides plus sections to be stained were placed into a slide holder and then immersed a series 
of reagents for different periods of time Table 2.4. Sections were dewaxed, rehydrated then 
stained. 
Table 2.4 : DAPI staining procedure. 
Step Solution Time 
1 Histo-clear III 10 Minutes 
2 Histo-clear III 10 Minutes 
3 100% Ethanol 3 Minutes 
4 100% Ethanol 2 Minutes 
5 100% Ethanol 2 Minutes 
6 70% Ethanol 2 Minutes 
7 Running tap water 3 Minutes 
8 DAPI working solution (DARK) 10 Minutes 
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Step Solution Time 
9 DPBS (DARK) 10 Minutes 
10 DPBS (DARK) 10 Minutes 
11 DPBS (DARK) 10 Minutes 
Sections were then mounted using Dako fluorescence mounting medium and left to set in the 
dark for a minimum of four hours. Sections were then viewed using an upright microscope 
using fluorescent microscopy with a DAPI filter and images captured with a digital camera 
and Image Pro Plus V5.1. 
2.6.6.5 Immunohistochemical labelling of paraffin embedded tissue sections using 
monoclonal antibodies specific for collagen IV 
Reagents: 
Sodium hydroxide solution (6 M)  
Sodium hydroxide (120 g) was dissolved into 500 ml of distilled water using a 
magnetic stirrer and stirrer bar. 
Dulbecco’s phosphate buffered saline (DPBS) 
See section 2.6.6.4 
Hydrogen peroxide solution (3 %; v/v)  
Hydrogen peroxide (20 ml 30 %; v/v) was added to 180 ml of DPBS and mixed by 
inverting (used immediately, excess discarded) 
Citrate Buffer (10 %; w/v)  
Anhydrous citrate buffer (1.92 g) was dissolved into 1 L of distilled water. 
Sodium chloride solution (3 M)  
Sodium chloride (175.32 g) was dissolved into 1000 ml of distilled water using a 
magnetic stirrer and was sterilised by autoclaving. 
Tris solution (2M)  
Trizma base (242.26 g) was dissolved into 500 ml of distilled water using a magnetic 
stirrer; the pH was adjusted to 7.6 using 6M hydrochloric acid or 6 M sodium 
hydroxide drop wise whilst using a magnetic stirrer. The volume was then made up to 
1000 ml using distilled water. The solution was sterilised by autoclaving. 
Tris buffered saline (TBS)  
Tris solution (25 ml, 2 M)  was mixed with 50 ml of 3 M sodium chloride solution using 
a magnetic stirrer, and the volume made up to 1000 ml using distilled water. The pH 
was adjusted to 7.6 using 6 M hydrochloric acid or 6 M sodium hydroxide drop wise 
whilst using a magnetic stirrer. The solution was sterilised by autoclaving. 
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TBS containing 0.05 % (w/v) Tween 20 (TBS-T)  
Tween 20 (500 µl) and 1000 ml of TBS were mixed using a magnetic stirrer.  
BSA solution (5 %; w/v BSA)  
Bovine serum albumin (0.25 g) was dissolved into 50 ml of DPBS using a magnetic 
stirrer and stirrer bar, the solution was then passed through a 0.2 µm filter into a 
sterile collection container in a class II cabinet. Volumes (5 ml) were then aliquoted 
into sterile universals and frozen at -20 °C 
Antibody diluent (TBS, 0.1 % (w/v) BSA, 0.1 % (w/v) sodium azide)  
Sodium azide (6 ml), 300 µl of 5 % (w/v) BSA solution and 40 ml of tris buffered 
saline were mixed together using a magnetic stirrer. The pH was adjusted to 7.6 
using 6 M hydrochloric acid or 6 M sodium hydroxide whilst stirring with a magnetic 
stirrer, the volume was made up to 60 ml with TBS. 
Antibody solution  
A ratio of 1:50 of 80 mg.L-1 collagen IV mouse monoclonal antibody was added to 
antibody diluent, the volume made up was approximately 20 µl per section. 
Antibody isotype solution  
A ratio of 1:63 of 100 mg.L-1 mouse IgG1 Kappa was added to antibody diluent, the 
volume made up is approximately 20 µl per section. 
Method: 
Firstly the slides plus section to be labelled were processed by dewaxing and rehydrating as 
shown in Table 2.5. 
Table 2.5 : Dewaxing and rehydration of sections. 
Step Solution Time 
1 Histo-clear III 10 Minutes 
2 Histo-clear III 10 Minutes 
3 100% Ethanol 3 Minutes 
4 100% Ethanol 2 Minutes 
5 100% Ethanol 2 Minutes 
6 70% Ethanol 2 Minutes 
7 Running tap water 3 Minutes 
 
Tissue sections then underwent antigen retrieval using 10 % citrate buffer (w/v) for 10 
minutes followed by blocking using 3 % (v/v) H2O2 for 10 minutes at room temperature and 
subsequent washing under running tap water. Slides were then placed into four well plastic 
slide holders and a hydrophobic marker pen was used to circle the sections to reduce the 
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volume of solution used. Subsequent steps were carried out on a shaker at 20 rpm until 
dehydration. Sections were rinsed in TBS and incubated with dual endogenous enzyme block 
( V Block; Ultravision kit) for ten minutes. The monoclonal antibody for collagen IV and the 
isotype control IgG1 Kappa were diluted with antibody diluent (1:50; 1:63 respectively) to 
suitable and equal concentrations and incubated for 1 hour, antibody diluent served as a 
second control. Sections were then washed with TBS-T for ten minutes (x2) followed by TBS 
for ten minutes (x2). Sections were then incubated for thirty minutes in the dark with labelled 
polymer-HRP (HRP Polymer; Ultravision kit). The sections were again washed in TBS-T (x2) 
followed by TBS (x2) for ten minutes each. Sections were then incubated with 3,3 – 
diaminobenzidine (DAB) plus chromogen (Ultravsion Kit) for ten minutes at room 
temperature.  Sections were then washed under running tap water before being 
counterstained with haematoxylin for 15 seconds and washed again under running tap water 
untill water ran clear. Dehydration of the tissues was carried out as shown in Table 2.6. The 
sections were then mounted using DPX mountant and air dried for four hours. The sections 
were viewed using an upright microscope under normal Koehler illumination and images were 
captured using a digital camera and Image Pro Plus V5.1. 
Table 2.6 : Dehydration of sections. 
Step Solution Time 
1 70% Ethanol 5 seconds 
2 100% Ethanol 1 Minute 
3 100% Ethanol 2 Minutes 
4 100% Ethanol 3 Minutes 
5 Histo-clear III 10 Minutes 
6 Histo-clear III 10 Minutes 
2.6.7 Isolation and Quantification of DNA 
Method: 
DNA was extracted using a commercially available DNeasy blood and tissue kit from QIAgen. 
Native artery (25-50 mg), acellular (100-250 mg) or sterilised acellular artery (100-250 mg) 
was macerated and placed in a sterile 2 ml microcentrifuge tube. Buffer ATL (180 µl, native; 
360 µl, acellular) and proteinase K (20 µl, native; 40 µl, acellular) from the QIAgen kit were 
then added, the solution was vortexed and incubated at 56 °C for a minimum of three hours 
or until the tissue was completely digested. Following digestion premixed Buffer AL (200 µl, 
native; 400 µl, acellular) from the QIAgen kit and ethanol (100 %; v/v; 200 µl, native; 400 µl, 
acellular) were added and vortexed. The samples were then centrifuged at 6000 x g for one 
minute in DNeasy mini spin columns in 600 µl volumes until all the sample had filtered 
through the column. The flow through was discarded and a new collection tube replaced; 500 
µl of Buffer AW1 was filtered through the spin column at 6000 x g for one minute. The flow 
through was discarded and a new collection tube replaced; 500 µl of Buffer AW2 was filtered 
- 57 - 
through the spin column at 20 000 x g for three minutes. The flow through was discarded and 
a new collection tube replaced. Buffer AE (200 µl) was filtered through the column twice to 
elute the DNA. The concentration of DNA was determined by loading 2 µl samples onto a 
nanodrop spectrophotometer and determining absorbance at 260 nm (Buffer AE was used as 
a blank). The concentration of each sample was normalised for volume and initial tissue mass 
to determine DNA concentration in ng.mg-1. 
2.6.8 Cell Culture and Maintenance 
2.6.8.1 Culture medium 
Reagents: 
Tryptone phosphate broth stock solution (TPB; 29.5 g/l) 
Tryptone phosphate broth (7.38 g) was dissolved in 250 ml of distilled water and 
filtered through a 0.2 µm filter unit. Aliquots of 20 ml were stored at – 20 °C for up to 
six months. 
DMEM (10 % FBS, 2 mM L-glutamine, pen/strep 100 U / 100 μg.ml-1) 
Fetal bovine serum (FBS, 10 ml; 10 % (v/v)), L-glutamine (1 ml; 1 % (v/v)) , penicillin 
(2 ml; 2 % (v/v)) and streptomycin (2 ml; 2 % (v/v)) were added to Dulbecco’s minimal 
essential medium (DMEM) (87 ml) and mixed by inversion.  
GMEM (5 % FBS, 10 % TPB, pen/strep 100 U / 100 μg.ml-1, 2 mM L-glutamine) 
Fetal bovine serum (FBS, 5 ml; 5 % (v/v)), tryptone phosphate broth stock solution 
(10 ml; 10% (v/v)), L-glutamine (1 ml, 1% (v/v)),Penicillin (2 ml, 1% (v/v)) and 
streptomycin (2 ml; 2% (v/v)) were added to Glasgow’s minimal essential medium 
(GMEM) (82 ml) and mixed by inversion.  
Method: 
Cell lines (Section 2.4) were cultured in either DMEM or GMEM with specific additives for 
each cell line. L929 cell lines were cultured in supplemented DMEM and BHK cell lines were 
cultured in supplemented GMEM. All medium and reagents were allowed to equilibrate to 37 
°C and all medium changes were performed aseptically. 
2.6.8.2 Cell resurrection  
Relevant culture medium was warmed to 37 °C in water bath. Cells stored in liquid nitrogen 
and frozen in cryopreservation medium (Section 2.6.8.5) were located from the cell log sheet 
and removed from Dewar’s and thawed in 37 °C water bath. When defrosted 9 ml of culture 
medium was added to a universal followed by the defrosted cell stock (1 ml). The suspension 
was then spun down at 150 g for 10 minutes and the supernatant discarded. The cell pellet 
was resuspended in 1 ml of fresh culture medium then diluted as necessary. The diluted cell 
suspension was then transferred to a T 75 culture flask and incubated at 37 °C in 5 % (v/v) 
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CO2 in air, the medium was subsequently changed approximately every 48 hours until 
confluent. 
2.6.8.3 Cell passaging 
When 80 % confluence was observed (microscopically) the cells were passaged. The 
medium was aspirated from the flask and the cell layer was washed in PBS without calcium 
and magnesium. The cells were then incubated with 3 ml of trypsin/EDTA solution for 5 
minutes at 37 °C in 5 % (v/v) CO2 in air to detach the cells from the flask. The cells were then 
suspended in 10 ml of medium to neutralise the trypsin and centrifuged at 150 g for 10 
minutes. The supernatant was removed and the cell pellet resuspended in 1 ml of fresh 
medium at which point a viable cell count (Section 2.6.8.4) was performed if necessary and 
the cell suspension separated into multiple flasks as needed, or cryopreserved (Section 
2.6.8.5). 
2.6.8.4 Determination of cell number and cell viability using Trypan blue 
Trypan blue dye stains dead cells determined by loss of membrane function and live cells 
remain clear as can be seen microscopically. The cell viability was determined by mixing a 
volume (100 µl) of cell suspension and Trypan blue dye in a bijou at a ratio of 1:1 (dilution 
factor of 2). A small volume (~14 µl) was then pipetted between a glass slide and 
haemocytometer and viewed under an inverted light microscope. The four 1 mm2 corner 
squares of the grid were counted and the cell count per ml was calculated as follows, where 
df = dilution factor: 
Equation 2-1 𝑁𝑢𝑚 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠. 𝑚𝑙
−1 =  
𝑣𝑖𝑎𝑏𝑙𝑒 𝑐𝑒𝑙𝑙 𝑐𝑜𝑢𝑛𝑡
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑠𝑞𝑢𝑎𝑟𝑒𝑠 𝑐𝑜𝑢𝑛𝑡𝑒𝑑 (4)
 × 104  × 𝑑𝑓  
2.6.8.5 Cryopreservation of cell lines 
Reagents: 
Cryopreservation medium; DMEM (20 % FBS, 10 % DMSO) 
Fetal bovine serum (2 ml; 10 % (v/v)), DMSO (1ml; 10 % (v/v)) were added to 
Dulbecco’s minimal essential medium (DMEM) (7.7 ml) and mixed by inversion.  
Method: 
The cell density was adjusted to 106.ml-1 in cryopreservation medium. The suspension was 
immediately aliquoted in 1 ml volumes into cryovials and placed into an isopropanol 
containing cryo freeze pot before being frozen at – 80 °C for 24 hours. Once frozen cryovials 
were transferred into liquid nitrogen for long-term storage.  DMSO was used to prevent ice 
crystal formation during the freezing process; and cell suspensions were frozen immediately 
to reduce its toxic effect. 
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2.6.9 Biocompatibility Assays of Arteries 
2.6.9.1 Sterility testing of samples 
A 5 mm2 sample was removed from acellular and acellular/sterilised arteries and incubated in 
nutrient broth at 37 oC for 48 hours. Sterility was determined by observation of a lack of 
turbidity compared to positive and negative controls. The positive control was nutrient broth 
exposed to human commensals and the negative control was sterile nutrient broth exposed to 
the HEPA filtered air. 
2.6.9.2 Contact cytotoxicity 
Reagents: 
Tryptone phosphate broth stock solution (29.5 g/l) 
See section 2.6.8.1 
 DMEM (10 % FBS, 2 mM L-glutamine, pen/strep 100 U / 100 μg.ml-1) 
See section 2.6.8.1 
GMEM (5 % FBS, 10 % TPB, pen/strep 100 U / 100 μg.ml-1, 2 mM L-glutamine) 
See section 2.6.8.1 
Method: 
Samples of arteries ~ 5 mm2 were attached to six-well tissue culture plates using steri strips, 
cyanoacrylate and steri strips were used as positive and negative controls respectively. The 
wells were washed three times in PBS without calcium and magnesium and then seeded with 
500,000 cells of BHK or L929 cells in 2 ml of culture medium and incubated at 37 oC in 5 % 
(v/v) CO2 in air until confluent (~ 48 hours). Phase contrast images were then taken of the cell 
sample interface. Medium was aspirated and cells were washed with PBS containing calcium 
and magnesium; cells were then fixed with neutral buffered formalin (NBF) for 10 min and 
stained with Giemsa solution (2 ml per well) for 5 min after which bright field images were 
taken. Images were captured through an upright microscope BX40 Olympus UK using a 
Digital colour camera XC50 Olympus UK. Images were used to view any changes in cell 
morphology and confluency.   
2.6.10 Denatured Collagen Assay 
Reagents: 
Sodium hydroxide solution (6 M)  
See section 2.6.6.5 
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Digest buffer  
Trizma base (1.21 g) and calcium chloride (0.15 g) were added to 100 ml of distilled 
water using a magnetic stirrer and stirrer bar. The pH was adjusted to 7.8 using 6 M 
hydrochloric acid or 6 M sodium hydroxide whilst stirring with a magnetic stirrer. The 
solution was sterilised by autoclaving. 
α-Chymotrypsin solution  
α-Chymotrypsin was dissolved at 5 mg.ml-1 into digest buffer using a magnetic stirrer 
and stirrer bar and used immediately 
Assay buffer  
Citric acid (13.3 g), glacial acetic acid (3.2 ml), sodium acetate (32 g) and sodium 
hydroxide (9.1 g) were dissolved into 220 ml of distilled water using a magnetic stirrer 
and stirrer bar. Propan-1-ol (80 ml) was added and the solution made up to 300 ml 
using distilled water. The pH was adjusted to 6-6.5 using 6 M hydrochloric acid or 6 
M sodium hydroxide whilst stirring with a magnetic stirrer. The final volume was 
adjusted to 400 ml using distilled water.  
Chloramine T  
Chloramine T (1.41 g) was dissolved into 220 ml of distilled water. The solution was 
used immediately and any excess was disposed of. 
Ehrlich’s reagent  
P-dimethylaminobenzaldehydeT (7.5 g) was dissolved into 30 ml of propan-1-ol using 
a magnetic stirrer and stirrer bar. Perchloric acid 60 % (v/v) (13.4 ml) and distilled 
water were added and stirred using a magnetic stirrer until fully dissolved. Solution 
was used within one hour and excess disposed of. 
Primary assay standard (1 mg.ml-1) 
Trans-4-hydroxy-L-proline (25 mg) was added to assay buffer (25 ml) and mixed by 
inversion. 
Secondary assay standard (100 mg.ml-1) 
Primary assay standard (1 ml) was added to assay buffer (9 ml) and mixed by 
inversion.  
Method: 
Lyophilisation and digestion of tissue 
Acellular and acellular/sterilised arteries were macerated (50 mg) and placed into a sterile 
bijou. The sample was lyophlised to a constant weight using a freeze dryer. Each sample was 
then incubated with 5 ml α-chymotrypsin solution (5 mg.ml-1) at 30 oC for 24 hours. Samples 
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were then centrifuged at 600 g for ten minutes; the supernatant (4 ml) was then transferred to 
a sterile glass universal along with 4 ml of 6 M hydrochloric acid and sealed. Each tube was 
autoclaved at two bars for four hours and  then allowed to cool to room temperature. Samples 
were neutralised to pH 7.0 by adding 6 M sodium hydroxide drop wise with stirring. 
Assay procedure 
A range of standards (50 µl) (Table 2.7) and test solutions (50 µl) were added to a clear flat-
bottomed 96 well plate. Chloramine T (100 µl) solution was added to each well and then 
shaken at 60 rpm for five minutes using a plate shaker at room temperature. Ehrlich’s reagent 
was then added to each well and sealed using a topseal cover then incubated for 45 minutes 
at 60 oC. Optical density was measured using a microplate spectrophotometer at 570 nm. 
Blank values were subtracted from all standards and unknown samples, then standard curves 
plotted and used to interpolate the concentration of denatured collagen in the artery. 
Table 2.7 : Denatured collagen assay standards. 
Standard Concentration (µg.ml-1) Volume of secondary standard (µl) Volume of buffer (µl) 
30 750  1750 
25 625 1875 
20 500 2000 
15 375 2125 
10 250 2500 
8 200 2300 
6 150 2350 
4 100 2400 
2 50 2450 
0 0 2500 
2.7 Statistical Analysis 
A list of basic statistical terms used throughout the project can be found in Appendix B. 
Confidence limits at 95 % (α = 0.05) were calculated with a minimum of n=3 using the 
equation shown: 
Equation 2-2 95 % 𝐶𝐿 = 𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑒𝑟𝑟𝑜𝑟 × 𝑡 − 𝑣𝑎𝑙𝑢𝑒 
Comparison between groups were analysed using one way analysis of variance (ANOVA) 
and differences between group means were calculated using the minimum significant 
difference at α = 0.05 (Sokal & Rohlf, 1981). All statistical analysis and manipulation of data 
was carried out using either Microsoft excel 2010 or Origin Pro 8.6.  
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Chapter 3 Production of Porcine Carotid Acellular Arteries 
3.1 Introduction 
As discussed in Chapter 1 there is a clinical need for “ an off the shelf” small diameter 
vascular graft. The approach that is the subject of this study is through the decellularisation of 
xenogeneic blood vessels that may be repopulated with autologous cells in vitro or in vivo 
with the potential to regenerate the extracellular matrix over time.  
3.1.1 Leeds Decellularisation Method 
There are many approaches taken to achieve successful decellularisation of tissues, 
incorporating a range of physical, chemical and enzymatic processes. At the University of 
Leeds, in the Institute of Medical & Biological Engineering, a patented (Fisher et al., 2001; 
Ingham et al., 2010)  decellularisation process has been developed.  
The proprietary decellularisation process was first established for use in porcine heart valves 
with the hypothesis that an acellular scaffold (seeded or non-seeded) would regenerate in-
vivo and grow with the recipient, creating a valve that would be beneficial to younger patients. 
Several decellularisation protocols were investigated with a variety of reagents and then 
assessed histologically. The valves were aseptically dissected and washed in disinfection 
solution then stored in phosphate buffered saline (PBS) containing protease inhibitors, 
ethylenediaminetetraacetic acid (EDTA) and aprotinin. EDTA is a chelating agent of metal 
ions; it has a high affinity for calcium ions, EDTA sequesters the calcium ions used by 
integrins involved in cell adhesion to the ECM. EDTA also has a high affinity for zinc ions 
making it a potent metalloproteinase inhibitor. The EDTA sequesters magnesium, calcium 
and zinc ions reducing cell attachment to the extracellular matrix and preventing auto 
digestion from metalloproteinases. Aprotinin is a broad spectrum inhibitor of serine 
proteinases; the use of aprotinin prevents released cellular enzymes auto digesting the 
scaffold. 
The first step in the process is to lyse the cells using a hypotonic buffer, again in the presence 
of protease inhibitors. The hypotonic buffer causes the cells to swell and burst through 
osmotic pressure. Secondly a series of detergents were assessed for their ability to remove 
the cells and cellular debris and the minimum concentration at which the detergents would 
achieve this. Thirdly scaffolds were washed repeatedly in isotonic buffer with proteinase 
inhibitors to remove residual reagents and cellular debris. Of the reagents tested, two ionic 
detergents were shown to decellularise porcine aortic valve leaflets, SDS and deoxycholate. 
SDS and deoxycholate are ionic detergents that cause disruption to the phospholipid bi-layer 
of cell membranes and form micelles around lipids. Decellularisation was achieved at 
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concentrations of 0.03 % (w/v) SDS and 0.5 % (w/v)  deoxycholate for valve leaflets, but to 
decellularise aortic roots as well as leaflets the SDS concentration was increased to 0.1 % 
(w/v). Histological analysis showed decellularisation, intact histo-architecture and the 
collagen, elastin and GAG content appeared preserved. Contrary to other published work 
using SDS for the decellularisation of tissues, deleterious effects were not observed. This was 
possibly due to the inhibition of proteinases since increased concentrations of 1 % (w/v) SDS 
caused no damage to the ECM (Booth et al., 2002). Mechanical characterisation of the 
acellular tissue showed no significant effects on the strength of the valve leaflets but a small 
increase in the extensibility, shrinkage, thickness and hydration was observed (Korossis et 
al., 2002). A further enhancement to the decellularisation process was the addition of a 
nuclease digestion step. DNAase and RNAase were added to the process to minimise 
residual DNA and RNA (Wilcox et al., 2005). The biocompatibility of decellularised porcine 
valve tissue was then demonstrated (Wilcox et al., 2005; (Knight et al., 2005). 
The process was then applied to a range of tissues including human amniotic membrane 
(Wilshaw et al., 2006), pericardium (Mirsadraee et al., 2006) and bladder (Bolland et al., 
2007).  
In later studies, the process was applied to porcine iliac and porcine carotid arteries and it 
was shown that it was necessary to include an initial high concentration EDTA wash to 
dislodge endothelial cells and add an additional wash with hypertonic buffer to ensure 
removal of the α-gal epitope (Ingham et al., 2010). The method developed for the 
decellularisation of porcine small diameter arteries had no effect on the biomechanical 
properties of the tissue (Ingham et al., 2010). This process for the decellularisation of porcine 
carotid arteries was adopted for this study.  
3.2 Aims and Objectives 
To apply the Leeds decellularisation protocol to batches of porcine carotid arteries to produce 
biocompatible acellular scaffolds for subsequent studies of the effects of different sterilisation 
processes. 
 To procure and dissect porcine carotid arteries  
 To decellularise porcine carotid arteries  
 To determine the effectiveness of the decellularisation process using histology and 
total DNA quantification 
 To determine the biocompatibility of the acellular porcine carotid arteries using 
contact cytotoxicity assay 
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3.3 Materials and Methods 
3.3.1 Tissue Procurement and Dissection  
Reagents: 
Dulbecco’s Phosphate Buffered Saline (DPBS) 
See section 2.6.6.4 
DPBS and EDTA (2.7 mM; 0.1 %; w/v) 
Five Oxoid Dulbecco’s PBS tablets and 0.5 g of EDTA were dissolved in 500 ml 
distilled water, The pH was adjusted to 7.2 – 7.4 using 6 M hydrochloric acid or 6 M 
sodium hydroxide drop wise whilst using a magnetic stirrer. The solution was 
sterilised by autoclaving. 
Initial Procurement Method: 
Porcine external carotid arteries were sourced from an abattoir from 7-8 month old Large 
White pigs with a carcass weight of 65-85 kg. Arteries were removed during slaughter, frozen 
at -20 oC and then couriered overnight in ice boxes. 
Final Procurement Method: 
Porcine external carotid arteries were sourced from an abattoir from 7-8 month old Large 
White pigs with a carcass weight of 65-85 kg. Arteries were removed during slaughter and 
delivered on the day of slaughter without freezing.  
Dissection Method: 
On arrival in the laboratory, the excess tissue and the adventitia was removed from the 
carotid arteries by blunt dissection to aid the decellularisation process. The arteries were then 
washed three times for 30 minutes in Dulbecco’s PBS containing EDTA (2.7 mM; 0.1 %; w/v) 
to remove excess blood. After washing any remaining adventitia was removed by blunt 
dissection (Figure 3.1). The left or right carotid artery was cut as close to the bifurcation as 
possible.  The length and internal diameters of the arteries were then measured and recorded 
using a purpose built conical ruler. Arteries were labelled and then stored individually at -80 
oC wrapped in DPBS soaked filter paper. 
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Figure 3.1 : Dissected porcine carotid artery 
3.3.2 Decellularisation Process 
Reagents: 
Sodium hydroxide solution (6 M)  
See section 2.6.6.5 
Dulbecco’s Phosphate Buffered Saline (DPBS) 
See section 2.6.6.4. Solutions stored at room temperature and incubated to 4 or 37 
oC for 24 hours prior to use. 
Disinfection Solution  
Sterile DPBS was preheated to 37 oC. Vancomycin, gentamicin and polymyxin B 
(Table 3.1) were defrosted and added to 100 ml of DPBS. The pH was adjusted to 
7.2 – 7.4 using 6 M hydrochloric acid or 6 M sodium hydroxide drop wise whilst using 
a magnetic stirrer. The solution was filtered through a 0.2 µm pore size filter into a 
sterile container and the volume made up to 500 ml with sterile DPBS. The solution 
was used immediately. 
 
Left Carotid 
Right Carotid 
Aortic Arch 
Right Subclavian 
Common Carotid 
Left Subclavian 
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Table 3.1: Antibiotic concentrations in the disinfection solution. 
Antibiotic  Working 
concentration 
Stock 
Concentration  
Volume of stock 
required 
Vancomycin hydrochloride 0.05 mg.ml-1 10 mg.ml-1 2.5 ml 
Gentamicin Sulphate 0.5 mg.ml-1 100 mg.ml-1 2.5 ml 
Polymyxin B 0.2 mg.ml-1 50 mg.ml-1 2.5 ml 
 
EDTA solution (200 mM) 
EDTA (74.4 g) of was dissolved into 1000 ml of distilled water and the pH was 
adjusted to 7.2 – 7.4 using 6 M hydrochloric acid or 6 M sodium hydroxide drop wise 
whilst using a magnetic stirrer. The solution was sterilised by autoclaving. Solution 
stored up to one month at room temperature and cooled  to 4 oC 24 hours before use 
DPBS and EDTA (2.7 mM; 0.1 %; w/v)  
See section 3.3.1 
DPBS and EDTA (2.7 mM) containing aprotinin (10 KIU.ml-1)   
Aprotinin (500 µl) was withdrawn using a needle and syringe aseptically and added 
to 500 ml of sterile DPBS and EDTA solution. Solution to be used on same day. 
SDS solution (10 %; w/v SDS)  
Sodium dodecyl sulphate (10 g) was dissolved into 100 ml of distilled water using a 
magnetic stirrer and stirrer bar, the solution was passed through a 0.2 µm filter into a 
sterile container, 5 ml volumes were then aliquoted into sterile universals and stored 
at room temperature. 
BSA solution (5 %; w/v BSA)  
Bovine serum albumin (0.25 g) was dissolved into 50 ml of DPBS using a magnetic 
stirrer and stirrer bar, the solution was then passed through a 0.2 µm filter into a 
sterile collection container in a class II cabinet. Volumes (5 ml) were then aliquoted 
into sterile universals and frozen at -20 oC. 
Hypotonic buffer (10 mM tris, 2.7 mM EDTA, 10 KIU.ml-1 aprotinin)  
Trizma base (1.21 g) and 1 g of EDTA was dissolved into 900 ml of distilled water, 
the pH was adjusted to 7.2 – 7.4 using 6 M hydrochloric acid or 6 M sodium 
hydroxide drop wise whilst using a magnetic stirrer. The volume was then made up to 
a litre and the solution was sterilised by autoclaving. Solution was stored at room 
temperature. Solution was cooled to 4 oC 24 hours before use.  Just prior to use 1 ml 
of aprotinin solution (10,00 KIU/ml stock) was added. 
- 67 - 
 
 
 
SDS Hypotonic buffer (0.1 % SDS 10 mM tris, 2.7 mM EDTA, 10 KIU.ml-1 aprotinin)  
Autoclaved hypotonic buffer was preheated to 37 oC. SDS solution (10 ml) and 
aprotinin (1 ml) was added to 990 ml of hypotonic buffer just before use. 
DNAase I stock 
DNAase I was rehydrated to a final concentration of 10,000 IU.ml-1 using 5 mM 
sodium acetate, 1 mM calcium chloride and 50 % (v/v) glycerol. The solution was 
then passed through a 0.2 µm filter into a sterile collection container and stored in 
aliquots at  -20 oC. 
RNAase A stock 
RNAase I was rehydrated to a final concentration of 100 IU.ml-1 in distilled water the 
solution was then passed through a 0.2 µm filter into a sterile collection container 
and stored in aliquots at  -20 oC. 
Nuclease solution ( 50 mM tris, 50 µg.ml-1 BSA, 50 IU.ml-1  DNAase, 1 IU.ml-1 RNAase) 
This solution was produced aseptically. Trizma base (6.1 g) and 2.0 g of magnesium 
chloride was dissolved in 80 ml of distilled water using a magnetic stirrer and stirrer 
bar. The pH was adjusted to 7.5 – 7.7 using 6 M hydrochloric acid or 6 M sodium 
hydroxide drop wise whilst using a magnetic stirrer. The volume was then made up to 
990 ml with distilled water and the solution was sterilised by autoclaving. The solution 
was stored at room temperature and incubated to 37 oC 24 hours before use. Just 
prior to use 10 ml of BSA solution, 10 ml of RNAase stock and 5 ml of DNAase stock 
was added to 975 ml of the buffer. 
Hypertonic Solution (50 mM tris, 1.5 M sodium chloride)  
Sodium chloride (87.66 g) and tris (6.06 g) was dissolved into 900 ml of distilled 
water, the pH was adjusted to 7.5 – 7.7 using 6 M hydrochloric acid or 6 M sodium 
hydroxide drop wise whilst using a magnetic stirrer. The volume was then made up to 
a litre and the solution was sterilised by autoclaving. Stored at room temperature and 
incubated at 37 oC for 24 hours prior to use. 
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Method: 
Native porcine carotid arteries sourced using the final procurement method were 
decellularised in four batches of n=10, n=15, n=21 and n=21. The arteries were thawed at 37 
oC. Decellularisation of the arteries was carried out by performing a series of washes; all the 
incubations were carried out with agitation at 120 rpm except the nuclease step which was 
agitated at 20 rpm. This method was used on vessels no larger than 200 mm in length and 
200 ml of solution was used for each vessel placed in 250 ml sterile pots. The washes were 
carried out as shown in Table 3.2. Acellular porcine carotid arteries were stored in DPBS at 5 
oC for up to one month. 
Table 3.2 : Decellularisation process for porcine carotid arteries 
Wash Day Solution Temperature Time 
1 Mon. Disinfection solution 37 oC 0.5 hours 
2 Mon. 200 mM EDTA 4 oC 24 hours 
3 Tue. Hypotonic buffer 4 oC 24 hours 
4 Wed. SDS in Hypotonic Buffer 37 oC 24 hours 
5 Thu. Hypotonic buffer 4 oC 24 hours 
6 Fri. DPBS EDTA containing aprotinin 4 oC 56 hours 
7 Mon. SDS in Hypotonic Buffer 37 oC 24 hours 
8 Tue. DPBS x 3 37 oC 0.5 hours 
9 Tue. DPBS 37 oC ~ 16 hours 
10 Wed. Nuclease solution x 2 37 oC 3 hours 
11 Wed. DPBS x 3 37 oC 30 minutes 
12 Wed. DPBS 37 oC ~ 16 hours 
13 Thu. Hypertonic solution 37 oC 24 hours 
14 Fri. DPBS x 3 37 oC 0.5 hours 
15 Fri. Disinfection solution 37 oC 0.5 hours 
16 Fri. DPBS 4 oC 56 hours 
17 Mon. DPBS 4 oC 24 hours 
18 Tue. DPBS 4 oC 24 hours 
 
3.3.3 Tissue Sampling For Biological And Mechanical Evaluation 
Native and acellular arteries were divided into smaller tissue samples using one of the 
following two methods throughout the study. Sampling method I provided tissues for 
quantitative analyses. Sampling method II was used to provide tissues predominantly for 
qualitative analysis. 
Acellular arteries from batch 1 (n=10) were sampled using method I (n=6) and method II 
(n=4) for direct comparison with native arteries sampled using the same method. Acellular 
arteries from batch 2 (n=15) were intended to be used to assess the effects of Gamma 
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irradiation (n=7 controls; n =8 tests) but were instead used to develop the sterilisation 
method. The Gamma irradiated arteries were sampled using method I (n=5) and method II 
(n=3) and were compared against acellular arteries sampled using method I (n=5) and 
method II (n=2). Acellular arteries from batch 3 (n=21) were used to assess the effects of 
Gamma (n=7 controls; n =7 tests) and E-Beam (n=7 controls; n =7 tests) irradiation. The 
acellular Gamma and E-Beam irradiated arteries were sampled using method I (n=5) and 
method II (n=2) for direct comparison with acellular arteries sampled using the same method. 
Acellular arteries from batch 4 (n=21) were used to assess the effects of freeze-drying (n=7 
controls; n =7 tests) and freeze-drying followed by EO treatment (n=7 controls; n =7 tests) . 
The freeze-dried acellular arteries were sampled using method I (n=6) and method II (n=1), 
the EO treated and acellular arteries used for direct comparison were sampled using method I 
(n=5) and method II (n=2). An overview of the above is displayed in Table 3.3. 
 
Table 3.3 : Overview of the sampling process for each batch and each sterilisation/process 
 Acellular Gamma (1) Gamma (2) E-Beam 
Freeze 
Dried 
EO 
Batch SMI SMII SMI SMII SMI SMII SMI SMII SMI SMII SMI SMII 
1 
(n=10) 
6 4           
2 
(n=15) 
5 2 5 3         
3 
 (n=21) 
5 2   5 2 5 2     
4 
(n=21) 
5 2       6 1 5 2 
Gamma (1) group of arteries used for method development, Gamma (2) irradiated arteries used for 
statistical comparisons. 
Reagents: 
Dulbecco’s Phosphate Buffered Saline (DPBS) 
See section 2.6.6.4 
Method: 
Native arteries were thawed for twenty minutes in a 37 oC water bath; acellular arteries were 
sampled aseptically in a class II hood. 
Sampling method I: 
Arteries were sampled as shown in Figure 3.2. Sampling began at the proximal end of the 
artery on a sterile petri dish for each artery.  
 
 
Figure 3.2 : Image depicting sampling method I of porcine carotid arteries 
Distal Proximal  
A   C   B   D             E                                    F 
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A. A 5 mm width sample for circumferential stress-strain analysis was removed and placed in a 
sterile bijou containing 15 ml of DPBS. Stored at 4 oC and used on the same day as 
sampling. Uniaxial tensile testing is described in section 4.3.4 
B. A 15 mm length x 5 mm width (length is longitudinal) sample for axial stress-strain analysis 
was removed and placed in a bijou containing 15 ml of DPBS. Stored at 4 oC and used on 
the same day as sampling.  
Uniaxial tensile testing is described in section 4.3.4 
C. For multiphoton imaging a circular disc was removed using a 5 mm diameter hole punch and 
stored at – 20 oC on DPBS soaked filter paper until used.  
The method for multiphoton imaging is later described in section 6.4.5 
D. For differential scanning calorimetry a circular disc was removed using a 5 mm diameter hole 
punch and stored at – 20 oC on DPBS soaked filter paper until used.  
The method for differential scanning calorimetry is later described in section 6.4.6 
E. A 50 mm length was used to carry out compliance and burst pressure testing. These were 
placed in universals containing 25 ml DPBS. Stored at 4 oC and used on the same day as 
sampling. 
Compliance and burst pressure testing is described in section 4.3.3 
F. The remaining tissue, when sufficient, was used for the denatured collagen assay and stored 
at – 20 oC on DPBS soaked filter paper until used. 
The method for the determination of denatured collagen content is described in section 
2.6.10. 
Sampling method II: 
Arteries were sampled as shown in Figure 3.3. Sampling began at the proximal end of the 
artery on a sterile petri dish for each artery.  
 
 
 
Figure 3.3 : Image depicting sampling method II of porcine carotid arteries. 
 
A. A 3 mm sample for histological analysis was removed and placed in a histology cassette and 
fixed in zinc fixative. 
The methods used for histological analysis are described in section 2.6.6  
B. A 50 mm length sample was removed either for thrombogenicity assessment or as control 
tissue. The sampled tissue was placed in universals containing 25 ml DPBS and stored at 4 
Distal Proximal  
A                      B                     CD     E         F 
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oC and used same day as sampling, control tissue was stored at -20 oC in a bijou surrounded 
by PBS soaked filter paper until used.  
C. A 5 mm2 square for contact cytotoxicity testing was removed and stored at -20 oC in a bijou 
surrounded by DPBS soaked filter paper until used. 
Methods for determining biocompatibility are described in section 2.6.9.1 
D. A 5 mm length sample for sterility assessment was removed and placed in 25 ml nutrient 
broth for sterility assessment. 
The method used for determining sterility is described 2.6.9.1 
E. A 15 mm length sample was either macerated for DNA quantification or stored as control 
tissue. These samples were stored at -20 oC in a bijou surrounded by PBS soaked filter 
paper until used. 
The method for DNA quantification was previously described in section 2.6.7 
F. A 15 mm length sample for control tissue was removed and stored at -20 oC in a bijou 
surrounded by DPBS soaked filter paper until used. 
3.3.4 Determination Of The Effectiveness Of The Decellularisation Process And 
The Biocompatibility Of Acellular Porcine Carotid Arteries 
After decellularisation acellular and native porcine carotid arteries were compared by histology using 
haematoxylin and eosin staining, DAPI staining and immunohistochemical labelling of collagen IV in 
tissue sections (Section 2.6.6). The DNA was extracted from the tissues for determination of total 
DNA content (Section 2.6.7). Sterility of the acellular tissues (Section 2.6.9.1) was assessed prior to 
biocompatibility testing using contact cytotoxicity assays (Section 2.6.8 and 2.6.9.2). 
3.4 Results 
Porcine carotid arteries were sourced from two abattoirs. Quality assessments were 
performed to identify arteries suitable for use. Following selection, four batches of arteries 
were then subjected to the Leeds decellularisation process and were subject to limited 
analysis to determine the success of the decellularisation process.  
Initial Procurement Investigation  
Porcine carotid arteries were initially procured from a long distance supplier. The process was 
not monitored correctly and initially arteries were being removed on the day of slaughter and 
then frozen at -20 oC after an unknown period at ambient temperature. Arteries were then 
delivered by overnight courier in ice boxes. Arteries arrived in the laboratory at different 
stages of the thawing process, ranging from frozen to completely thawed. Arteries were then 
blunt dissected (Section 3.3.1) and frozen at -80 oC. Histological analysis of the porcine 
carotid arteries after thawing provided images of the microstructure of the arteries. The 
images showed repeated areas of perforations in the arteries. An alternative source of 
arteries enabled delivery of porcine carotid arteries on the day of slaughter, these arteries 
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were also blunt dissected and frozen at -80 oC and stored for one week before thawing. After 
thawing the arteries were subject to histological analysis and imaging of histological sections 
showed that these arteries had normal histo-architecture. Images of histological sections of 
deteriorated arteries from the first supplier (left) and normal arteries from the second supplier 
(right) are presented in  Figure 3.4. 
  
Figure 3.4: Representative images of histological sections of fresh porcine common carotid arteries 
from two different suppliers. 
(A) Long distance tissue supplier (B) tissue supplied on the day of slaughter. The sections were stained with 
haematoxylin and eosin; the images were captured at 40x and 20x magnification respectively. 
3.4.1 Sterility Testing Of Acellular Porcine Carotid Arteries 
Samples from each batch of acellular porcine carotid arteries were tested to determine 
sterility by placing them in nutrient broth and incubating at 37 oC for 48 hours. In the first 
batch samples were taken from the extra tissue from each artery in sampling method I as well 
as sampling method II. No contamination was found in any batches  
 
 
Figure 3.5 : Images of sterility tests carried out on batch 1 of acellular arteries.  
Images of sterility testing of acellular porcine carotid arteries from sampling method I and sampling method II. 
Positive controls of dermal commensal organisms and negative controls of sterile nutrient broth were 
incubated alongside samples.  
-VE          -VE     +VE       +VE     
  +VE   +VE     +VE   
-VE       -VE       -VE 
  Sampling Method II  
  Sampling Method I  
A B 
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3.4.2 Histological Analysis 
Haematoxylin and eosin and DAPI stained sections (Figure 3.6) confirmed the presence of 
cell nuclei and nuclear material in native arteries as well as the typical arterial structure, 
consisting of the intima, media and adventitia. In acellular arteries there was a distinct 
absence of cell nuclei and nuclear material; there was also preservation of the arterial 
structure but collagen and elastin fibres exhibited a wave pattern due to the absence of cells. 
  
  
Figure 3.6 : Representative images of histological sections of native and acellular porcine common 
carotid arteries from batch 1. 
Sections were stained with haematoxylin and eosin (A, B) or DAPI (C, D). Native arteries showed the 
presence of nuclei (A, C) . There was an absence of nuclei in acellular arteries (B, D). The images confirmed 
the presence of nuclei in native arteries and the absence of nuclei in decellularised arteries as well as the 
preservation of ECM structure. 
 
 
 
 
 
 
 
A B 
C D 
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3.4.3 Immunohistochemical Labelling Of Collagen IV 
Immunohistochemical labelling of collagen IV in tissue sections showed positive staining in 
regions of native and decellularised arteries (Figure 3.7). Both the intima and media were 
strongly stained across the whole region with an absence of staining in the adventitial region. 
There was no observable staining in the section used for either the isotype antibody control or 
the antibody diluent. 
  
  
Figure 3.7 : Representative images of sections of native and acellular porcine common carotid 
arteries (batch 1) labelled using immunohistochemistry with an antibody to collagen IV.  
Sections were labelled with antibodies to collagen IV (A, C) and isotype antibody control (B) as well as an 
antibody diluent control (D). Native (A) and acellular arteries (C) showed positive staining across the intima 
and media but no staining in the adventitia. Controls showed no positive staining.. The images confirmed the 
presence of collagen IV in the intima and media of native and decellularised arteries. 
 
 
 
 
 
 
 
A B 
C D 
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3.4.4 DNA Content 
DNA was extracted from samples of native (n = 6) and acellular (n = 4) arteries using a DNA 
isolation kit (Qiagen). The total DNA content was quantified by measuring the absorbance 
using a nanodrop spectrophotometer at 260 nm (Figure 3.8). Native tissue had 708 ± 184 
ng.mg-1 (mean ± 95 % confidence intervals) DNA per wet weight of tissue and acellular 
arteries had 8 ± 4 ng.mg-1 DNA per wet weight of tissue demonstrating a 97.6 to 99.6 % 
(w/w) reduction in DNA content (batch 1). 
 
Figure 3.8 : Total DNA content of native and acellular porcine carotid arteries from batch 1.  
Post decellularisation there was a 97.8 to 99.5 % reduction in total DNA content. Data expressed as the 
mean (native, n=6; acellular, n=4) ± 95% C.L. 
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3.4.5 Contact Cytotoxicity  
Acellular arteries were incubated with L929 and BHK cell lines to assess biocompatibility, 
steri strips were used as a negative control and cyanoacrylate was used a positive control. 
The phase contrast (Figure 3.9) and giemsa stained (Figure 3.10) images at 48 hours showed 
that the cell lines grew up to both acellular arteries and steri strips indicating there was no 
cytotoxic effect on both L929 and BHK cells. Normal cell morphology was observed 
compared to confluent cells alone and cyanoacrylate was highly cytotoxic and caused cell 
lysis. 
   
   
Figure 3.9 : Representative images captured using phase contrast microscopy of BHK and L929 cells 
growing in contact with acellular porcine carotid artery samples from batch 1. 
BHK (A-C) and L929 (D-F) cell lines Incubated with acellular arteries (A, D), steri-strips (B, E) and 
cyanoacrylate (C, F). Images were captured at x40 magnification. 
 
   
   
Figure 3.10 : Representative images captured using light microscopy of BHK and L929 cells stained 
with geimsa growing in contact with acellular porcine carotid artery samples from batch 1.   
BHK (A-C) and L929 (D-F) cell lines Incubated with acellular arteries (A, D), steri-strips (B, E) and 
cyanoacrylate (C, F). Images were captured at x40 magnification. 
B 
D 
A 
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3.4.6 Summary Of Data On Determination Of The Effectiveness Of 
Decellularisation Of The Four Different Batches Of Acellular Porcine Carotid 
Arteries 
A summary of the data on the assessment of the effectiveness of decellularisation for the four 
batches of decellularised arteries used throughout the project is presented in Table 3.4. 
Table 3.4 : Summary of analysis of four batches of acellular arteries for the effectiveness of the 
decellularisation process. 
Batch Absence of 
nuclei in 
H&E/DAPI 
Positive 
staining for 
collagen IV 
Total DNA Content 
(ng.mg-1) 
 
Biocompatibility 
contact 
cytotoxicity 
(1), PCA1-6 (n=10)     8.2 ± 4.2   
(2), PCA7-12 (n=15)     8.0 ± 23.6   
(3), PCA13-33 (n=21)     7.6 ± 1.4   
(4), PCA34-54 (n=21)     6.3 ± 2.1   
3.5 Discussion 
The aim of the research described in this chapter was to produce acellular vascular scaffolds 
derived from porcine carotid arteries using the patented vascular decellularisation process 
(Ingham et al., 2010), for use in subsequent studies of the effects of different sterilisation 
processes. 
Once the evidence of damage to porcine carotid arteries had been identified in artery 
supplies arriving on site, it was important to investigate the cause to prevent further 
incidences occurring that may have the potential to give false positive results for damage. As 
the problem was intermittent at first, it was not picked up initially, this highlighted the 
necessity of monitoring the delivery process of tissues and having routine quality measures in 
place to check the suitability of the arteries. A large body of work had been carried out before 
switching supplier and although this was a substantial oversight this knowledge can be 
passed on to colleagues to prevent similar issues arising.   
The cause of the damage to the arteries delivered by the long distance supplier could be 
attributed to two root causes. Firstly, damage may have been caused by the freezing process 
of the arteries. Slow freezing rates could have promoted extracellular over intracellular ice 
crystal formation, which has been shown to cause increased damage to the extracellular 
matrix (Gage & Baust, 1998; Meryman, 1960; Devireddy et al., 2003). Secondly, damage may 
have been caused by autolysis. As the time after slaughter that the arteries were frozen was 
not monitored and the thaw cycle occurring in transit, there was opportunity for the arteries to 
degrade before freezing or after thawing. After slaughter, cells are subject to ischemic injury 
to a lethal extent and cells die via necrosis. Cell death via necrosis causes leakage of cellular 
enzymes such as metalloproteinases and serine proteinases. These proteinases have the 
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ability to digest the ECM and could have caused the atypical gaps observed in the 
histological images. The  arteries from the local supplier were delivered on the day of 
slaughter,  this enabled control of the freeze-thaw process and prevented any further supply 
issues.  
Once the quality of the source material was established, arteries were decellularised in four 
separate batches. Although no definitive criteria have been set at which a tissue can be 
considered decellularised, Crapo et al. (2011) has described a set of minimum requirements: 
1. < 50 ng dsDNA per mg ECM dry weight 
2. < 200 bp DNA fragment length 
3. Lack of visible nuclear material in tissue sections with 4',6-diamidino-2-phenylindole 
(DAPI) or H&E 
Previous studies within the department have validated the effectiveness of the 
decellularisation process on porcine internal carotid arteries and porcine external iliac arteries 
(Ingham et al., 2010). As this part of the study was not novel or intended to create acellular 
arteries for clinical trials it was the aim of this chapter to show the effectiveness of the 
decellularisation process in my hands with a limited set of tests. The acellularity was 
assessed with the use of total DNA quantification, visual inspection of histological sections 
stained for nuclear material and a biocompatibility assay. 
The test method used in this study for the quantification of DNA content has been used 
historically within the department. Total DNA content showed a greater than 80 % reduction in 
all four of the batches. The method determines the total DNA content based on the wet 
weight of the tissue, this can be approximated as 3 times less than the dry weight 
concentration meaning all the results were well below the total DNA content specified by 
Crapo et al. (2011). The total DNA content of porcine carotid arteries before and after 
decellularisation were also similar to those found previously in the department for porcine 
carotid and iliac arteries (Ingham et al., 2010; Owen et al., 2012). 
Both DAPI and H&E staining were used to confirm the absence of visible nuclear material in 
sections of acellular porcine carotid arteries and positive controls of native porcine carotid 
arteries were used to demonstrate the validity of the method. H&E/DAPI staining was 
negative in histological sections of all four batches of acellular arteries and positive in 
histological sections of native porcine carotid arteries.  
The biocompatibility was confirmed through the use of contact cytotoxicity assay. Normal 
cellular morphology was observed with no zone of inhibition in microscopic images for both 
cell lines tested using tissue samples from all batches of acellular arteries.  
These results demonstrated that decellularisation was effective on porcine carotid arteries 
and correlated well with previous data from testing on porcine external iliac arteries. 
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By these assessments the aims of this part of the study had been achieved. Acellular arteries 
derived from porcine carotid arteries were reproduced consistently, that were biocompatible 
and sterile, and therefore suitable for subsequent studies. Prior to using the acellular arteries 
to assess the effects of different  sterilisation processes, it was necessary to develop robust 
methods to determine the biomechanical properties of the acellular arteries.  This was the 
focus of the next part of the study described in Chapter 4. 
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Chapter 4 Development of Mechanical Testing Methods  
4.1 Introduction 
Tissues in the body vary in composition and orientation of cells, fibres and extra-cellular 
matrix, which is dependent on the functional requirement. The main structural components 
within tissues are elastin, collagen and glycosaminoglycans.   
The extension and recoil characteristics of elastin are primarily responsible for the elasticity 
and compliance properties of a tissue, the triple helical structure of collagen is primarily 
responsible for the high tensile stiffness and ultimate tensile strength and 
glycosaminoglycans are primarily responsible for the compressive properties of a tissue. 
In arteries the tunica media is the thick central layer and contributes most to the overall 
mechanics of an artery. It is populated by predominantly smooth muscle cells, organised in 
the circumferential direction, and surrounded by a dense mesh of collagen and elastin fibres 
orientated circumferentially.   
Determination of the biomechanical properties of vascular grafts is an important aspect to be 
considered. In order for a graft to be suitable for use it should have adequate strength to 
resist the extremes of physiological pressure that it will be subjected to and it should also 
have a compliance that provides a similar or better response to haemodynamics than 
analogous tissue.  
Uniaxial tensile testing, compliance and burst pressure testing are common methods 
employed to determine the mechanical characteristics in arteries.  
With regard  to uniaxial tensile testing, it is important to consider preloading. Dependent on 
the test method employed it can be difficult to ascertain if the tissue is in a zero-stress or 
natural state before loading. Preloading is a method of applying a small load, usually within 0-
10 % of the failure load and then assigning zero to the strain and load at this preload. This is 
carried out  to ensure any slack has been taken up, which could potentially impact the data 
for the derived parameters. The zero-stress state is critically dependent on the design and 
setup of the equipment being used, therefore if preloading is being used it is essential to 
determine the correct level of preloading for that particular piece of equipment. If the preload 
is set too high it may mask any differences in properties derived from the parameters for 
different samples.  
Dependent on the design of equipment and the method being used, compliance testing can 
be a very useful tool for determining three dimensional behaviour of the mechanical 
properties of arteries. Since  compliance mismatch has been highlighted as one of the key 
- 81 - 
failure mechanisms of arterial grafts, development of a reliable method to assess the 
compliance of the native, acellular and acellular sterilised arteries was essential to this study.  
The  focus of the research in this chapter was to develop a robust method to determine the 
compliance of native and acellular porcine carotid arteries and to investigate the required 
level of preloading using a purpose built rig for the determination of stress-strain parameters 
of native and acellular vascular grafts. 
4.2 Aims and Objectives 
The aim of this chapter was to develop robust methods to determine mechanical properties of 
porcine carotid arteries and evaluate the effects caused by decellularisation by comparing the 
mechanical properties of native and acellular arteries. The specific objectives were: 
 To develop a robust working method for compliance testing of porcine carotid arteries 
 To determine the compliance of native and acellular porcine carotid arteries 
 To investigate the effects of preloading of porcine carotid artery tissue and determine 
an acceptance preload for use in uniaxial tensile tests. 
 To determine the uniaxial tensile parameters of native and acellular porcine carotid 
arteries 
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4.3 Materials and Methods 
4.3.1 Tissue Procurement And Dissection 
The native porcine carotid arteries used in this chapter were procured and dissected 
according to the method described in Section 3.3.1. 
4.3.2 Decellularisation Of Native Porcine Carotid Arteries 
The acellular arteries used in this chapter were from batch 1 (Section 3.4.6) and were 
processed using the method described in Section 3.3.2. 
Tissue sampling for mechanical evaluation  
The samples used for mechanical evaluation were obtained as described in Section 3.3.3. 
4.3.3 Development Of Compliance And Burst Pressure Testing 
4.3.3.1 Preliminary analysis of methods 
Reagents: 
Dulbecco’s Phosphate Buffered Saline (DPBS) 
Described in Section 2.6.6.4  
Method: 
Native arteries were mounted to a custom built rig. The rig consisted of a pressure inlet, a 
compliance chamber, a pressure gauge and an inflation chamber containing a scale ruler 
(Figure 4.1).  
 
Figure 4.1 : Image of the equipment setup used  for determination of the compliance and burst 
pressure testing. 
 
Compliance 
Chamber 
Pressure 
Gauge 
Inflation 
Chamber 
Pressure inlet 
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Four methods for determination of the compliance of the arteries were investigated. In all 
methods, the proximal end of the artery was attached to the rig inside the inflation chamber. 
The four methods varied in approach to the mounting of the distal end of the vessel (Figure 
4.2). In the first method the distal end was ligated and left to freely orientate in space (Original 
Method). In  the second method the distal end was fixed to a static hose barb (Fixed Position 
Method). For the third method the distal end was ligated  and tension was applied manually 
along a suture (Manually Adjusted Method). The fourth method involved applying tension 
along a suture via a constant load of 15 g (Constant Weight Method).  
 
 
  
Figure 4.2 : Compliance and Burst Pressure Rig Setup. 
Depiction of the four methods investigated for compliance testing of arteries.: Original Method (A), Fixed 
Position Method (B), Manually Adjusted Method (C), and Constant Weight Method (D). 
 
The arteries were filled with 120 ml DPBS from a compliance chamber and then subjected to 
increasing pressure in increments of ~20 mmHg up to 200 mmHg at room temperature. At 
each measurement the pressure was recorded and an image taken using an aerial mounted 
digital camera.  After 200 mmHg the pressure was steadily increased incrementally by 50 
mmHg until either bursting or a pressure safety valve of 3700 mmHg was met. The images 
were then imported into Image Pro Plus (MediaCybernetics) and used to measure the 
diameter and the length at each pressure increment. The measurements from the final 
adopted method were used to calculate the percentage diameter and length change using the 
following equation where X = diameter or length, X’ = original diameter or length and P = 
pressure: 
 
 
A 
C D 
B 
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∆𝑪 =
(𝑿𝒏 − 𝑿
′) × 𝟏𝟎𝟎
𝑷′
 
 
4.3.3.2 Reproducibility 
The constant weight method was repeated with native arteries (n=3) to determine if the 
method was consistent. The percentage diameter and length change data was arcsine 
transformed, the means and 95 % confidence intervals calculated and the data was back-
transformed for presentation purposes. 
4.3.3.3 Sensitivity Analysis 
The constant weight method was then investigated to determine its sensitivity to the mass of 
the constant load for both percentage diameter and length increase. The method was 
repeated on native arteries (n=5) ,altering the weight between 5, 10 and 15 g on each artery. 
4.3.3.4 Compliance testing of native and acellular arteries 
Compliance and burst pressure testing was carried out on native (n=3) and acellular (n=5) 
arteries using the constant weight method with a 10 g load to determine the effects of 
decellularisation. 
4.3.4 Uniaxial Tensile Testing  
Reagents: 
Dulbecco’s Phosphate Buffered Saline (DPBS) 
As described in Section 2.6.6.4  
Method: 
Uniaxial tensile testing was carried out on an Instron 3365 tensile tester using a 50 N load 
cell. Samples of native and acellular porcine carotid artery were cut using a purpose built 
cutter at a constant width of 3 mm. At this point the  tissue thickness was measured using a 
Mitutoyo thickness gauge (± 0.01 mm) and then replaced in PBS until tested.  Once all test 
samples had been prepared individual strips were then mounted using a purpose built rig that 
allowed the gauge length to be set at 6 mm using a spacer bar. The rig prevented loading 
until the start of the test (Figure 4.3).  
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Figure 4.3 : Schematic of the purpose built rig for tensile testing of arteries 
 
The test sample was  immersed in PBS at room temperature for the duration of the testing 
using a water bath (Instron). Samples were then loaded and extended at 10 mm·min−1  and 
the load measured using a 50 N load cell. Samples were then loaded to failure (Figure 4.4). 
 
Figure 4.4 : Image of porcine carotid artery loaded to faliure using a purpose built rig placed in a 
waterbath.  
 
The resulting force extension curves were transformed into stress strain curves using the 
following formulas: 
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Engineering stress     𝜎 𝑒𝑛𝑔 =
𝐹
𝐴𝑜
  
Engineering strain  𝜀 𝑒𝑛𝑔 =  
∆𝐿
𝐿𝑜
 
Where, E is the engineering stress in MPa, F is the measured force in N, Ao is the 
undeformed cross-sectional area in mm2, Es is the engineering strain ratio, DL is the 
extension of the specimen in mm and Lo is the original length of the specimen in mm. 
To apply a preloading at ranges of 0.01 N, 0.02 N, 0.05 N. 0.1 N and 0.2 N, data was 
manipulated by subtracting as a constant the extension at the given preload from all 
extension data points. The original length was modified by adding the extension at a given 
preload to create a new original length. The force was zeroed by subtracting the given 
preload as a constant from all force measurements.  
 
Preloaded engineering stress     𝜎 𝑒𝑛𝑔 =
𝐹−𝑃𝐿𝐹
𝐴𝑜
  
Preloaded engineering strain  𝜀 𝑒𝑛𝑔 =  
∆𝐿−𝑃𝐿𝑒
𝐿𝑜+𝑃𝐿𝑒
 
 
Each stress strain curve was then analysed by means of six parameters: elastin modulus, 
collagen modulus, transition stress, transition strain, ultimate tensile stress and ultimate 
tensile strain. The elastin and collagen modulus were determined from the slope of the 
respective phases using regression analysis to provide the Young’s modulus. 
The parameters for native and acellular arteries were averaged and expressed as means ± 
95 % CL. Using SPSS statistical software, a two way ANOVA was carried out followed by 
post-hoc Tukey test to compare the group means. 
 
Figure 4.5 : Chart representing the six parameters derived from stress strain curves from uniaxial 
tensile testing 
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4.4 Results 
4.4.1 Development Of Compliance And Burst Pressure Test Method 
In order to develop a burst pressure test method it was first necessary to compare the 
proposed methods visually and analytically to gain an initial understanding of which method 
was suitable. 
4.4.1.1 Preliminary analysis of methods 
Native porcine carotid arteries were tested for compliance using the following four methods: 
1. Original Method - distal end of artery ligated and left to freely orientate in space (n=2) 
2. Fixed Position Method - distal end of artery fixed to a static hose barb (n=1) 
3. Manually Adjusted Method- and tension applied manually along a suture (n=2) 
4. Constant Weight Method - distal end of artery ligated and tension applied along a 
suture via a constant load of 15 g (n=2) 
The results are presented in Figure 4.6. Images captured using each test method are 
presented in Figure 4.7. Testing of the arteries using the original and the manually adjusted 
methods gave varied and inconsistent measurement of the change in percentage diameter. 
Visual inspection of the original and fixed position methods showed the artery moving out of 
the camera view plane. The constant weight method gave rise to data which had less 
fluctuation. The curves for percentage diameter increase with increase in pressure for the 
constant weight method exhibited a biphasic pattern with an initial phase of steeper diameter 
increase followed by a shallower diameter increase.  
 
Figure 4.6 : Percentage diameter change in arteries with increasing pressure determined using four 
methods of compliance measurement.  
Curves showing the percentage diameter increase with pressure increase for the four preliminary methods 
investigated including: Original Method, Fixed Position Method, Manually Adjusted Method, and Constant 
Weight Method. 
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Figure 4.7 : Representative images of arteries captured during testing using the four different 
methods of measuring compliance. 
Original Method (A), Fixed Position Method (B), Manually Adjusted Method (C), and Constant Weight Method 
(D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
C D 
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4.4.1.2 Reproducibility of the Constant Weight Method for Measurement of Compliance 
The percentage diameter change was measured and compared in three native porcine 
carotid arteries with increasing pressure using the constant weight method (15 g). The results 
are presented in Figure 4.8. The compliance curves showed similar patterns with an initial 
sharper percentage diameter increase with increasing pressure, followed by a shallower 
gradient. There was greater variation in the percentage diameter increase at low pressures 
than there was at increased pressure, resulting in a decrease in  95 % confidence levels with 
increasing pressure. 
 
 
Figure 4.8 : Reproducibility of percentage diameter increase of porcine carotid arteries tested using 
the constant weight method.  
Individual and average curves showing the percentage diameter increase with pressure increase of native 
arteries using the constant weight method. Data (average curve) expressed as the mean (n=3) ± 95% C.L. 
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4.4.1.3 Sensitivity Analysis to Investigate the Impact of Load on Compliance  
A sensitivity analysis to investigate the impact of varying load on the compliance of native 
arteries (n=5) was carried out. The load applied to the arteries was varied using 5, 10 and 15 
g for each artery and the percentage diameter and length change with increasing pressure 
determined. The results are presented in Figure 4.9 and Figure 4.10. All data was arcsine 
transformed before it was analysed by analysis of variance and Tukey post-hoc testing. The 
average percentage diameter increase curves showed an initial rapid dilation with increasing 
pressure, followed by a shallower period of dilation for the three loads tested. With increased 
load the percentage diameter increase curves became aligned. At 20 mmHg the percentage 
diameter increase using the 5 g load was significantly less (ANOVA with Tukey post-hoc test; 
p<0.05)  than the percentage diameter change using the 10 and 15 g load. At 40 mmHg and 
above there was no significant difference between the percentage diameter for the three 
loads. The average percentage length change curves showed a linear extension for all three 
loads tested, with length increasing with increasing load. At 20 and 40 mmHg the percentage 
length change using a 5 g load was significantly less (ANOVA with Tukey post-hoc test; 
p<0.05)  than with the 15 g load. Above 40 mmHg there was no significant difference 
between the percentage length increase for the three loads (ANOVA with Tukey post-hoc 
test; p<0.05).  
 
Figure 4.9 : Sensitivity Analysis of Load on Percentage Diameter Change of Arteries with Increasing 
Pressure.  
Averaged percentage diameter increase curves under  5, 10 and 15 g loads with increasing pressure. Data 
expressed as the mean (n=5) ± 95 % C.L. Data was arcsine transformed and analysed by analysis of 
variance and individual differences between group means determined by the Tukey posy-hoc test. This 
showed a significantly lower mean diameter increase with the 5 g load compared to the 10 and 15 g loads at 
20 mmHg. 
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Figure 4.10 : Sensitivity Analysis of Load on Percentage Length Change of Arteries with Increasing 
Pressure.  
Averaged percentage length increase curves under  5, 10 and 15 g loads with increasing pressure. Data 
expressed as the mean (n=5) ± 95 % C.L. Data was arcsine transformed and analysed by analysis of 
variance and individual differences between group means determined by the Tukey post-hoc test. This 
showed a significantly lower mean length change with the 5 g load compared to the 15 g loads at 20 and 40 
mmHg . 
 
Following these results all compliance and burst pressure testing was carried out by attaching 
a constant weight of 10 g to the ligated artery.  
- 92 - 
4.4.1.4 Determination of Compliance of Native and Acellular Porcine Carotid Arteries 
Using the compliance method developed native (n=3) and acellular (n=5) arteries were 
subjected to burst pressure and compliance testing. Arteries were inflated incrementally up to 
200 mmHg and the length and diameter measured at each increment. From these 
measurements the percentage diameter change was calculated and is displayed in Figure 
4.11, and the percentage length change was calculated and is displayed in Figure 4.12. 
Means for percentage diameter and length change at 100 mmHg were arcsine transformed 
before being statistically compared by analysis of variance ;p>0.05. The results are shown in 
Table 4.1 and Table 4.2, respectively.  After 200 mmHg arteries were inflated to rupture.  
Native and acellular arteries exhibited a slightly steeper incline below 40 mmHg before 
maintaining a linear increase in percentage diameter change. At 100 mmHg there were no 
significant differences (ANOVA; p>0.05) in percentage diameter change. 
Native and acellular arteries exhibited a linear constant rate of percentage length change with 
increasing pressure there. At 100 mmHg there were no significant differences (ANOVA; 
p>0.05) in percentage diameter length. 
All arteries exceeded a burst pressure of 3000 mmHg. 
 
 
Figure 4.11 : Average Percentage Diameter Change of Native and Acellular Arteries with Increasing 
Pressure. 
Averaged percentage diameter increase curves of native (n=3) and acellular (n=5) arteries with increasing 
pressure. Data was arcsine transformed and analysed by one way ANOVA, p>0.05 and then back 
transformed for presentation purposes. Data  expressed as the mean ± 95 % C.L.  
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Table 4.1 : Average Percentage Diameter Change of Native and Acellular Arteries at 100 mmHg 
Percentage Diameter Change (100 mmHg) 
Native  Acellular 
Mean Upper 95 % CL Lower 95 % CL Mean Upper 95 % CL Lower 95 % CL 
15.31 11.47 8.70 9.21 4.98 3.99 
Data was arcsine transformed and analysed by one way ANOVA which showed no significant difference 
(p>0.05) and then back transformed for presentation purposes. Data  expressed as the mean ± 95 % C.L. 
Means were not significantly different. 
 
 
Figure 4.12 : Average Percentage Length Change of Native and Acellular Arteries with Increasing 
Pressure. 
Averaged percentage length change curves of native (n=3) and acellular (n=5) arteries with increasing 
pressure. Data was arcsine transformed and analysed by one way ANOVA, p>0.05 and then back 
transformed for presentation purposes. Data  expressed as the mean ± 95 % C.L.  
 
 
Table 4.2 : Average Percentage Length Change of Native and Acellular Arteries at 100 mmHg 
Percentage Length Change (100 mmHg) 
Native  Acellular 
Mean Upper 95 % CL Lower 95 % CL Mean Upper 95 % CL Lower 95 % CL 
2.79 4.88 2.49 3.75 3.94 2.57 
Data was arcsine transformed and analysed by one way ANOVA which showed no significant difference 
(p>0.05) and then back transformed for presentation purposes. Data  expressed as the mean ± 95 % C.L. 
Means were not significantly different. 
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4.4.2 Investigation Of The Effects Of Preloading In Tensile Testing Of Native And 
Acellular Porcine Carotid Artery Tissue 
4.4.2.1 Effects of Varying Preload on Individual Parameters Extracted from Stress 
Strain Curves  
Three native arteries and six acellular arteries were subjected to uniaxial tensile testing in 
both the axial and circumferential directions. The data was then manipulated to apply varying 
levels of preloading. This was carried out by zeroing the force extension curves at increasing 
levels of loading (0.01, 0.02, 0.05, 0.10 and 0.20 N) and then creating stress strain curves 
with transformed data. Six parameters: transition strain, transition stress, ultimate tensile 
strain, ultimate tensile stress, collagen modulus and elastin modulus were extracted from the 
data at each level of preload and were compared using two way ANOVA (tissue type vs pre-
load) and the Tukey post-hoc test (p<0.05). The results are presented as average stress 
strain curves in Figure 4.13 and Figure 4.14 and the extracted parameters are displayed in 
Table 4.3-Table 4.8. Each stress strain curve exhibited biphasic characteristics with an initial 
shallow gradient in which the artery was more extensible followed by a secondary steep 
gradient in which the artery became stiffer and less extensible. Varying the levels of 
preloading had little effect on the transition stress, ultimate tensile stress and collagen 
modulus parameters; no significant differences between testing without preloading were 
found below 0.2 N of preloading. Transition strain and ultimate tensile strain parameters were 
the most sensitive to variations in the level of preload. These parameters were significantly 
lower at 0.02 N of preload compared to 0 N of preload. There were also significant effects on 
the elastin modulus but at much higher levels of preload with significantly lower results 
beginning at 0.1 N of preload when compared to 0 N of preload. 
 
Figure 4.13 Average Stress Strain Curves of Native and Acellular Arteries Tested in the 
Circumferential Direction at Varying Levels of Preload 
Stress strain curves of native (n=3) and acellular (n=6) arteries exhibited biphasic characteristics. The initial 
phase had a shallow gradient in which was more extensible under stress. The second phase had a steeper 
gradient in which the artery became stiffer and less extensible under stress. Applying preload showed little 
effect on the ultimate tensile stress and the gradient of the second phase however the initial phase showed 
an increased gradient as well as large reduction in strain parameters.  
- 95 - 
 
Figure 4.14 Average Stress Strain Curves of Native and Acellular Arteries Tested in the Axial 
Direction at Varying Levels of Preload 
Stress strain curves of native (n=3) and acellular (n=6) arteries exhibited biphasic characteristics. The initial 
phase had a shallow gradient in which was more extensible under stress. The second phase had a steeper 
gradient in which the artery became stiffer and less extensible under stress. Applying preload showed little 
effect on the ultimate tensile stress and the gradient of the second phase however the initial phase showed 
an increased gradient as well as large reduction in strain parameters.  
 
Table 4.3 : The Average Transition Strain for Native and Acellular Arteries in the Circumferential and 
Axial Direction at Varying Levels of Preload 
Transition Strain Mean ± 95 % CL 
Preload 0.00 N 0.01 N 0.02 N 0.05 N 0.10 N 0.20 N 
Native Circumferential 0.66±0.07 0.61±0.01 0.57±0.11 0.47±0.11* 0.36±0.08* 0.22±0.04* 
Native Axial 0.85±0.51 0.67±0.25 0.6±0.22 0.45±0.18* 0.29±0.2* 0.11±0.16* 
Acellular Circumferential 0.6±0.09 0.55±0.08 0.52±0.07 0.43±0.06* 0.34±0.05* 0.24±0.04* 
Acellular Axial 0.97±0.06 0.85±0.05 0.77±0.06* 0.6±0.07* 0.43±0.09* 0.24±0.09* 
Data was analysed by analysis of variance and individual differences between group means determined by 
the Tukey posy-hoc test p<0.05. *significantly different from the same tissue type at 0.00 N preload.  
 
Table 4.4 : The Average Transition Stress for Native and Acellular Arteries in the Circumferential and 
Axial Direction at Varying Levels of Preload 
Transition Stress Mean ± 95 % CL (MPa) 
Preload 0.00 N 0.01 N 0.02 N 0.05 N 0.10 N 0.20 N 
Native Circumferential 0.28±0.14 0.27±0.14 0.27±0.15 0.27±0.16 0.26±0.15 0.24±0.15 
Native Axial 0.11±0.04 0.1±0.04 0.1±0.04 0.09±0.05 0.08±0.06 0.05±0.06 
Acellular Circumferential 0.46±0.14 0.46±0.14 0.46±0.14 0.46±0.14 0.46±0.14 0.46±0.14 
Acellular Axial 0.26±0.07 0.26±0.07 0.26±0.07 0.25±0.07 0.24±0.07 0.21±0.07 
Data was analysed by analysis of variance which showed no significant effect of the preload on a given 
tissue type. 
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Table 4.5 : The Average Ultimate Tensile Strain for Native and Acellular Arteries in the Circumferential 
and Axial Direction at Varying Levels of Preload 
Ultimate Tensile Strain Mean ± 95 % CL 
Preload 0.00 N 0.01 N 0.02 N 0.05 N 0.10 N 0.20 N 
Native Circumferential 1.12±0.03 1.06±0.03 1±0.05* 0.88±0.06* 0.72±0.04* 0.53±0.02* 
Native Axial 1.71±0.52 1.45±0.4 1.33±0.37* 1.1±0.22* 0.83±0.07* 0.53±0.04* 
Acellular Circumferential 1.14±0.15 1.08±0.13 1.03±0.12 0.91±0.1* 0.79±0.07* 0.65±0.07* 
Acellular Axial 1.57±0.08 1.42±0.1 1.3±0.11 1.07±0.14* 0.83±0.16* 0.57±0.15* 
Data was analysed by analysis of variance and individual differences between group means determined by 
the Tukey posy-hoc test p<0.05. *significantly different from the same tissue type at 0.00 N preload. 
 
Table 4.6 : The Average Ultimate Tensile Stress for Native and Acellular Arteries in the 
Circumferential and Axial Direction at Varying Levels of Preload 
Ultimate Tensile Stress Mean ± 95 % CL (MPa) 
Preload 0.00 N 0.01 N 0.02 N 0.05 N 0.10 N 0.20 N 
Native Circumferential 1.88±1.64 1.87±1.64 1.87±1.64 1.86±1.64 1.84±1.64 1.8±1.64 
Native Axial 0.61±0.41 0.6±0.41 0.6±0.41 0.58±0.41 0.56±0.4 0.52±0.39 
Acellular Circumferential 2.62±0.67 2.61±0.67 2.61±0.67 2.6±0.67 2.58±0.67 2.54±0.67 
Acellular Axial 1.36±0.44 1.36±0.44 1.35±0.44 1.34±0.44 1.31±0.44 1.26±0.44 
Data was analysed by analysis of variance which showed no significant effect of the preload on a given 
tissue type. 
 
Table 4.7 : The Average Collagen Modulus for Native and Acellular Arteries in the Circumferential and 
Axial Direction at Varying Levels of Preload 
Collagen Modulus Mean ± 95 % CL (MPa) 
Preload 0.00 N 0.01 N 0.02 N 0.05 N 0.10 N 0.20 N 
Native Circumferential 4.12±4.12 4.26±4.19 4.38±4.29 4.73±4.69 5.14±5.09 5.78±5.75 
Native Axial 0.84±0.63 0.93±0.58 0.97±0.62 1.08±0.66 1.2±0.72 1.43±0.79 
Acellular Circumferential 5.19±1.71 5.32±1.71 5.45±1.72 5.75±1.77 6.14±1.86 6.52±1.85 
Acellular Axial 2.57±0.84 2.75±0.89 2.9±0.93 3.29±1.06 3.79±1.19 4.54±1.36 
Data was analysed by analysis of variance which showed no significant effect of the preload on a given 
tissue type. 
 
Table 4.8 : The Average Elastin Modulus for Native and Acellular Arteries in the Circumferential and 
Axial Direction at Varying Levels of Preload 
Elastin Modulus Mean ± 95 % CL  (MPa) 
Preload 0.00 N 0.01 N 0.02 N 0.05 N 0.10 N 0.20 N 
Native Circumferential 0.22±0.2 0.19±0.07 0.21±0.09 0.25±0.09 0.35±0.08 0.63±0.19* 
Native Axial 0.1±0.08 0.12±0.1 0.13±0.1 0.17±0.1 0.21±0.12 0.47±0.38* 
Acellular Circumferential 0.32±0.11 0.37±0.1 0.42±0.11 0.54±0.18 0.72±0.28* 0.97±0.31* 
Acellular Axial 0.13±0.04 0.15±0.04 0.17±0.05 0.23±0.05 0.31±0.06* 0.57±0.14* 
Data was analysed by analysis of variance and individual differences between group means determined by 
the Tukey posy-hoc test p<0.05. *significantly different from the same tissue type at 0.00 N preload.   
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4.4.2.2 Preload Selection 
The toe region of force extension curves was inspected for extension of hyper relaxed 
samples (Figure 4.15). Samples inspected were native and acellular porcine carotid arteries 
in the circumferential  and axial direction. Observable extension due to hyper relaxation was 
only identified in one sample and the sample became taught at less than 0.01 N.  
 
Figure 4.15 : Force Extension Curves of Native and Acellular Porcine Carotid Arteries in the 
Circumferential and Axial Directions. 
4.4.2.3 Comparison of parameters derived from low strain rate to failure testing of 
native and acellular arteries at 0.01 N 
The average stress strain curves at 0.01 N preload for the native and acellular arteries tested 
in the circumferential and axial directions are presented in Figure 4.16 and Figure 4.17. 
Analysis of the data presented in Tables 4.3-4.8 using two-way analysis of variance (tissue 
type vs pre-load) allowed comparison of the parameters derived from the low strain rate to 
failure testing of native and acellular arteries in the axial and circumferential directions at 
0.01N pre-load. Six parameters were compared: transition strain, transition stress, ultimate 
tensile strain, ultimate tensile stress, collagen modulus and elastin modulus. The elastin 
modulus of acellular arteries was significantly greater than the elastin modulus of native 
arteries in the both the circumferential and axial directions (Table 4.8; p<0.05). The collagen 
modulus of acellular arteries in the circumferential direction was not significantly different than 
the collagen modulus of the native arteries, however, there was a significant increase 
(p<0.05) in the axial direction following decellularisation (Table 4.7). The transition strain in 
acellular arteries was not significantly different in the circumferential direction when compared 
to native arteries (Table 4.3; p>0.05) but was significantly higher (p<0.05) in the axial 
Native Circumferential 
 
Native Axial 
 
Acellular Circumferential 
 
Acellular Axial 
 
Observed slippage 
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direction when compared to native arteries. The transition stress of acellular arteries was 
significantly higher (Table 4.4; p<0.05) in both the axial and circumferential directions when 
compared to native arteries. The ultimate tensile strain was not significantly different in 
acellular arteries when compared to native arteries in either the circumferential or axial 
direction. The ultimate tensile stress in the acellular arteries in both the circumferential and 
axial directions was significantly higher (Table 4.6 ; p<0.05) in acellular arteries when 
compared to native arteries.  A summary of the changes in the material properties of the 
porcine carotid arteries as a result of the decellularisation process is presented in Table 4.9. 
 
Table 4.9 : Changes in the mechanical parameters of porcine carotid arteries post decellularisation in 
the circumferential and axial directions.  
 Significant difference (P < 0.05) post decellularisation 
Native vs Acellular 
Elastin 
Modulus 
Collagen 
Modulus 
Transition 
Strain 
Transition 
Stress 
Ultimate 
Tensile 
Strain 
Ultimate 
Tensile 
Stress 
Circumferential ↑  ↑  ↑ 
Axial ↑ ↑ ↑ ↑  ↑ 
 
 
Figure 4.16 : Average Stress Strain Curves of Native and Acellular Arteries Tested in the 
Circumferential Direction at 0.01 N preload. 
Stress strain curves of native (n=3) and acellular (n=6) arteries exhibited biphasic characteristics. The initial 
phase had a shallow gradient in which was more extensible under stress. The second phase had a steeper 
gradient in which the artery became stiffer and less extensible under stress. There was a distinct upward and 
left shit of the acellular curve compared to the native arteries curve. 
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Figure 4.17 : Average Stress Strain Curves of Native and Acellular Arteries Tested in the Axial 
Direction at 0.01 N preload. 
Stress strain curves of native (n=3) and acellular (n=6) arteries exhibited biphasic characteristics. The initial 
phase had a shallow gradient in which was more extensible under stress. The second phase had a steeper 
gradient in which the artery became stiffer and less extensible under stress. There was a distinct upward and 
left shit of the acellular curve compared to the native arteries curve. 
4.5 Discussion  
The mechanical properties of arteries are largely influenced by the quantity and orientation of 
collagen and elastin. The compliance properties are attributable to the highly branched and 
extensible characteristics of elastin. The overall strength of an artery is greatly dictated by the 
stiffness characteristics of collagen.  
It was important to develop a robust method for the determination of mechanical properties so 
that the effects of decellularisation on native arteries could be assessed and enable further 
studies of the effects of sterilisation processes on the acellular arteries.  
The method that had previously been developed to determine compliance and burst pressure 
testing was not robust. The arteries were free to orientate in space and would follow the 
natural curvature of the artery when pressurised and cause exaggerated movement below 
and across the plane of view making the determination of the compliance subject to large 
amounts of variance. Equally the fixed position method caused arteries to bend out of plane 
and therefore it was difficult to take accurate measurements. The manually adjusted method 
resulted in the artery being taught in the plane of view when images were captured, however 
it was difficult to control how much tension was being applied and therefore this gave rise to 
fluctuations in the measurements in between pressure increments. The constant weight 
method provided a method of applying a consistent load to the arteries and kept them in the 
plane of view for taking accurate measurements. The load applied can also be considered to 
replicate the internal tension of the artery under physiological conditions. When the method 
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was repeated with arteries it was clear by the small 95 % CL that the method was robust. It 
was then necessary to determine how much load was required to keep the arteries taught 
under increasing pressure. By measuring the percentage diameter change it was apparent 
that arteries loaded with 10 or 15 g weights had become aligned and there were no significant 
differences between data presented using 10 or 15 g weights.. Arteries loaded with 5 g 
weights resulted in percentage diameter changes that were significantly lower below 40 
mmHg than arteries loaded with 10 or 15 g weights.. By examining the percentage length 
change it was evident that a change in load affected the initial extension on the artery which 
remained constant over the test. The 5g load produced significantly smaller increase in length  
than the 10 or 15 g loads below 40 mmHg. The combination of these two observations 
justified the selection of a 10 g load for future compliance tests as this was the minimum load 
that provided stability.  
Determination of the appropriate preload to apply to a soft tissue is an important factor to be 
considered before analysing any properties derived from stress strain curves. Preloading is 
used to negate the effects caused by hyperrelaxation of samples allowing increased 
extension of a sample without increased load. However, applying too great a preload could 
cause other effects on the parameters derived from stress strain curves and when making 
comparison between groups. None of the stress parameters were significantly affected by the 
level of preloading. The moduli were also minimally affected by the level of preloading. 
Although there were some significant increases in the elastin modulus at the highest level of 
preloading, which can be explained by the fact that the elastin phase is subject to larger 
deformations under load than the collagen modulus. The parameters most affected by the 
level of preload were the strain parameters since these were concerned with extension and 
original length. With increased preloading the extension value was reduced and the original 
length value was increased. The strain is determined by dividing an increasingly smaller 
number by an increasingly larger number thus leading to a reduction of strain values with 
increased preload. This effect had the potential to mask differences between groups by 
causing stress-strain curves to become increasingly aligned. 
The correct level of preloading for a particular system can be selected by a combination of 
two factors. Firstly the lowest value of preload that does not give rise to a significant 
difference in parameters compared to none preloaded samples. Secondly, the minimum level 
needed to negate any extension due to hyperrelaxation observed by inspection of the toe 
region. Ideally each individual curve should be analysed for the correct level of preloading for 
that curve. It was clear by inspection of the toe region of the stress-strain curves that a 
minimum of 0.01 N of preloading was required for the system used and at this level there 
were no significant differences compared to non-preloaded samples. 
Having developed robust methods to determine compliance and uniaxial tensile testing a 
comparison of mechanical properties  between native and acellular arteries could be made to 
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determine the effects of decellularisation. There were significant differences in the mechanical 
properties of acellular arteries caused by the decellularisation process when compared to 
native arteries. These effects are seen to varying levels dependent on the orientation of the 
tissue. However, the characteristic biphasic shape of the arterial stress strain curves 
remained. 
By visual inspection of the percentage length change during compliance testing, both native 
and acellular arteries increased linearly, but there was a high degree of variation in the data, 
indicated by the large 95% CL. There was no significant difference between the percentage 
length change of native and acellular arteries at 100 mmHg. By visual inspection of the 
percentage diameter change curves with increasing pressure, both native and acellular 
arteries had an initial steeper slope, where the artery expanded more under pressure followed 
by a longer shallow slope, where the deformation was less with increasing pressure. When 
comparing native and acellular arteries it was evident that the acellular arteries dilated less 
than native arteries and there was a trend towards reduced compliance, however there was 
no significant difference in the percentage diameter change at 100 mmHg. Albeit using 
different methods for the determination of compliance, these results correlated well with 
previous findings, which found no significant differences between the compliance of acellular 
porcine ureters (Derham et al., 2008) and femoral arteries (Wilshaw et al., 2012) and their 
respective native tissues.  
It is important to maintain compliance in vascular grafts close to that of the analogous tissue 
which it is replacing. It is widely accepted that compliance mismatch can contribute 
considerably to the failure of a vascular graft and is reflected in clinical outcomes shown in 
Table 4.10. 
Table 4.10 : Patency Rates and Compliance Values of Clinically Used Vascular Grafts. 
Graft Type Compliance % / 100 mmHg Patency 
Host artery 5.9 ±0.5  
Saphenous vein 4.4 ± 0.8 75 
Umbilical Vein 3.7 ±0.5 60 
Bovine Heterograft 2.6±0.3 59 
Dacron 1.9±0.3 50 
PTFE 1.6±0.2 40 
Data adapted from Salacinski et al. (2001)  
Grafts with too great a compliance may become aneurysmal (Khaira & Vohra, 2002; Van 
Damme et al., 2005) and those that lack compliance develop intimal hyperplasia (Bassiouny 
et al., 1992). This is a major factor in surgeries in which the artery anastomoses are attached 
in an end to side configuration. There is an increased incidence in intimal hyperplasia in less 
compliant grafts at the distal anastomosis (Sottiurai et al., 1989; Trubel et al., 1994), where 
there are higher stresses at the suture line (Ballyk et al., 1998)  and, on the bed floor on the 
opposing host artery, where stagnation occurs (Morinaga et al., 1985). Interestingly when 
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looking at autologous grafts used for coronary artery bypass grafts, the saphenous vein has a 
much higher incidence of intimal hyperplasia related occlusion when compared to the more 
compliant internal mammary artery (Mitra et al., 2006). Considering this the internal mammary 
artery has been found to have a compliance of 11.5 ± 3.9 % / 100  mmHg (Konig et al., 
2009), which matches closely to acellular porcine carotid arteries (9.21 + 4.98 – 3.99 % / 100  
mmHg),  therefore although native and acellular porcine carotid arteries were not significantly 
different it may be that the decellularisation process is having a beneficial effect by reducing 
the compliance closer to the desired compliance of analogous tissue.  
However, it is difficult to truly compare these results due to the wide discrepancies in the 
methods used for the determination of compliance. There are guidelines set out in ISO 7198 
(International Standard  ISO/DIS 7198, 1998), however, this standard leaves a large amount 
of interpretation open to the reader. To truly compare results either a standardised model 
needs to be adopted for compliance testing or a range of data using host arteries needs to be 
collated using the same test method to identify when ideal properties are being met.  
The parameters derived from stress-strain curves created from uniaxial tensile testing data 
can further help in the understanding of the biomechanics of native and acellular vascular 
porcine carotid arteries. Perusal of the stress strain curves from the uniaxial tensile tests 
showed that the curves for the acellular arteries shifted upwards and to the left indicating a 
decreased extensibility and increased strength compared to native arteries. This could 
explain the trend in the compliance being lower in acellular porcine carotid arteries than 
native porcine carotid arteries. 
In the circumferential and axial directions the ultimate tensile stress, the transition stress and 
the elastin modulus were significantly higher in acellular porcine carotid arteries than native 
porcine carotid arteries. The collagen modulus of acellular porcine carotid arteries was also 
significantly higher in the axial direction, when compared to native porcine carotid arteries. It 
is expected to find some differences in the mechanical data owing solely to the natural 
variance of the porcine arteries between animal to animal, however there is an indication from 
this data that the decellularisation process is causing an increased stiffness particularly 
affecting the elastin in the artery, which would again explain the slight trend towards a 
reduced compliance. This could be due to conformational changes in the structure and the 
incompressibility of water. With the absence of cells, an intake of water into the interstial 
spaces of ECM may be providing a small increase in stiffness.  
There were no significant differences in the ultimate tensile strain in either circumferential or 
axial directions when comparing native and acellular porcine carotid arteries indicating that 
the extensibility was not compromised significantly by the decellularisation process, which 
mirrors the results found with the compliance testing. However, the transition strain was 
significantly higher in the axial direction of acellular porcine carotid arteries when compared to 
native porcine carotid arteries. This was contrary to the compliance data found. These results 
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may not be indicative of the true picture; the transition strain is determined to be where the 
tangent of the collagen slope intercepts with x axis, if the collagen modulus is changed the 
transition point changes. If the collagen modulus becomes stiffer a greater transition strain will 
be recorded and if it becomes weaker then a lower transition strain will be recorded, when in 
reality the transition start may not have actually changed. This observation can also be seen 
in previous work with parameters derived from stress-strain curves for native and acellular 
porcine ureter in the circumferential direction where the transition stress has increased but 
the elastin modulus has decreased. This can only be accounted for by the increase in 
collagen modulus bringing the transition strain forward (Derham et al., 2008).  It is therefore 
worth considering calculation of the transition point in an alternative manner for future studies. 
A proposed method to account for this would be to create a line at the intercept between the 
collagen and elastin slope tangents that is of equal angle to the collagen and elastin slope 
tangents. This is depicted in Figure 4.18. 
 
Figure 4.18 : Proposed Method to Calculate the Transition Strain Using a Line of Equal Angle 
Between the Tangents of the Collagen and Elastin Slopes. 
 
When comparing mechanical properties of the porcine carotid artery obtained using uniaxial 
tensile testing to data presented by other research groups it is difficult to make true 
comparisons due to the varied test methods used. The main difference is either testing a 
ringlet of artery vs a strip of artery being loaded under tension. The ringlet method has 
limitations since it can only be used for testing mechanical properties in the circumferential 
direction and the strip method must then be adopted to obtain the properties in the axial 
direction. One study of the biomechanics of the vertebral artery compared the ringlet method 
in the circumferential direction with the strip method in the axial direction and the study 
indicated  that the arteries were anisotropic (Johnson et al., 2000). It may have been prudent 
in addition to compare ringlets and strips in the same direction to establish whether any 
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differences were found in the methods. The anisotropy correlated well with arterial structure in 
which longitudinally the strength is weaker than in the circumferential direction. The range in 
UTS was approximately 0.5 to 2 MPa and the elastic modulus ranged from approximately 1 to 
5 MPa.  The advantage of the ringlet method is that it eliminates the clamping issues found 
with the strip method. In the strip method, often failure at the grips can occur if too much 
compression is applied and slippage occurs if too little tension is applied. If the tissue breaks 
at the grips then an underestimation of the UTS may occur and so it is important check the 
break point of a sample, however when dealing with small samples this may be difficult to 
identify. Another common difference in test methods used by different groups is whether a 
biobath is used. This can be used to maintain hydration of the sample and the temperature. 
Alternatively, PBS spray has been used to maintain hydration, however the problem with this 
method is that it is not possible to determine whether the sample has been fully soaked in 
PBS and what intervals of spraying are required to maintain hydration.  
Overall consideration of the effects of the decellularisation process on the mechanical 
integrity of the arteries indicated they were maintained. There were changes to the 
mechanical properties some of which can be attributed to the natural variance in porcine 
arteries from animal to animal. There is a slight trend to a reduction in compliance and 
increase in elastic stiffness, however the mechanical properties of the acellular porcine 
carotid arteries were similar to those of host arteries.  
Now that robust methods to establish the mechanical properties of native and acellular 
porcine carotid arteries had been achieved, the effects of sterilisation processes on the 
mechanical properties could be compared, and this is the focus of the research described in 
the following chapter.  
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Chapter 5 Mechanical properties of Sterilised Acellular Porcine Carotid 
Arteries 
5.1 Introduction 
In the research and development of novel biological grafts, sterilisation of the final product is 
an important aspect to be considered, which is often overlooked during the early phases. It is 
absolutely necessary for an implantable medical device to be sterile before being used 
clinically. This is carried out by ensuring that the device has a minimum sterility assurance 
level of 10-6, this gives the probability of a microorganism being present on the device as 1 in 
a million.  The most common and historical industry practiced sterilisation processes are: dry 
heat, moist heat, gas plasma, peracetic acid, Gamma irradiation, E-Beam irradiation and 
ethylene oxide (EO). Each of these processes utilises differing mechanisms and 
environments to inactivate microorganisms. Variables such as temperature, pressure, 
humidity and sterilisation mechanism can have detrimental effects on biological materials 
which could compromise the biological and mechanical function of biological grafts. For the 
sterilisation of acellular porcine carotid artery vascular grafts, several  processes can be  
excluded from consideration due to: high temperatures, penetration depth and the desire for a 
terminal sterilisation process rather than chemical sterilisation followed by post-sterilisation 
aseptic processing. Therefore, the sterilisation processes selected for investigation in this 
study were limited to Gamma irradiation, E-Beam irradiation and EO sterilisation processes. 
These three sterilisation methods inactivate microorganisms by causing structural instability in 
cells or by interrupting replication (as discussed in Chapter 1). Gamma and E-Beam 
irradiation  ionise molecules  and cause cleavage of covalent bonds in DNA. Ionisation and 
free radical formation, however might also have detrimental effects on the biochemical and 
biomechanical properties of biological vascular grafts. Ionising radiation has the ability to form 
crosslinks in elastin and collagen which can increase strength and stiffness. In addition, 
irradiation  can cause chain scission which can shorten the length of the fibres which may 
have effects on elasticity. The mechanism of action of EO is via direct alkylation. This 
alkylation process restructures or denatures functional proteins, enzymes and DNA/RNA.  
This highly reactive alkylation mechanism also has the potential to alter the properties of 
biological vascular grafts. In order to apply EO sterilisation to  acellular porcine carotid artery 
vascular grafts the graft  must first be freeze-dried. Therefore it was necessary to determine 
the effects  of freeze-drying on the graft material in addition to the effects of the EO 
sterilisation process.    
The methods used to assess the biomechanical properties of the acellular porcine carotid 
artery vascular grafts before and after sterilisation treatment were developed and discussed 
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in Chapter 4. This chapter focuses on the effects of sterilisation processes on the 
biomechanical properties of acellular porcine carotid arteries.  
5.2 Aims and objectives 
The aims of this study were to investigate the effects of Gamma irradiation, E-Beam 
irradiation, freeze-drying and EO treatment on the biomechanical properties of acellular 
porcine carotid arteries 
The specific objectives were:  
 To subject acellular porcine carotid arteries to Gamma irradiation (30 kGy) and 
determine the effects on the properties of the arteries using uniaxial tensile, 
compliance and burst pressure testing.  
 To subject acellular porcine carotid arteries to E-Beam irradiation (30 kGy) and 
determine the effects on the properties of the arteries using uniaxial tensile, 
compliance and burst pressure testing.  
 To freeze-dry acellular porcine carotid arteries and determine the effects on the 
properties of the arteries using uniaxial tensile, compliance and burst pressure 
testing.    
 To subject freeze-dried acellular porcine carotid arteries to EO sterilisation and 
determine the effects on the properties of the arteries using uniaxial tensile, 
compliance and burst pressure testing.  
5.3 Materials and Methods 
5.3.1 Arteries 
Native porcine carotid arteries used in this chapter were procured and dissected according to 
the method described in Chapter 3; Section 3.3.1. Acellular arteries (n=57)  were produced in 
three batches (Batches 2, 3 and 4; Chapter 3, Section 3.4.6) using the method described in 
Chapter 3; Section 3.3.2. Arteries from batches were then separated to be tested as quality 
controls or subject to sterilisation as follows: 
Arteries from batch 2 were split into two groups: 
1. Acellular porcine carotid arteries (n=7) 
2. Acellular porcine carotid arteries to be processed by Gamma irradiation (n=8) 
Arteries from batch 3 were split into three groups: 
1. Acellular porcine carotid arteries (n=7) 
2. Acellular porcine carotid arteries to be processed by Gamma irradiation (n=7) 
3. Acellular porcine carotid arteries to be processed by E-Beam irradiation (n=7) 
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Arteries from batch 4 were split into three groups: 
1. Acellular porcine carotid arteries (n=7) 
2. Acellular porcine carotid arteries to be processed by freeze drying (n=7) 
3. Acellular porcine carotid arteries to be processed by freeze drying followed by EO 
treatment. (n=7) 
The sampling method of arteries for biological and mechanical evaluation has been described 
previously in Chapter 3; Section 3.3.3. Sampling method I was used to provide tissue for 
quantitative analyses including mechanical testing. Sampling method II was used for primarily 
qualitative analyses. Below is a table to show the sample size for sampling method I and II for 
each group within the batch. 
Table 5.1:Sample Sizes for sampling method I and II for each batch of acellular arteries 
Batch 2 SM I SM II Batch 3 SM I SM II Batch 4 SM I SM II 
Acellular 5 2 Acellular 5 2 Acellular 5 2 
Gamma Irradiated 6 2 Gamma Irradiated 5 2 Freeze-Dried 6 1 
   E-Beam Irradiated 5 2 
Freeze-Dired 
EO Treated 
5 2 
 
5.3.2 Irradiation Sterilisation 
Acellular arteries were placed on polyethyleneglycol (PEG) semi-circular supports  to prevent 
flattening of the artery by the pressure of the packaging itself or from the vacuum process.  
 
 
 
Figure 5.1 : Diagram of the artery support for packaging 
 
Arteries were then vacuum sealed in an inner foil pouch and an outer Tyvek membrane 
pouch (Figure 5.2). Arteries were then couriered to Synergyhealth PLC and were either 
Gamma or E-Beam irradiated at a dose of 30 kGy (Minimum, 25 kGy).   
 
Figure 5.2 : Acellular Artery on PEG Support Structure and Vaccum Sealed in Inner Foil Membrane 
and Outer Tyvek 
Artery 
Inner Foil Packaging 
PEG Support 
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5.3.3 Freeze Drying 
Acellular arteries were placed on PEG semi-circular supports. Arteries were then freeze-dried 
under vacuum at -60 oC (Figure 5.3). to a constant weight. A constant weight was determined 
after three consecutive measurements differed to a resolution of ± 0.0001 g measured using 
a four figure balance  
 
Figure 5.3 : Freeze Dried Acellular Arteries on PEG Support Structure 
5.3.4 Ethylene Oxide Sterilisation 
Acellular arteries were freeze-dried as described in Section 5.3.3. Arteries were then vacuum 
sealed in Tyvek membrane pouches, then couriered to Sterigenics International LLC and 
were treated using a low temperature (<55 oC) ethylene oxide sterilisation cycle.  
5.3.5 Rehydration Of Arteries   
Reagents: 
Physiological saline 
Sodium chloride (0.85 g) was  dissolved in 800 ml distilled water. The pH was 
adjusted to 7.0 – 7.4 using 6 M hydrochloric acid or 6 M sodium hydroxide drop wise 
whilst using a magnetic stirrer. The final volume was adjusted to 1 L using distilled 
water. The solution was sterilised by autoclaving. 
Method: 
Acellular freeze-dried and acellular freeze-dried EO treated arteries were rehydrated in 
physiological saline prior to sampling. Rehydration was determined after a constant weight 
was achieved using a four figure balance.  
5.3.6 Mechanical Testing Of Samples 
All sampling of arteries for mechanical testing was performed using sampling method I as 
described in Section 3.3.3. The sample sizes for mechanical testing deviated from intended; 
the actual sample sizes are presented in Table 5.2. During the setup of compliance testing, in 
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some arteries, holes in the arterial walls from arterial branching prevented testing in some 
samples and were discarded. During the setup of tensile testing, in some arteries, the 
curvature of the artery when being cut into strips sometimes caused non rectangular strips 
and therefore these samples were also discarded.  The sample size of freeze dried arteries 
was increased as the determination of the mechanical properties due to freeze drying was 
more beneficial than the biological evaluation. 
Table 5.2 : Intended (I) and Actual (A) Sample Sizes for Mechanical Testing 
  Native Acellular Gamma E-Beam Freeze Dried EO 
Batch Test Method I A I A I A I A I A I A 
3 
Compliance 5 3 5 5 5 5 5 4     
SS (Circumferential) 5 4 5 4 5 5 5 5     
SS  (Axial) 5 3 5 5 5 5 5 4     
4 
Compliance 5 3 5 4     6 6 5 3 
SS (Circumferential) 5 4 5 5     6 6 5 5 
SS  (Axial) 5 4 5 5     6 6 5 5 
   SS=Stress Strain 
Native, acellular, acellular freeze-dried, acellular ethylene oxide treated, acellular Gamma 
irradiated and acellular E-Beam irradiated porcine carotid arteries were subjected to uniaxial 
tensile testing as described in Section 4.3.4 and compliance testing as described in Section 
4.3.3. A sample of native porcine carotid arteries (n=3) fixed in NBF for 16 – 24 hours and 
were also mechanically tested. The NBF fixed arteries were used as a positive control for 
damage but were not included in the overall analysis of the data.  
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5.4 Results 
5.4.1 Mechanical Properties of Gamma and E-Beam Irradiated Acellular Porcine 
Carotid Arteries 
5.4.1.1 Uniaxial Tensile Testing of  Gamma and E-Beam Irradiated Acellular Porcine 
Carotid Arteries 
Native, native NBF fixed, acellular and acellular Gamma and E-Beam irradiated porcine 
carotid artery samples were subjected to uniaxial tensile testing in both the axial and 
circumferential directions. The data was then manipulated to apply a preload of 0.01 N. Six 
parameters: transition strain, transition stress, ultimate tensile strain, ultimate tensile stress, 
collagen modulus and elastin modulus were extracted from the data and were compared 
using one way ANOVA and Tukeys post-hoc test. The control NBF treated arteries were 
excluded from statistical analysis. The parameters extracted from the stress strain curves 
obtained for circumferential samples are presented in Table 5.3 and depicted as average 
stress strain curves in Figure 5.4. The parameters extracted from the stress strain curves 
obtained for axial samples are presented in Table 5.4 and depicted as stress strain curves in 
Figure 5.5. 
In the circumferential direction, the ultimate tensile stress was significantly increased post 
decellularisation. Acellular arteries that had been Gamma irradiated had significantly stiffer 
elastin and collagen moduli and a significantly higher ultimate tensile stress compared to 
native arteries but were not significantly different to acellular arteries. In addition, acellular 
arteries that had been Gamma irradiated exhibited a significantly lower transition strain than 
native arteries but not significantly different than acellular arteries. Acellular arteries that 
underwent E-Beam irradiation had a significantly higher elastin modulus and a significantly 
lower transition strain compared to both native and acellular arteries. Acellular arteries that 
underwent E-Beam irradiation also had a significantly lower ultimate tensile strain compared 
to native arteries. 
In the axial direction there were no significant differences between native and acellular 
arteries. Acellular arteries that underwent Gamma irradiation had a significantly lower 
transition strain compared to acellular arteries but otherwise showed no significant differences 
to native or acellular arteries. Acellular arteries that underwent E-Beam irradiation had 
significantly higher collagen modulus and transition stress than native and acellular arteries, 
the ultimate tensile stress was also significantly higher than in native arteries.  
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Table 5.3 : Parameters Extracted from Stress Strain Curves Derived from Low Strain Rate to Failure 
Uniaxial Tensile Testing in the Circumferential Direction Of Native, Acellular, Gamma and E-Beam 
Irradiated Porcine Carotid Arteries. 
Tissue 
Thickness 
(mm) 
Elastin  
(MPa) 
Collagen 
(MPa) 
TStrain 
 
TStress 
(MPa) 
UTStrain 
 
UTStress 
(MPa) 
Native 0.91±0.29 0.17±0.04 2.7±1.14 0.77±0.15 0.26±0.14 1.68±1.03 1.58±0.52 
Acellular 0.9±0.34 0.21±0.14 4.23±2.23 0.57±0.15 0.5±0.49 1.06±0.45 2.6±1.26* 
Gamma 0.83±0.18 0.74±0.38* 5.69±2* 0.53±0.18* 0.61±0.14 1.05±0.23 2.74±0.2* 
E-Beam 0.98±0.21 1.64±0.5*** 4.49±1.14 0.29±0.09*** 0.56±0.26 0.8±0.13* 2.27±0.59 
Data is presented as the mean (Native, n=4; Acellular, n=4; Gamma, n=5; E-Beam, n=5)  ± 95% CL. Data for 
each parameter was analysed by one way ANOVA and Tukey test (p<0.05). * Significantly different to native, *** 
Significantly different to native and acellular 
 
Figure 5.4 : Average Stress Strain Curves Derived From Low Strain Rate To Failure Uniaxial Tensile 
Testing In The Circumferential Direction Of Native, Acellular, Gamma And E-Beam Irradiated Porcine 
Carotid Arteries. 
Acellular arteries showed a significant increase in ultimate tensile stress compared to native arteries. 
Acellular Gamma sterilised arteries showed significant stiffening of the collagen and elastin modulus and a 
significant increase in ultimate tensile stress compared to native arteries as well as a significant reduction in 
transition strain resulting in an observed shift of the curve upwards and to the left. Acellular E-Beam sterilised 
arteries had significantly higher collagen modulus and transition stress than native and acellular arteries. The 
ultimate tensile strain was also significantly higher than in native arteries. This resulted in a shift of the curve 
upwards and left past that of Gamma sterilised arteries and NBF fixed arteries.  
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Table 5.4 : Parameters Extracted From Stress Strain Curves Derived From Low Strain Rate To Failure 
Uniaxial Tensile Testing In The Axial Direction Of Native, Acellular, Gamma And E-Beam Irradiated 
Porcine Carotid Arteries. 
Tissue 
Thickness 
(mm) 
Elastin  
(MPa) 
Collagen 
(MPa) 
TStrain 
 
TStress 
(MPa) 
UTStrain 
 
UTStress 
(MPa) 
Native 0.74±0.36 0.1±0.03 0.92±1.04 0.64±0.29 0.09±0.1 1.29±0.47 0.59±0.77 
Acellular 0.63±0.16 0.14±0.03 2.06±0.71 0.8±0.21 0.19±0.09 1.43±0.23 1.21±0.4 
Gamma 0.75±0.05 0.33±0.19 2.08±0.42 0.48±0.1** 0.21±0.05 1.21±0.43 0.98±0.12 
E-Beam 0.84±0.2 0.31±0.2 3.4±1.79*** 0.68±0.22 0.37±0.1*** 1.17±0.15 1.46±0.7* 
Data is presented as the mean (Native, n=3; Acellular, n=5; Gamma, n=5; E-Beam, n=4)  ± 95% CL. Data for 
each parameter was analysed by one way ANOVA and Tukey test (p<0.05).* Significantly different to native, ** 
Significantly different to Acellular *** Significantly different to native and acellular 
 
 
Figure 5.5 : Average Stress Strain Curves From Parameters Extracted From Stress Strain Curves 
Derived From Low Strain Rate To Failure Uniaxial Tensile Testing In The Axial Direction Of Native, 
Acellular, Gamma And E-Beam Irradiated Porcine Carotid Arteries. 
Acellular arteries were not significantly different from native arteries in any of the six parameters. Acellular 
arteries sterilised by Gamma or E-Beam showed an upwards and left shift in the stress strain curve. Gamma 
sterilised arteries showed a significant decrease in transition strain when compared to acellular arteries and 
E-Beam Sterilised arteries had significant increases in collagen modulus and transition stress compared to 
native and acellular arteries as well as a significant increase in ultimate tensile stress compared to native 
arteries. 
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5.4.1.2 Compliance Testing of  Gamma and E-Beam Irradiated Acellular Porcine Carotid 
Arteries 
Native, acellular, acellular Gamma and E-Beam irradiated and NBF fixed porcine carotid 
arteries were subjected to burst pressure and compliance testing. Arteries were inflated 
incrementally up to 200 mmHg and the length and diameter measured at each increment. 
From these measurements the percentage diameter change was calculated and is displayed 
in Figure 5.6 and the percentage length change was calculated and is displayed in Figure 5.7. 
Data for the native, acellular, acellular Gamma and E-Beam irradiated artery groups was 
compared using one way ANOVA with Tukeys post hoc test (p<0.05) at 100 mmHg for 
percentage diameter and length change and the results are shown in Table 5.5 and Table 5.6 
respectively.  After 200 mmHg arteries were inflated to rupture and all of the arteries tested 
burst above 3000 mmHg. 
Native, acellular and acellular Gamma sterilised arteries exhibited an initial steeper incline 
before maintaining a linear increase in percentage diameter change. NBF fixed arteries 
showed very little increase in percentage diameter change and maintained a near constant  
value. Acellular E-Beam sterilised arteries had a constant decrease in percentage diameter 
change and maintained a constant rate with increasing pressure. With regard to percentage 
diameter change at 100 mmHg change there was no significant difference between native 
and acellular arteries, however acellular Gamma and E-Beam irradiated arteries had 
significantly lower percentage diameter change compared to native arteries and acellular E-
Beam irradiated arteries also showed significantly lower percentage diameter change than 
acellular arteries. 
 
Figure 5.6 : Average Percentage Diameter Change of Native, Acellular, Acellular Gamma and E-Beam 
Irradiated and NBF fixed Arteries with Increasing Pressure. 
Average percentage diameter change of native, acellular, acellular Gamma and E-Beam irradiated and NBF 
fixed arteries with increasing pressure. Data was arcsine transformed for calculation of the mean ± 95 % CL 
and back transformed to percentages for presentation.  
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NBF fixed, acellular arteries exhibited a linear constant rate of percentage length change. 
Native and E-Beam sterilised arteries exhibited a linear but increasing percentage length 
change. Native and E-Beam irradiated arteries had significantly higher percentage length 
change compared to acellular arteries. 
Table 5.5 - Average Percentage Diameter Change Native, Acellular, Acellular Gamma and E-Beam 
Irradiated Arteries at 100 mmHg 
Percentage Diameter Increase (100 mmHg) 
Native  Acellular Gamma  E-Beam  
Mean 
Upper  
95 % CL 
Lower 
95 % CL 
Mean 
Upper  
95 % CL 
Lower 
95 % CL 
Mean 
Upper  
95 % CL 
Lower 
95 % CL 
Mean 
Upper  
95 % CL 
Lower 
95 % CL 
14.22 6.89 5.72 9.44 5.24 4.18 7.02* 3.86 3.07 -3.44** 2.06 2.95 
Data is presented as the mean (Native, n=3; Acellular, n=5; Gamma, n=5; E-Beam, n=4)  ± 95% CL. Following 
arcsine transformation, data for each parameter was analysed by one way ANOVA and Tukey test (p<0.05). 
*Significantly different from Native, **Significantly different from native and acellular 
 
 
Figure 5.7 : Average Percentage Length Change of Native, Acellular, Acellular Gamma and E-Beam 
Irradiated and NBF fixed Arteries with Increasing Pressure. 
Average Percentage Length Change of Native, Acellular, Acellular Gamma and E-Beam Irradiated and NBF 
fixed Arteries with Increasing Pressure. Data was arcsine transformed for calculation of mean ± 95% CL and 
back transformed to percentages for presentation. 
 
Table 5.6 - Average Percentage Length Change of Native, Acellular, Acellular Gamma and E-Beam 
Irradiated Arteries at 100 mmHg 
Percentage Length Increase (100 mmHg) 
Native  Acellular Gamma  E-Beam  
Mean 
Upper  
95 % CL 
Lower 
95 % CL 
Mean 
Upper  
95 % CL 
Lower 
95 % CL 
Mean 
Upper  
95 % CL 
Lower 
95 % CL 
Mean 
Upper  
95 % CL 
Lower 
95 % CL 
5.54* 4.30 3.12 0.93 1.70 0.84 3.67 4.66 2.82 5.36** 6.34 3.97 
 Data is presented as the mean (Native, n=3; Acellular, n=5; Gamma, n=5; E-Beam, n=4)  ± 95% CL. Following 
arcsine transformation, data for each parameter was analysed by one way ANOVA and Tukey test (p<0.05). 
*Significantly different from acellular, **Significantly different from native and acellular. 
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5.4.2 Mechanical Properties Of Freeze-Dried and Freeze-dried Ethylene Oxide 
Treated Acellular Porcine Carotid Arteries  
5.4.2.1 Uniaxial Tensile Testing of Freeze-Dried and Freeze-Dried Ethylene Oxide 
Treated Acellular Porcine Carotid Arteries 
Native, native freeze dried, acellular, acellular freeze dried and ethylene oxide sterilised 
arteries were subjected to uniaxial tensile testing in both the axial and circumferential 
directions. The data was then manipulated to apply 0.01 N of preload. Six parameters: 
transition strain, transition stress, ultimate tensile strain, ultimate tensile stress, collagen 
modulus and elastin modulus were extracted from the data and were compared using one 
way ANOVA and Tukeys post-hoc test (p<0.05). The parameters extracted from 
circumferential samples are presented in Table 5.7 and depicted as average stress strain 
curves in Figure 5.8. The parameters extracted from axial samples are presented in Table 5.8 
and depicted as stress strain curves in Figure 5.9. 
In the circumferential direction native freeze-dried arteries had no significant differences in 
mechanical properties compared to native arteries. Acellular freeze dried arteries had no 
significant differences in mechanical properties when compared to acellular arteries. Acellular 
arteries had a significantly lower transition strain than native arteries and acellular freeze 
dried arteries had a significantly lower transition stress than native arteries. Ethylene oxide 
sterilised arteries had a significantly higher elastin and collagen modulus than native and 
acellular arteries as well as significantly reduced transition strain. The ultimate tensile strain 
was significantly lower and the ultimate tensile stress significantly higher when compared to 
native arteries.  
In the axial direction native, native freeze dried, acellular and acellular freeze dried arteries 
had no significant differences in mechanical properties. Acellular freeze dried ethylene oxide 
sterilised arteries had significantly higher elastin modulus and ultimate tensile stress than 
native and acellular arteries. The transition strain was significantly lower when compared to 
acellular arteries and the transition stress significantly higher when compared to native 
arteries. 
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Table 5.7 : Parameters Extracted From Stress Strain Curves Derived From Low Strain Rate To Failure 
Uniaxial Tensile Testing In The Circumferential Direction Of Native, Native Freeze-Dried, Acellular, 
Acellular Freeze-Dried And Ethylene Oxide Treated Porcine Carotid Arteries. 
Tissue 
Thickness 
(mm) 
Elastin  
(MPa) 
Collagen 
(MPa) 
TStrain 
 
TStress 
(MPa) 
UTStrain 
 
UTStress 
(MPa) 
Native 0.96±0.02 0.15±0.06 3.63±2.85 0.84±0.15 0.29±0.16 1.4±0.34 1.87±1.26 
Native 
FD 
0.97±0.08 0.22±0.09 3.67±1.26 0.73±0.26 0.32±0.14 1.3±0.24 1.99±0.72 
Acellular 0.93±0.08 0.77±0.37 4.13±0.77 0.55±0.17* 0.52±0.18 1.11±0.23 2.32±0.95 
Acellular 
FD 
0.94±0.15 0.76±0.34 4.82±0.62 0.6±0.16 0.63±0.16* 1.18±0.3 2.64±0.63 
EO 0.81±0.21 2.52±0.93*** 6.02±0.63*** 0.12±0.05*** 0.3±0.12 0.81±0.4* 3.35±0.92* 
Data is presented as the mean (Native, n=4; Native Freeze-dried, n=5; Acellular, n=5; Acellular Freeze-dried, 
n=6; ethylene oxide, n=5)  ± 95% CL. Data for each parameter was analysed by one way ANOVA and Tukey 
test (p<0.05). * Significantly different to native, *** Significantly different to native and acellular 
 
Figure 5.8 Average Stress Strain Curves Derived From Low Strain Rate To Failure Uniaxial Tensile 
Testing In The Circumferential Direction Of Native, Native Freeze-Dried, Acellular, Acellular Freeze-
Dried And Ethylene Oxide Treated Porcine Carotid Arteries 
Native, native freeze-dried, acellular, acellular freeze-dried arteries exhibited typical biphasic curves with a 
observable upwards and left shit in acellular arteries. Ethylene oxide treated arteries had a linear curve. The 
transition strain was significantly lower in acellular arteries when compared to native arteries and the acellular 
freeze-dried arteries had significantly higher transition stress than native arteries. Ethylene oxide treated 
arteries has significantly higher elastin and collagen moduli and significantly lower transition strain when 
compared to native and acellular arteries . Ethylene oxide treated arteries had a significantly higher  ultimate 
tensile stress and significantly lower ultimate tensile strain when compared to native arteries.  
 
 
 
 
- 117 - 
Table 5.8 : Parameters Extracted From Stress Strain Curves Derived From Low Strain Rate To Failure 
Uniaxial Tensile Testing In The Axial Direction Of Native, Native Freeze-Dried, Acellular, Acellular 
Freeze-Dried And Ethylene Oxide Treated Porcine Carotid Arteries. 
Tissue 
Thickness 
(mm) 
Elastin  
(MPa) 
Collagen 
(MPa) 
TStrain 
 
TStress 
(MPa) 
UTStrain 
 
UTStress 
(MPa) 
Native 0.87±0.24 0.1±0.03 1.35±0.84 0.65±0.22 0.1±0.05 1.37±0.48 0.64±0.35 
Native 
FD 
0.78±0.11 0.19±0.08 3.07±0.57 0.63±0.15 0.23±0.08 1.13±0.22 1.4±0.6 
Acellular 0.73±0.1 0.19±0.05 2.67±1.37 0.82±0.15 0.26±0.1 1.45±0.29 1.09±0.25 
Acellular 
FD 
0.79±0.18 0.24±0.09 2.94±2.27 0.68±0.25 0.24±0.1 1.27±0.24 1.21±0.44 
EO 0.68±0.11 0.83±0.33*** 2.71±1.52 0.39±0.21** 0.38±0.26* 1.21±0.23 1.82±0.52*** 
Data is presented as the mean (Native, n=4; Native Freeze-dried, n=5; Acellular, n=5; Acellular Freeze-dried, 
n=6; ethylene oxide, n=5)  ± 95% CL. Data for each parameter was analysed by one way ANOVA and Tukey 
test (p<0.05). * Significantly different to native, ** Significantly different to Acellular *** Significantly different to 
native and acellular 
 
 
Figure 5.9 Average Stress Strain Curves Derived From Low Strain Rate To Failure Uniaxial Tensile 
Testing In The Axial Direction Of Native, Native Freeze-Dried, Acellular, Acellular Freeze-Dried And 
Ethylene Oxide Treated Porcine Carotid Arteries 
Native, native freeze-dried, acellular, acellular freeze-dried arteries exhibited typical biphasic curves with a 
observable upwards and left shit in acellular and freeze dried arteries. Ethylene oxide treated arteries had a 
linear curve. There were no significant differences between native, native freeze-dried, acellular and acellular 
freeze-dried arteries. Ethylene oxide treated arteries had a significantly higher elastin modulus and ultimate 
tensile stress when compared to native and acellular arteries. Ethylene oxide treated arteries had a 
significantly lower transition strain when compared to acellular arteries and a significantly higher transition 
stress when compared to native arteries. 
 
 
- 118 - 
5.4.2.2 Compliance 
Native, native freeze dried, acellular, acellular freeze dried, ethylene oxide sterilised and NBF 
fixed porcine carotid arteries were subjected to burst pressure and compliance testing. 
Arteries were inflated incrementally up to 200 mmHg and the length and diameter measured 
at each increment. From these measurements the percentage diameter change was 
calculated and is displayed in Figure 5.10 and the percentage length change was calculated 
and is displayed in Figure 5.11. Means were statistically compared at 100 mmHg for 
percentage diameter and length change and the results are shown in Table 5.9 and Table 
5.10 respectively.  After 200 mmHg arteries were inflated to rupture. All arteries exceeded a 
burst pressure of 3000 mmHg. 
Native, native freeze dried, acellular and acellular freeze dried porcine carotid arteries 
exhibited an initial steeper incline before maintaining a linear increase in percentage diameter 
change. NBF fixed porcine carotid arteries showed very little increase in percentage diameter 
change and maintained a near constant value. Ethylene oxide sterilised arteries had a 
constant decrease in percentage diameter change and maintained a constant rate with 
increasing pressure. At 100 mmHg there was no significant difference in percentage diameter 
change between Native, native freeze dried, acellular and acellular freeze dried arteries. 
Ethylene oxide sterilised arteries had a significantly lower percentage diameter change than 
all other groups. 
Native, native freeze dried, acellular, acellular freeze dried and ethylene oxide sterilised 
arteries exhibited a linear but increasing percentage length change. NBF fixed porcine carotid 
arteries exhibited a constant rate of percentage length change. There was a large amount of 
variance and no significant differences were found between any of the groups. 
 
Figure 5.10 : Average Percentage Diameter Change Native, Native Freeze-dried, Acellular, Acellular 
Freeze-dried, Ethylene Oxide Treated and NBF Fixed Arteries with Increasing Pressure. 
Data was arcsine transformed for calculation of mean ± 95% CL and back transformed to percentages for 
presentation. 
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Table 5.9 - Average Percentage Diameter Change Native, Native Freeze-dried, Acellular, Acellular 
Freeze-dried  and Ethylene Oxide Treated Arteries at 100 mmHg 
Percentage Diameter Increase  
Native Native Freeze dried Acellular 
Acellular Freeze 
Dried 
EO Sterilised 
Mean 
Upper  
95 % 
CL 
Lower 
95 % 
CL 
Mean 
Upper  
95 % 
CL 
Lower 
95 % 
CL 
Mean 
Upper  
95 % 
CL 
Lower 
95 % 
CL 
Mean 
Upper  
95 % 
CL 
Lower 
95 % 
CL 
Mean 
Upper  
95 % 
CL 
Lower 
95 % 
CL 
10.75 8.14 6.05 12.57 4.21 3.68 14.84 12.06 8.93 11.92 5.98 4.90 -4.51* 3.23 5.07 
Data is presented as the mean (Native, n=3; Native Freeze-dried, n=4; Acellular, n=4; Acellular Freeze-dried, 
n=6; ethylene oxide, n=3)  ± 95% CL. Following arcsine transformation, data for each parameter was analysed 
by one way ANOVA and Tukey test (p<0.05). *Significantly different from Native, **Significantly different from 
native and acellular 
 
 
Figure 5.11 : Average Percentage Length Change Native, Native Freeze-dried, Acellular, Acellular 
Freeze-dried, Ethylene Oxide Treated and NBF Fixed Arteries with increasing pressure.  
Data was arcsine transformed for calculation of mean ± 95% CL and back transformed to percentages for 
presentation 
 
Table 5.10 - Average Percentage Length Change Native, Native Freeze-dried, Acellular, Acellular 
Freeze-dried and Ethylene Oxide Treated Arteries at 100 mmHg 
Percentage Length Increase  
Native Native Freeze dried Acellular 
Acellular Freeze 
Dried 
EO Sterilised 
Mean 
Upper  
95 % 
CL 
Lower 
95 % 
CL 
Mean 
Upper  
95 % 
CL 
Lower 
95 % 
CL 
Mean 
Upper  
95 % 
CL 
Lower 
95 % 
CL 
Mean 
Upper  
95 % 
CL 
Lower 
95 % 
CL 
Mean 
Upper  
95 % 
CL 
Lower 
95 % 
CL 
5.71 4.04 3.01 8.41 7.98 5.49 5.51 7.82 4.51 5.59 8.83 4.82 4.98 7.00 4.05 
Data is presented as the mean  (Native, n=3; Native Freeze-dried, n=4; Acellular, n=4; Acellular Freeze-dried, 
n=6; ethylene oxide, n=3)± 95% CL. Following arcsine transformation, data for each parameter was analysed by 
one way ANOVA and Tukey test (p<0.05). *Significantly different from Native, **Significantly different from native 
and acellular 
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5.5 Discussion 
The mechanical properties of arteries are attributed largely to the content and orientation of 
elastin and collagen. The elastin and collagen both have the potential to be affected by 
ionising radiation or EO treatment and therefore the mechanical properties of acellular 
porcine carotid arteries had the potential to be affected by sterilisation processes. The aims of 
the work described in this chapter were therefore to determine whether Gamma, E-Beam or 
EO sterilisation processes had any effect on the mechanical properties of the acellular 
arteries using the test methods developed in Chapter 4. 
The effects of the decellularisation process on the mechanical properties of native porcine 
carotid arteries from batch 3 and batch 4 described in this Chapter were largely consistent 
with those found for previous batches of acellular arteries described in Chapter 4 and any 
differences observed could be attributed to the natural variance that occurs within animal 
derived tissues.  
Observations of the stress-strain curves for the E-Beam irradiated samples revealed that 
much of the characteristic biphasic nature of native and acellular porcine carotid arteries was 
removed. Although the elastin and collagen modulus were not the same the stress-strain 
curves had become linear in comparison to native or acellular porcine carotid arteries. In the 
circumferential direction the elastin modulus was significantly higher than that of native and 
acellular porcine carotid arteries. In the axial direction the collagen modulus was significantly 
higher than that of the native and acellular porcine carotid arteries and the elastin modulus 
was also elevated. This suggested increased crosslinking due to E-Beam irradiation. In 
particular a major effect was observed on the elastin phase.  
The effects of cross linking on the collagen phase by E-Beam irradiation on acellular porcine 
carotid arteries were not as noticeable in the circumferential direction but were clearly evident 
in the axial direction. As there is a higher content of collagen fibres orientated in the 
circumferential direction, the effects of E-Beam irradiation are likely to be most pronounced in 
this direction. Therefore any effects caused by chain-scission are also most likely to be most 
pronounced in this direction. Again, therefore any increased stiffness may have been masked 
by a reduction in chain length, which would also support the observable reduction in the 
ultimate tensile stress. 
The contribution of elastin to the compliance of an artery was clearly highlighted by the 
negative effects that the increased elastin modulus had on the percentage diameter change 
of E-Beam irradiated acellular porcine carotid arteries. The elastin modulus was stiffened to 
the extent at which when pressurised the vessel would only extend longitudinally and caused 
a constant narrowing of E-Beam irradiated acellular porcine carotid arteries. The elastin 
modulus in the axial direction was less than half the elastin modulus in the circumferential 
direction of E-Beam irradiated acellular porcine carotid arteries making this the easiest route 
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for expansion. Increased chain scission in the circumferential direction may have also allowed 
for easier longitudinal movement in E-Beam irradiated acellular porcine carotid arteries.  
E-Beam irradiation clearly had detrimental effects on acellular arteries to the point at which it 
would not be feasible to use them as a functional graft. The most important effect being the 
large reduction in the compliance of the acellular arteries, which is a recognised factor for the 
increase in intimal hyperplasia and ultimately failure in vascular grafts (Sarkar et al., 2006).  
With regard to the stress strain parameters of Gamma irradiated acellular porcine carotid 
arteries there was a significant reduction in the transition strain in the axial direction when 
compared to native and acellular porcine carotid arteries and a significant reduction in the 
transition strain in the circumferential direction when compared to native porcine carotid 
arteries. This indicated that the elastin was becoming less distensible and that Gamma 
irradiation could have increased cross-linking in the elastin phase. In addition, the elastin 
modulus of Gamma irradiated acellular porcine carotid arteries was significantly stiffer  than 
native but not acellular porcine carotid arteries, providing further evidence that the elastin was 
susceptible to changes from Gamma irradiation particularly in the circumferential direction. 
Since, higher quantities of elastin are aligned in the circumferential direction compared to the 
axial direction, an increase in cross-linking in the circumferential direction could explain the 
observed increased stiffness. 
With regard to the stress strain parameters in the circumferential direction of Gamma 
irradiated acellular porcine carotid arteries, the collagen modulus and the ultimate tensile 
strength were significantly higher than native porcine carotid arteries. This might be explained 
by increased crosslinking occurring as the predominant mechanism over chain-scission in the 
collagen phase. 
The compliance testing of Gamma irradiated acellular porcine carotid arteries showed that the 
percentage diameter change was not significantly different from acellular porcine carotid 
arteries but was significantly lower than native porcine carotid arteries. This indicated that the 
compliance had been reduced which reinforced the findings from the data extracted from 
stress-strain curves.  
The burst pressure for all arteries tested exceeded 3000 mmHg which is in excess of the 
2000 mmHg minimum requirement. Unfortunately limitations of the equipment used 
prevented bursting at higher pressures and therefore statistical comparisons could not be 
made.   
E-Beam and Gamma irradiation both caused significant changes to acellular porcine carotid 
arteries. The elastin in the circumferential direction was most affected causing an increase in 
stiffness and a reduction in extensibility. This was more apparent with E-Beam irradiated 
samples. The collagen modulus and ultimate tensile strength were increased more in Gamma 
irradiated samples than in E-Beam irradiated samples this could be explained by chain 
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scission having a greater role in E-Beam irradiated porcine carotid arteries than Gamma 
irradiated porcine carotid arteries and therefore masking the effects caused by any cross-
linking. The high intensity short burst of E-Beam irradiation could be the reason behind this 
effect. The overall strength of both Gamma and E-Beam irradiated porcine carotid arteries 
was not compromised but only Gamma irradiated porcine carotid arteries were similarly 
extendable to native and acellular porcine carotid arteries. In addition to this the compliance 
of Gamma irradiated arteries at 7.02 + 3.86 – 3.07 % / 100 mmHg  was still closely matched 
to that of native human arteries  (femoral artery, 5.9 ± 0.5 % / 100 mmHg ; saphenous vein, 
4.4 ± 0.8 % / 100 mmHg;Walden et al. (1980); Internal mammary artery, 11.5 ± 3.9 % / 100  
mmHg Konig et al. (2009) ) . 
With regard to ethylene oxide treated arteries, the effects of freeze-drying were initially  
assessed since if the freeze-drying process adversely effected the mechanics of the arteries 
there was no value in pursuing ethylene oxide as a potential sterilisation method.  Freeze-
drying before EO treatment is employed for two reasons, firstly to reduce the water content 
which in turn reduces the build up of the toxic by-product ethylene glycol and secondly to 
maximise the penetration of EO gas into the matrix and tissue. Previous studies in bone 
allografts have shown a lack of penetration in wet tissues (Kearney et al., 1989; Kearney et 
al., 1993; Prolo et al., 1980). It is also common practice to irrigate tissues prior to EO 
treatment to reduce chloride content that could react with EO to form another toxic by-product 
ethylene chlorohydrin. As the decellularisation process is a continual series of washes the 
probability of a high chloride content was reduced.  
There were no significant differences in the mechanical parameters derived from uniaxial 
tensile testing of native freeze-dried porcine carotid arteries and acellular freeze-dried porcine 
carotid arteries in the circumferential and axial directions when compared to their respective 
non freeze-dried native or acellular porcine carotid artery. There were also no significant 
differences for the percentage diameter change and the percentage length change at 100 
mmHg for native freeze-dried porcine carotid arteries and acellular freeze-dried porcine 
carotid arteries when compared to their respective non freeze-dried native or acellular porcine 
carotid artery. This suggested that any effects of freeze-drying on acellular and native arteries 
were negated after adequate rehydration in saline solution and that the arteries returned to 
their original state in terms of mechanics. Based on this it was possible to assess the effects 
of ethylene oxide sterilisation on acellular porcine carotid arteries. 
Ethylene oxide treatment of acellular porcine carotid arteries had similar effects to E-Beam 
irradiation but the effects were more pronounced. With regard to the mechanical parameters 
derived from uniaxial tensile testing of ethylene oxide treated acellular porcine carotid 
arteries, the elastin modulus in both the circumferential and axial directions was significantly 
higher than native and acellular porcine carotid arteries and the collagen modulus was also 
significantly higher in the circumferential direction. The ultimate tensile stress was also 
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significantly higher in EO treated samples than native porcine carotid arteries. This increase 
in stiffness and strength could be explained by cross-linking caused by ethylene oxide. 
Collagen and elastin have a large number of functional groups that are susceptible to 
alkylation by ethylene oxide. The higher quantities of collagen aligned in the circumferential 
direction compared to the axial direction was the likely cause of the collagen modulus being 
effected more in this direction.  
In addition to this the transition strain of EO treated porcine carotid arteries was significantly 
reduced in the circumferential direction when compared to native and acellular porcine carotid 
arteries and in the axial direction when compared to native porcine carotid arteries. This might 
be explained by increased crosslinking reducing the extensibility of the artery. This was 
further supported by observation of the compliance parameters of EO treated acellular 
porcine carotid arteries. The elastin stiffness increased to such an extent that when under 
pressure, expansion occurred longitudinally and thinned the artery causing a negative 
percentage diameter change an effect also seen in E-Beam irradiated arteries. However, 
unlike E-Beam treated acellular arteries, there was a significant increase in ultimate tensile 
stress in the circumferential direction of EO treated acellular arteries when compared to 
native porcine carotid arteries and in the axial direction when compared to native and 
acellular porcine carotid arteries. This might be explained by no chain scission occurring in 
ethylene oxide treatment and supports the hypothesis that chain scission is occurring in 
irradiated samples. Similarly to E-Beam, EO treatment reduced the compliance of the artery 
to such an extent that it would not be functional as a vascular graft. 
The effects of EO treatment, Gamma irradiation and E-Beam irradiation are widely disputed 
with the later being least investigated. Most of the information about the effects of these 
sterilisation treatments on the mechanical properties of tissues can be found in the tissue 
banking literature on the effects on bone or tendon. The differences found by tissue banks in 
mechanical properties of tendon and bone caused by ionising radiation is well reported 
(Nather et al., 2007). Some studies have found a decrease in strength and modulus 
implicating chain scission as the predominant mechanism and some studies have found an 
increase in strength implicating cross-linking as the predominant mechanism.  The structure 
of bone and tendon is however vastly different compared to soft tissues such as arteries.  
A study investigating the effects of Gamma irradiation on an acellular tissue matrix derived 
from cadaveric human skin also discussed the predominant mechanism (crosslinking/chain-
scission) effecting the mechanical parameters with increasing dose (2.5 to 30 kGy). They 
found that at lower doses of Gamma irradiation there was an initial increase in tensile 
strength and stiffness and an initial reduction in ultimate tensile strain compared to control 
tissue.  With increasing dose the tensile strength and stiffness decreased and the ultimate 
tensile strain increased. This supported the hypothesis that chain-scission increased with 
higher doses reducing the stiffness of the graft and allowing it to extend more (Gouk et al., 
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2008). Interestingly another study into the effects of Gamma irradiation on collagen coated 
vicryl meshes reported that the predominance of chain-scission occurred in dry tissues and 
the predominance of cross-linking occurred in wet tissues. This indicated that the hydration of 
the tissue during ionising irradiation could be a significant factor in determining what structural 
changes occur (Gorham et al., 1993).  
One study reporting the development of acellular human dermis for clinical use adopted a 
similar EO treatment to the one used in this chapter. The tissue was freeze-dried before being 
treated with EO at low temperature (Chakrabarty et al., 1999). The results presented found 
similar effects to the data in this chapter, the failure strength of acellular human dermis was 
increased significantly compared to controls and the failure strain was reduced, although not 
significantly. Conversely Freytes et al. (2008) found a decrease in stiffness for EO treated 
freeze-dried urinary bladder matrix (UBM) compared to non sterilised freeze-dried UBM. They 
also found that Gamma and E-Beam irradiated freeze-dried UBM  had decreased in stiffness 
and failure strength when compared to non sterilised freeze-dried UBM. However the 
reduction in mechanical parameters for all these samples including the control might have 
been attributed to the incomplete rehydration of the sample. A clinical approach for 
rehydration was taken in which the sample was rehydrated for 5 minutes in 9 % saline 
whereas the rehydration of freeze-dried acellular porcine carotid arteries in this study was 
found to require over 1 hour (data not shown).  
It is clear that an investigation into each of these industrial standard methods of sterilisation 
should be carried out for different types of biomaterials and tissues intended for clinical use. 
The findings from the present study of acellular porcine carotid arteries indicated that Gamma 
irradiation would be the preferred method for potential sterilisation whereas E-Beam 
irradiation and EO treatment were shown to have considerable detrimental effects on the 
tissue. This, however may not be the case for harder or denser tissues such as bone or 
tendon.  
Further characterisation is necessary in order to determine the effects of the different 
sterilisation processes on the biological characteristics of the porcine carotid arteries. This is 
the focus of the following chapter. 
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Chapter 6 Biological Assessment of Acellular Porcine Arteries after 
Sterilisation using Different Methods 
6.1 Introduction  
In the previous Chapter, the effect of different methods of sterilisation on the mechanical 
properties of acellular arteries was assessed. It was also important to consider the effects of 
sterilisation using the same methods of Gamma irradiation, E-Beam irradiation and ethylene 
oxide (EO) on the biological properties of the acellular arteries. For example it was important 
to assess the effects of sterilisation on the microscopical structure, collagen integrity and 
biocompatibility of the arteries.   
It is recognised that EO sterilisation of biomaterials can create toxic residuals such as 
ethylene glycol and ethylene chlorohydrin and that without proper aeration these residuals 
can remain within an EO treated product (Prolo et al., 1980). It was therefore considered 
important to determine whether any of the EO treated or Gamma and E-Beam irradiated 
acellular porcine carotid arteries were toxic to cells (cytotoxic) since this would adversely 
affect the capacity of the acellular scaffolds for repopulation and regeneration in vitro or vivo.  
Evaluation of the sterilised acellular porcine carotid arteries and comparison with non-
sterilised arteries using histology with H&E staining of tissue sections was deemed to be a 
simple approach to determine whether there were any gross effects of the sterilisation 
methods on the structure of the arteries. Collagen IV is a predominant collagen type present 
in arteries and is also associated with the basement membrane (Shekhonin et al., 1985; 
Timpl, 1996). Previous studies of the effects of chemical sterilisation on acellular porcine 
arteries have indicated that the sterilisation method may lead to a reduction in 
immunostaining for collagen IV leading to an increase in the thrombogenicity of the scaffold 
(Wilshaw personal communication). It was therefore considered relevant to assess the effects 
of Gamma, E-beam and EO sterilisation on the presence of collagen IV by immunostaining..  
There are a range of methods available for assessing the integrity of structural collagens in 
biological materials. These include assays to determine the denatured collagen content 
(Mirsadraee et al., 2006), assays to assess cross-link density (Schwartz et al., 2006; Jiang et 
al., 2006), multiphoton microscopy (Williams et al., 2005; Theodossiou et al., 2006) and 
differential scanning calorimetry (Goissis et al., 2000). In this study, three such methods 
(multiphoton microscopy, denatured collagen content and DSC) were selected to determine 
the effects of sterilisation on the integrity of the collagen within the acellular arteries. The use 
of assays to determine cross-link density was beyond the scope of the initial studies.  
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Second harmonic generation multiphoton microscopy is a technique that has been adapted 
previously for the imaging of collagen structures such as rat tendon. The technique works by 
firing multiple photons at a sample (incident light), the annihilation of two photons occurs on 
interaction with the material creating a single photon emitted with half the wave length of the 
original photons (second harmonic light) (Figure 6.1).  
 
 
 
 
 
 
 
The excitation light is separated from the emitted light through filters and the resultant signal 
is detected. The technique provides a three dimensional view of the sample with high-
resolution and high contrast. The technique is most effective when applied to non-
centrosymmetric structures which is why the highly crystalline triple-helix structure of collagen 
is such a good generator of the second harmonic.  
Differential scanning calorimetry (DSC) is a thermo-analytical technique used to analyse the 
denaturation temperature of materials. DSC is used to measure the enthalpy (change in heat 
energy) required to increase the temperature of a sample compared to a reference material. 
The temperature is increased linearly at a constant rate and both the reference material and 
the sample are maintained at the same temperature. With respect to samples of proteinous 
nature, the influx of heat disrupts intermolecular hydrogen bonds and disulphide bridges 
altering the three-dimensional conformational shape (known as denaturation). The structural 
rearrangement results in a net absorption of heat known as an endotherm and the peak 
temperature at which this occurs is called the denaturation temperature. Any changes in 
denaturation temperature could imply structural changes in the acellular porcine carotid artery 
due to the sterilisation process. It can also provide evidence to preclude certain high 
temperature sterilisation processes from being tested. The denatured collagen content of 
tissues can also be determined using simple biological assays such as treating the tissues 
with alpha chymotrypsin followed by determination of the levels of hydroxyproline released 
(Mirsadraee et al., 2006) 
1064 nm 
532 nm 
532 nm 
1064 nm 1064 nm 
Figure 6.1 : The Second Harmonic Generation of Light 
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6.2 Aims and objectives 
The aims of this part of the study were to investigate the effects of Gamma irradiation, E-
Beam irradiation, freeze-drying and EO treatment on the biological properties of acellular 
porcine carotid arteries 
The specific objectives were:  
 To subject acellular porcine carotid arteries to Gamma irradiation (30 kGy) and 
determine the effects on the properties of the arteries using histology, the contact 
cytotoxicity assay, immunohistochemical labelling for collagen IV, multiphoton 
imaging, differential scanning calorimetry and denatured collagen content. 
 To subject acellular porcine carotid arteries to E-Beam irradiation (30 kGy) and 
determine the effects on the properties of the arteries using histology, the contact 
cytotoxicity assay, immunohistochemical labelling for collagen IV, multiphoton 
imaging, differential scanning calorimetry and denatured collagen content. 
 To freeze-dry acellular porcine carotid arteries and determine the effects on the 
properties of the arteries using histology, the contact cytotoxicity assay, 
immunohistochemical labelling for collagen IV, multiphoton imaging, differential 
scanning calorimetry and denatured collagen content. 
 To subject freeze-dried acellular porcine carotid arteries to EO sterilisation and 
determine the effects on the properties of the arteries using histology, the contact 
cytotoxicity assay, immunohistochemical labelling for collagen IV, multiphoton 
imaging, differential scanning calorimetry and denatured collagen content. 
6.3 Materials and Methods 
6.3.1 Arteries and Sampling 
The native porcine carotid arteries used in this chapter were procured and dissected 
according to the method described in Chapter 3; Section 3.3.1. Acellular arteries were 
produced in three batches (Chapter 3; Section 3.4.6) using the method described in Chapter 
3; Section 3.3.2. The acellular arteries studied in this chapter were from the same groups 
described in Chapter 5; Section 5.3.1 but here they were used for biological evaluation. The 
methods used to sample the  arteries for biological and mechanical evaluation has been 
described Chapter 3; Section 3.3.3. Sampling method I was used to provide tissue for 
quantitative analyses. Sampling method II was used for qualitative analyses. 
6.3.2  Irradiation Sterilisation 
Acellular porcine carotid arteries from batch 2 were vacuum sealed in an inner foil pouch and 
an outer Tyvek membrane pouch. Arteries were then couriered to Synergyhealth PLC and 
were Gamma irradiated at a dose of 30 kGy (Min, 25 kGy).  
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Acellular porcine carotid arteries from batches 3 and 4 were packaged with a PEG support 
and then subject to Gamma or E-Beam irradiation as previously described in Section 5.3.2.   
6.3.3 Freeze Drying 
Acellular porcine carotid arteries from batch 4 were subject to freeze drying as described in 
Section 5.3.3 
6.3.4 EO Method 
Freeze dried acellular porcine carotid arteries from batch 4 were subject to EO sterilisation as 
described in Section 5.3.4 
6.3.5 Sterility Testing 
Sterility testing of samples (n=2) was carried out according to Section 2.6.9 using tissue 
obtained using sampling method II for each group as shown in Chapter 5; Section 5.3.1. 
Arteries from the freeze-dried group were not tested for sterility since they were not freeze 
dried using aseptic technique. 
6.3.6 Histological and Immunohistochemical Analysis 
For histological analysis sections of porcine carotid arteries (n=2) from each group were 
stained using haematoxylin and eosin and immunohistochemically labelled using an antibody 
to collagen IV as described in Section 2.6.6.  
6.3.7 Multiphoton Imaging 
For multiphoton analysis 5 mm circular samples (n=2) of porcine carotid arteries from each 
group were imaged. Images  210 µm by 210 µm were obtained using a Zeiss LSM 510Meta 
inverted confocal microscope with an EC Plan-Neofluar 40x/1.30 Oil DIC objective, with a 
pixel dwell time of 12.8 µs. Collagen fluorophores were excited using a two-photon Ti-
Sapphire laser with 940 nm wavelength and 10 % transmission. Emission was filtered to 
detect wavelengths between 458 and 480 nm. All image analysis was performed using Zen 
2012 image analysis software. Z-stack images were taken at 1 µm intervals. 
6.3.8 Contact Cytotoxicity  
Samples (n=2) 5 mm2 of porcine carotid arteries from each group that had been shown to be 
sterile were tested to determine cytotoxicity as described in Section 2.6.9. 
6.3.9 Differential Scanning Calorimetry 
To determine the denaturation temperature of native, acellular, Gamma irradiated, E-Beam 
irradiated, freeze-dried EO treated, boiled and NBF fixed porcine carotid arteries samples 
(n=5) were placed on PBS soaked filter paper in bjoux containers and couriered overnight on 
ice to the Department of Materials Science at the University of Cambridge. Samples were 
then tested using modulated differential scanning calorimetry. Samples were placed in 
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hermetically sealed pans and subjected to a heat flow at a rate of 1 oC.min-1 up to a 
temperature of 110 oC and the heat energy required for this change was measured.  
6.3.10 Denatured Collagen Assay 
The denatured collagen content of samples  of native (n=8), acellular (n=4), Gamma 
irradiated (n=4), E-Beam irradiated (n=5), freeze-dried EO treated (n=5), boiled (n=6) and 
NBF fixed (n=6) porcine carotid arteries was determined using the method described in 
Section 2.6.10 
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6.4 Results 
6.4.1 Sterility of Sterilised Acellular Porcine Carotid Arteries 
It was important to confirm that the arteries were sterile following sterilisation treatment since 
any contamination would adversely affect the other biological assays to be conducted on the 
arteries such as contact cytotoxicity testing and denatured collagen assays. Sampling of 
arteries was therefore carried out after each sterilisation process. Circular samples (5 mm; 
n=2) from each batch were tested to confirm sterility by placing them in nutrient broth and 
incubating at 37 oC for 48 hours. No microbial growth was found in any samples tested 
(Figure 6.2).  
 
 
 
Figure 6.2 : Images of sterility tests carried out on batches of acellular arteries post sterilisation. 
Images of samples of Gamma (A) and E-Beam (B) irradiated and EO (C) treated porcine carotid arteries  
incubated in nutrient broth at 37 oC for 48 hours. Positive control was created by immersing a finger in 
nutrient  broth and negative control was a bottle of nutrient broth exposed to the HEPA filtered air.  
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6.4.2 Histological Evaluation of Sterilised Acellular Porcine Carotid Arteries 
Circumferential and longitudinal histological sections of native, acellular, Gamma and E-Beam 
irradiated and freeze-dried EO treated porcine carotid arteries were stained with haematoxylin 
and eosin. Representative images are presented in Figures 6.3 and 6.4. The histo-
architecture remained consistent in Gamma and E-Beam irradiated acellular arteries when 
compared to decellularised arteries. EO treated acellular arteries appeared to have some 
slight contraction and separation between the collagen/elastin layers of the extracellular 
matrix (Figure 6.3 E; 6.4 E).   
 
   
  
 
Figure 6.3 Representative images of histological sections of native, acellular, Gamma and E-Beam 
irradiated and freeze-dried EO treated porcine porcine common carotid arteries in the circumferential 
direction. 
Sections were stained with haematoxylin and eosin. Native arteries showed the presence of nuclei (A).  
There was an absence of nuclei in acellular arteries (B). Gamma (C) and E-Beam (D) irradiated porcine 
carotid arteries retained the histo-architecture shown in decellularised arteries. Ethylene oxide (E) treated 
arteries showed some contraction and separation between layers of the ECM.  The images were captured at 
40 x magnification.  
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Figure 6.4 : Representative images of histological sections of native, acellular, Gamma and E-Beam 
irradiated and freeze-dried EO treated porcine porcine common carotid arteries in the longitudinal 
direction. 
Sections were stained with haematoxylin and eosin. Native arteries showed the presence of nuclei (A). There 
was an absence of nuclei in acellular arteries (B). Gamma (C) and E-Beam (D) irradiated porcine carotid 
arteries retained the histo-architecture shown in decellularised arteries. Ethylene oxide (E) treated arteries 
showed some contraction and separation between layers of the ECM.  The images were captured at either 
40 or 100 x magnification.  
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6.4.3 Biocompatibility of Sterilised Acellular Porcine Carotid Arteries 
Samples of acellular, Gamma and E-Beam irradiated and freeze-dried EO treated acellular 
porcine carotid arteries were tested for biocompatibility using the contact cytotoxicity assay 
with L929 and BHK cells. Steri-strips and cyanoacrylate were used as negative and positive 
controls respectively. The phase contrast (Figure 6.5 and Figure 6.6) and Giemsa stained 
(Figure 6.7 and Figure 6.8) images captured at 48 hours showed that the cell lines grew up to 
Gamma and E-Beam irradiated and freeze-died EO treated acellular porcine carotid arteries 
indicating there was no cytotoxic effect on both the cell lines. Normal cell morphology was 
observed. The cyanoacrylate was highly cytotoxic and caused cell lysis.  
   
   
Figure 6.5: Representative images captured using phase contrast microscopy of L929 cells growing 
in contact with acellular, Gamma and E-Beam irradiated and freeze-dried EO treated acellular porcine 
carotid arteries from batches 3 and 4. 
L929 cells Incubated with acellular (A), Gamma (D) and E-Beam (E) irradiated and freeze-dried EO treated (B) 
porcine carotid acellular arteries, steri-strips (C) and cyanoacrylate (F). Images captured at x40 magnification. 
   
   
Figure 6.6: Representative images captured using phase contrast microscopy of BHK cells growing 
in contact with acellular, Gamma and E-Beam irradiated and freeze-dried EO treated acellular porcine 
carotid arteries from batches 3 and 4. 
BHK cells Incubated with acellular (A), Gamma (D) and E-Beam (E) irradiated and freeze-dried EO treated (B) 
acellular porcine carotid arteries, steri-strips (C) and cyanoacrylate (F). Images captured at x40 magnification 
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Figure 6.7: Representative images captured using light microscopy of L929 cells stained with Geimsa 
growing in contact with acellular, Gamma and E-Beam irradiated and freeze-dried EO treated acellular 
porcine carotid arteries from batches 3 and 4.  
L929 cells Incubated with acellular (A), Gamma (D) and E-Beam (E) irradiated and freeze-dried EO treated 
(B) acellular porcine carotid arteries, steri-strips (C) and cyanoacrylate (F). Images were captured at x40 
magnification. 
 
   
   
Figure 6.8: Representative images captured using light microscopy of L929 cells stained with Geimsa 
growing in contact with acellular, Gamma and E-Beam irradiated and freeze-dried EO treated acellular 
porcine  carotid arteries from batches 3 and 4. 
L929 cells Incubated with acellular (A), Gamma (D) and E-Beam (E) irradiated and freeze-dried EO treated 
(B) acellular porcine carotid arteries, steri-strips (C) and cyanoacrylate (F). Images were captured at x40 
magnification. 
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6.4.4 Immunostaining For Collagen IV in Sterilised Acellular Porcine Carotid 
Arteries 
6.4.4.1 Gamma Irradiation Artefacts Without Support Scaffold 
On initial testing, acellular arteries to be Gamma sterilised were placed in the appropriate 
packaging and vacuum sealed.  Following sterilisation using Gamma irradiation it was  
grossly evident that the process had altered the structure of the arteries. A permanent crease 
remained in the tissue and when sections of the tissue were immuno-stained using antibodies 
to collagen IV obvious artefacts could be seen. Representative images are presented in 
Figure 6.9. There was no background labelling present in any control sections of Gamma 
irradiated tissue including the antibody diluent and isotype control. There was a slight 
increase in intensity of the collagen IV immuno-staining when acellular tissue was compared 
to native tissue. In acellular arteries sterilised by Gamma irradiation there was a reduction in 
the labelling of collagen IV in the central region of the artery but a localised presence around 
an artefact created by the artery orientation during the sterilisation process. 
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Figure 6.9 : Representative images of collagen IV immuno-stained sections of native (A) , acellular (B) 
and acellular Gamma (C, D) irradiated porcine carotid arteries. Acellular Gamma irradiated isotype 
control (F) and antibody diluent control (E).  
Arteries post decellularisation were observed to have a slight increase in intensity of collagen IV 
immunostaining when compared to native arteries. Gamma irradiated acellular arteries were observed to 
have a reduction on collagen IV presence in the central region but a localised presence remained within 
artefacts created by the artery orientation in space during Gamma irradiation 
 
 
 
 
 
A B 
F E 
D C 
    100 µm    .          100 µm    .      
    100 µm    .          100 µm    .      
    100 µm    .      
    100 µm    .      
- 137 - 
6.4.4.2 Gamma Irradiation Effects with Support Scaffold 
Due to unwanted artefacts created in Gamma irradiated acellular arteries a new approach 
was taken. Arteries were rested in a polyethyleneglycol half cylinder support scaffold to 
maintain and hold the artery structure, the artery was then placed in the appropriate 
packaging before sterilisation. The addition of this support structure completely removed the 
visually apparent creasing and when viewed microscopically no artefact could be seen. 
Sections of native, acellular and Gamma and E-Beam irradiated and EO treated acellular 
arteries were immunohistochemically labelled for the presence of collagen IV. Representative 
images are presented in Figure 6.10. 
Native arteries exhibited positive immuno-staining for collagen IV. After decellularisation the 
presence of collagen IV was retained but with a slightly increased intensity observed 
compared to the native artery. Gamma irradiated arteries also retained positive labelling for 
collagen IV but with patches of reduced intensity. E-Beam irradiated arteries showed a 
reduction in intensity of collagen IV immuno-staining with patches of very low intensity 
staining. Ethylene oxide treated arteries showed no positive labelling for collagen IV. No 
background staining was observed in any isotype controls or antibody diluent controls. 
    
    
    
Figure 6.10 : Representative images of collagen IV immune-labelling in sections of native (A), 
acellular (B, C) , acellular Gamma (D) irradiated, acellular E-Beam (G) irradiated, acellular EO (J) 
treated porcine carotid arteries. Isotype controls (E, H, K) and antibody diluent controls (F, I, L).  
Native and acellular arteries exhibited positive immune-labelling for collagen IV but with a slightly increased 
intensity observed in the acellular artery. Gamma irradiated acellular arteries also retained positive labelling 
for collagen IV, E-Beam irradiated acellular arteries had a slight intensity reduction and EO treated acellular 
arteries showed no immune-labelling for collagen IV. No background staining was observed in any isotype 
controls or antibody diluent controls. 
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6.4.5 Multiphoton Imaging of Sterilised Acellular Porcine Carotid Arteries 
Multiphoton second harmonic generated images were taken of the luminal side of native, 
acellular, boiled, NBF fixed, acellular Gamma and E-Beam irradiated, acellular freeze-dried 
and acellular freeze dried EO treated porcine carotid arteries to assess any damage caused 
to the collagen structure by each of the sterilisation processes. Representative images are 
depicted in (Figure 6.11-6.15). Z-stacked images of acellular, Gamma and E-Beam irradiated 
and EO treated porcine carotid arteries were also captured and depicted in Figure 6.16. 
Images of native porcine carotid arteries showed the natural crimped collagen structure in a 
repeated but random pattern orientated in space with a number of small perforations. 
Acellular porcine carotid arteries also retained this structural pattern, while exhibiting signs of 
elongation of the crimped structure and slightly larger perforations. Images of boiled porcine 
carotid arteries showed an absence of the crimped pattern and exhibited a merged sheet 
containing multiple perforations of various sizes. Images of neutral buffered formalin fixed 
porcine carotid arteries showed areas of the crimped pattern observed in native tissue with 
less distinction and a more unidirectional stretched appearance (Figure 6.11). 
Images of Gamma irradiated acellular porcine carotid arteries exhibited a reduction in the 
second harmonic light compared to native arteries and pockets of areas in which the crimped 
structure could still be observed. The perforations were more frequent and elongated in a 
particular direction when compared to native or acellular non-sterilised tissue(Figure 6.12). 
Similarly E-Beam irradiated acellular porcine carotid arteries exhibited a reduction in second 
harmonic light compared to native arteries and pockets of areas in which the crimped 
structure could still be observed. The perforations seemed to be aligned more heavily in one 
direction and large rifts were evident perpendicular to this arrangement (Figure 6.12). 
Prior to EO sterilisation, freeze dried acellular porcine carotid arteries exhibited similar 
characteristics to acellular tissue but with a reduction in second harmonic light compared to 
native arteries (Figure 6.14). Multiphoton images of freeze dried EO sterilised acellular 
porcine carotid arteries had equal second harmonic light compared to images of native and 
acellular arteries. Elements of the crimped structure remained but appeared in a more 
condensed mesh. There were also spherical artefacts unique to ethylene oxide sterilised 
acellular arteries observed in multiple areas of the tissue (Figure 6.15). 
Z-stacked images of Gamma irradiated acellular arteries showed pockets of damage in which 
the collagen structure no longer emitted second harmonic light. This was also observed in the 
Z-stacked images of E-Beam irradiated acellular arteries but to a far greater extent (Figure 
6.16, C). Z-stacked images of EO treated acellular porcine carotid arteries appeared to be 
similar to acellular arteries however spherical artefacts were observed (Figure 6.16, D). 
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Figure 6.11 Second harmonic image generation of (A)  Native, (B) Acellular, (C) Boiled and (D) NBF 
fixed porcine carotid arteries.  
Collagen fluorophores were excited using a two-photon Ti-Sapphire laser with 940 nm wavelength and 10 % 
transmission. Emission was filtered to detect wavelengths between 458 and 480 nm 
  
Figure 6.12 : Second harmonic image generation of Gamma irradiated acellular porcine carotid 
arteries (A,B). 
Collagen fluorophores were excited using a two-photon Ti-Sapphire laser with 940 nm wavelength and 10 % 
transmission. Emission was filtered to detect wavelengths between 458 and 480 nm 
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Figure 6.13 : Second harmonic image generation of E-Beam irradiated acellular porcine carotid 
arteries (A,B). 
Collagen fluorophores were excited using a two-photon Ti-Sapphire laser with 940 nm wavelength and 10 % 
transmission. Emission was filtered to detect wavelengths between 458 and 480 nm 
 
Figure 6.14 : Second harmonic image generation of freeze-dried acellular porcine carotid arteries. 
Collagen fluorophores were excited using a two-photon Ti-Sapphire laser with 940 nm wavelength and 10 % 
transmission. Emission was filtered to detect wavelengths between 458 and 480 nm 
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Figure 6.15 : Second harmonic image generation of freeze-dried EO treated acellular porcine carotid 
arteries (A, B).  
Collagen fluorophores were excited using a two-photon Ti-Sapphire laser with 940 nm wavelength and 10 % 
transmission. Emission was filtered to detect wavelengths between 458 and 480 nm 
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Figure 6.16 : Z stacked Second harmonic image generation of acellular (A),  Gamma (B) and E-Beam 
(C) irradiated and EO (D) treated acellular porcine carotid arteries. 
Collagen fluorophores were excited using a two-photon Ti-Sapphire laser with 940 nm wavelength and 10 % 
transmission. Emission was filtered to detect wavelengths between 458 and 480 nm. Z- stack images were 
captured at  1 um intervals.  
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6.4.6 Differential Scanning Calorimetry 
Differential scanning calorimetry was used to measure the denaturation temperature of 
native, acellular, boiled and NBF fixed, Gamma irradiated, E-Beam irradiated, freeze-dried 
EO treated acellular porcine carotid arteries and the results are depicted in Figure 6.17. The 
acellular arteries measured were from Batch 3 and Batch 4 (Table 3.3) and were the quality 
control (QC) samples for the Gamma and E-Beam irradiated group and for the EO treated 
group. The data was analysed using one way ANOVA (p<0.05). Positive controls 
demonstrated significant damage to the arteries. DSC could not detect a denaturation point in 
boiled arteries and showed that the denaturation point for NBF fixed arteries was 95.52 ± 
1.11 ºC. This was significantly higher (p<0.05) than all other artery groups. The denaturation 
temperature of native, acellular Gamma irradiated, E-Beam irradiated, freeze-dried EO 
treated acellular porcine carotid arteries sterilised arteries were approximately 60 ºC and 
were not significantly different from each other p>0.05. 
 
Figure 6.17 : Bar chart depicting denaturation temperatures of native, boiled and NBF fixed, acellular, 
Gamma irradiated, E-Beam irradiated, freeze-dried EO treated acellular porcine carotid arteries.  
Data is expressed as the mean (n=5; boiled and NBF,  n=4) ± 95 % C.L. Data was analysed using one way 
ANOVA (p<0.05). DSC could not detect a denaturation point in boiled arteries. The denaturation point for 
NBF fixed arteries was 95.52 ± 1.11, this was significantly (p<0.05) higher than all other artery groups. The 
denaturation temperature of native, acellular, Gamma irradiated, E-Beam irradiated, and ethylene Oxide 
treated arteries were approximately 60 oC and were not significantly different from each other. *Significantly 
higher than all other arteries. 
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6.4.7 Denatured Collagen Content 
The denatured collagen content was quantified in native, acellular, Gamma irradiated, E-
Beam irradiated and freeze-dried EO treated acellular porcine carotid arteries, the denatured 
collagen content in a second group was quantified to compare positive controls for damage 
the samples consisted of native, boiled and NBF fixed porcine carotid arteries. Results are 
depicted in Figure 6.18. Data was analysed using a one way ANOVA and Tukey post-hoc 
testing. Ethylene oxide sterilised samples were found to contain significantly (p<0.05) more 
denatured collagen than all other samples. Boiled samples were found to have significantly 
(p<0.05) higher denatured collagen content than NBF and native samples but significantly 
(p<0.05) lower than freeze-dried ethylene oxide treated samples. Native, acellular, Gamma 
and E-Beam irradiated and NBF fixed samples did not show any significant differences 
(p>0.05) in denatured collagen content.  
 
Figure 6.18 : Bar chart of denatured collagen content in native, acellular, acellular Gamma and E-
Beam irradiated, EO treated, boiled and NBF fixed porcine carotid arteries 
Data expressed as the mean (native, n=8,Blue, n=5, Red ; acellular. n=4; Gamma, n=4; E-Beam, n=5; EO, 
n=5; boiled, n=6; and NBF,  n=6) ± 95 % C.L. Data was analysed using one way ANOVA and Tukey post-
hoc testing. Native, boiled and NBF fixed, acellular, Gamma and E-Beam irradiated, freeze-dried ethylene 
oxide treated acellular porcine carotid arteries had no significant differences in denatured collagen content. 
Freeze-dried EO treated acellular samples had significantly higher denatured collagen content than all other 
samples (*). Boiled samples had significantly more denatured collagen content than NBF fixed and native 
arteries but significantly less than freeze-dried ethylene oxide treated acellular samples (**). 
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6.5 Discussion 
The research presented in this chapter investigated the biological characteristics of the 
acellular porcine carotid arteries after treatment with Gamma and E-Beam irradiation or EO. 
Initially when the arteries were first sent for Gamma irradiation they were not placed in any 
support scaffold. On return it was clear that structural changes had occurred. Where the 
arteries had flattened in the packaging, permanent creases had occurred in the apex. When 
evaluated by histology with immunohistochemical labelling using an antibody to collagen IV, 
the creases could be observed and caused an artefact of localised increased intensity of 
labelling for collagen IV. This also created difficulties in mechanical testing and therefore this 
batch of  arteries was scrapped and a new method to resolve the issue was introduced. A 
PEG semi-circular scaffold was created from vacuum formed moulds. The arteries were then 
placed into these scaffolds before packaging and vacuum sealing. On return from sterilisation 
treatment, the arteries no longer had creases and the artefact was no longer present. The 
creasing was likely due to the irradiation cross linking the arteries fixed in the flattened 
position. By placing them in a support structure the arteries were fixed in the natural 
cylindrical formation.  
Histology showed no obvious changes in the structure after any of the sterilisation treatments 
showing that largely the ECM matrix appeared unchanged.  Labelling for collagen IV following 
Gamma irradiation appeared to show a slight reduction in intensity but the immuno-staining 
was generally consistent with control acellular arteries, E-Beam irradiation reduced the 
intensity of collagen IV immuno-staining greatly and EO treatment removed all staining for 
collagen IV. As mentioned previously biological molecules are highly susceptible to alkylation 
due to the high incidence of accepting functional groups, it was therefore possible that the 
collagen IV epitopes recognised by the antibody had undergone conformational changes to 
such an extent that antibody binding no longer occurred.  With respect to Gamma and E-
Beam irradiated samples, both had patches of reduced intensity indicating that the collagen 
IV epitopes may also have been affected by irradiation, to varying extents. Gamma irradiation 
had far less effect with fewer patches of reduced immuno-staining for collagen IV when 
compared to E-Beam irradiated samples which showed a much higher reduction in intensity 
of immunostaining and more patchy areas of reduction. For the same dose of irradiation, E-
Beam irradiation occurs as a high intensity electron beam with a short exposure time when 
compared to Gamma irradiation where a measured dose occurs over a long exposure time. It 
was perhaps this short burst of higher intensity that has caused E-Beam irradiation to have a 
more detrimental effect than Gamma irradiation on the collagen and elastin structure. These 
effects were consistent with those found with multiphoton imaging. When comparing images 
of Gamma irradiated samples with acellular samples there were small pockets where no 
signal was produced and an overall reduced intensity showed that significant structural 
changes had occurred but evidence of a similar pattern compared to the images of the 
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untreated acellular artery tissue remained. Multiphoton images of the E-Beam irradiated 
samples showed clear elongated structures of collagen but with large rifts in the tissue, 
highlighting the fact that E-Beam had significant damaging effects on the collagen structure 
when compared to images of the acellular control samples. Multiphoton images of freeze-
dried acellular porcine carotid arteries showed a very similar pattern to multiphoton images of 
acellular porcine carotid arteries but with a slight reduction in intensity. This showed that the 
effects of freeze-drying on the collagen structure were minimal. Multiphoton images of freeze-
dried EO treated acellular porcine carotid arteries showed that the intensity of the signal 
increased compared to freeze-dried arteries but the pattern seemed to represent less of an 
uncrimped collagen structure and more of a compact mesh. There were also numerous 
perforations and spherical artefacts. These artefacts could potentially have been caused by 
alkylation having a shrinking effect where pockets of increased EO concentrations had settled 
in the artery. This showed that EO treatment drastically changed the architecture of the 
artery.  
It is well known that EO forms toxic residuals (Lucas et al., 2003) and irradiation creates 
radiolytic by-products (Gehring, 1995). It was therefore necessary to determine if either 
irradiation or EO treatment resulted in cytotoxic acellular porcine carotid arteries   The results 
from the incubation of treated arteries with BHK and L929 cells showed that there were no 
cytotoxic effects from either process. In the EO treatment process the chamber undergoes a 
degassing period and cycles of nitrogen washes to help dilute the number of EO residuals. 
Further to this the arteries undergo aeration in which controlled pressure gradients and 
temperature help to reduce EO residuals over time. It is the addition and control of these 
steps by industrial sterilisation providers that will help to reduce instances of cytotoxic failure 
in EO sterilised products(Jackson et al., 1990). In irradiated products the low levels and quick 
degradation rate of free radicals and radiolytic products may have limited the potential to 
cause the acellular porcine carotid arteries to become cytotoxic and the results shown here 
support this. 
The differential scanning calorimetry results for the sterilised arteries showed that there were 
no significant reductions in denaturation temperature of the arteries. This indicated that the 
structural changes occurring as result of the processes were not sufficient to increase or 
decrease the peak temperature at which the collagen structure unfolded. In irradiated 
samples this could have been due to an increase in bonds due to cross-linking being 
counterbalanced by any reduction in protein length and for EO treated samples the increase 
in cross-linking showed no significant effect on the denaturation temperature. This also 
showed that the temperature of the sterilisation processes needed to be below 60 oC as 
typically EO cycles are carried out at much higher temperatures. Hence, using a low 
temperature cycle at 55 oC was justified.  
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The denatured collagen content of all sterilised samples was low in terms of weight per 
weight content. There were however still significant differences. The positive control of boiled 
porcine carotid arteries was only significantly higher temperature than NBF fixed porcine 
carotid arteries and not higher than native or acellular arteries as might be expected. This 
was probably because as the collagen is boiled at a higher than the denaturation temperature 
it becomes gelatinous and forms new bonds. A better denatured collagen content control 
could have been achieved by heating at just above the denaturation temperature for a period 
of time. It was however significantly lower than the denatured collagen content of the EO 
treated arteries. This could perhaps have been because at 55 oC, the temperature of the EO 
sterilisation process, is close to the denaturation temperature of collagen. This coupled with 
conformational changes occurring due to the EO treatment could have caused an increase in 
denatured collagen content. 
To summarise, all of the sterilisation processes had no effect on the biocompatibility of the 
acellular arteries but all the process had an effect on the collagen structure to varying 
degrees. The histo-architecture of the arteries underwent some clearly observable changes, 
which were most apparent in the E-Beam irradiated and EO treated arteries which was also 
reflected in the mechanical data reported in Chapter 5. Gamma irradiated acellular arteries 
also showed definite changes to the collagen structure compared to acellular arteries but 
remained similar in nature. 
The results presented in this chapter give a broader picture of the changes occurring in 
acellular porcine carotid arteries due to each of the sterilisation processes. This overall 
picture created by the biomechanical and biological findings for each sterilisation process will 
be discussed in the final chapter. 
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Chapter 7 Discussion 
There is a clinical need for vascular conduits for a range of applications such as coronary 
artery bypass grafts, treatment of peripheral arterial disease and kidney dialysis access 
(Andros et al., 1986; Madden et al., 2005). For small diameter applications the current gold 
standard is autograft tissue such as the saphenous vein (Goldman et al., 2004). Unfortunately 
autograft tissue is not available in approximately one third of patients due to previous surgery, 
donor site morbidity or atherosclerosis (Bourassa, 1994). The major alternative, when no 
autograft tissue is available, is the use of synthetic graft. Synthetic grafts have limitations of 
low patency rates and have poor clinical prognosis when used in small diameter applications 
(Kannan et al., 2005). Therefore the possibility of a functional “off the shelf graft” is highly 
desirable. The aims of the research presented in this study were to develop a robust set of 
methods to assess the effects of different sterilisation processes on the mechanical and 
biological properties of a novel small diameter acellular xenogeneic vascular graft. 
The acellular xenogeneic vascular grafts that were utilised during the study were produced 
from porcine carotid arteries using a previously patented decellularisation method (Ingham et 
al., 2010). Subsequent work had shown that the acellular porcine carotid arteries had 
regenerative capacity when tested in a large animal model (Wilshaw S. et al., 2014.). 
However, in order to translate the acellular porcine carotid arteries into a commercial product 
for clinical use, it is important that the arteries are sterile. For other acellular xenogeneic 
biological scaffolds produced using a similar decellularisation process at the University of 
Leeds, the scaffolds have been sterilised using a chemical sterilant and then aseptically 
transferred into packaging. This is not ideal and it is highly desirable that a terminal 
sterilisation process is adopted which has minimal effects on the biological and biomechanical 
properties of the acellular porcine carotid arteries.    
Ideally, a terminal sterilisation method that is industrially available which enables the product 
to be sterilised in its final packaging should be used. The main industrially available 
sterilisation processes are Gamma and E-Beam irradiation and ethylene oxide (EO) 
treatment.  
An implantable medical device requires a sterility assurance level (SAL) of 10-6. It was, 
however beyond the scope of this study to validate the sterilisation processes that were 
investigated since these were contracted out to industry and were the standard doses and 
cycles commonly used in industry for the terminal sterilisation of medical devices. Hence the 
work presented here should be viewed as a feasibility study to determine the compatibility of 
these sterilisation processes when applied to acellular porcine carotid arteries.  
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For irradiation sterilisation a commonly practiced method is to apply VDMax 25 to sterilise the 
product (ISO, 11137-2:2012). This allows a validation using a small number of samples based 
on the product bioburden being less than 1000 colony forming units. Since the acellular 
porcine carotid arteries were disinfected and the decellularisation process inherently reduced 
product bioburden, this approach was adopted in this study. For EO sterilisation a commonly 
adopted method within industry is the overkill method (ISO, 11135:2014 ). This entails 
treating the product with half the concentration of EO required to achieve a SAL of 10-6 and 
then applying a cycle at double this dose giving a SAL of 10-12.  
The effects of Gamma and E-Beam irradiation and EO treatment on biological grafts such as 
bone and tendon have been well documented in the literature with contrasting results. 
Irradiation processes are well known to induce two mechanisms that can affect the 
mechanical properties of proteinaceous materials, polypeptide chain scission (Cheung et al., 
1990) and cross-linking (Gouk et al., 2008). Chain scission reduces protein length and can 
reduce the ultimate tensile strength and moduli of proteinaceous materials, whereas cross 
linking can cause increasing strength and stiffness. Therefore the extent to which either of 
these mechanisms occurs during the sterilisation process will determine the effect on the 
mechanical properties. The effects of Gamma and E-Beam irradiation on bone and tendon 
has been widely reported with differing conclusions. Some comparative studies on the effects 
of Gamma and E-Beam irradiation have suggested that the treatments have similar effects on 
the mechanical properties and reduce the elastic modulus and ultimate tensile stress of 
tendons (Seto et al., 2009), whereas other studies suggest that Gamma irradiation had a 
greater impact on reducing the stiffness and ultimate tensile strength of tendons compared to 
E-Beam irradiation (Hoburg et al., 2015). 
Acceptable levels of EO residuals for implantable medical devices been set in the ISO 
standards, however these levels might not reflect the levels required for a regenerative graft 
to be successful. It was therefore particularly important to assess the biocompatibility of EO 
treated grafts. The removal of chloride ions through washing pre-sterilisation (Kaku et al., 
2002) and the use of heated aeration post sterilisation (Kakiuchi et al., 1996) are two ways to 
aid in the reduction of EO residuals. It has also been identified that wet tissues reduce the 
penetration depth of EO gas and that freeze–dried tissues allow better gas penetration 
(Kearney et al., 1989). Taking this into account, if EO treatment was to be considered as a 
possible sterilisation method then the effects of freeze-drying on the acellular graft prior to 
sterilisation also needed to be considered as part of this study. It has been reported that the 
combined effects of freeze-drying and EO sterilisation on tendon grafts does not have a 
significant impact on the mechanical properties (Smith et al., 1996; Bechtold et al., 1994).  
When considering the literature on the effects of sterilisation on tendons it is important to note 
that the biological composition of tendons, in terms of elastin and collagen content is quite 
different compared to elastic soft tissues such as arteries.  
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Therefore, it was important that both the biological and mechanical effects of the sterilisation 
processes on the acellular porcine carotid arteries were fully investigated. It was equally 
important to ensure that the methods used to assess these effects were robust. Hence, a 
large proportion of the work presented in this study involved development of the methods to 
establish the effects of the sterilisation processes on the biomechanical properties of the 
acellular porcine carotid arteries. 
Firstly it was necessary to determine whether the acellular porcine carotid arteries could be 
produced repeatedly and consistently using the previously established decellularisation 
process. This was demonstrated in Chapter (3) through the production of several batches of 
acellular porcine carotid arteries with a greater than 80 % reduction in DNA content and 
preservation of the histoarchitecture when observed in haematoxylin and eosin stained 
sections. The acellular porcine carotid arteries were also shown to be biocompatible using 
contact cytotoxicity analysis.  These studies also provided sufficient material to conduct the 
studies described in the subsequent Chapters.   
Two sets of mechanical test methods were adopted and developed to assess the mechanical 
properties of the acellular porcine carotid arteries, uniaxial tensile testing and burst pressure 
and compliance testing. Uniaxial tensile testing has historically been used to assess the 
biphasic nature of collagenous tissues (Fung, 1993) although, due to the anisotropy of 
arteries it was necessary to test samples in both the circumferential and axial directions. The 
uniaxial tensile testing method was adopted from previous studies and then optimised for 
performance with porcine carotid arteries. The most significant development was the 
determination of the correct amount of preloading for the jig being used and new 
understanding of how overestimating this result could easily mask any differences in 
properties between groups. The developed uniaxial testing protocol allowed in-depth 
comparisons to be made of mechanical properties of the arteries that had been subject to 
different treatments including the collagen and elastin phase modulus and the ultimate tensile 
strength. 
Compliance testing allowed a multi-axial assessment of the arteries to gain an understanding 
of how the artery might perform physiologically. In addition, it was essential to ensure that  the 
method for determining compliance of the arteries was accurate  and reliable since 
compliance is a known factor for failure of vascular grafts (Walden et al., 1980; Abbott et al., 
1987; Seifert et al., 1979). Failure to determine the compliance properties of a potential 
vascular graft correctly could have a large impact on the functionality of the graft in-vivo. Due 
to the natural tendency of the arteries to bend under inflation, it was necessary to test various 
methods in order to keep the artery within the plane of the camera. Similarly, the method of 
measuring of the artery diameter using image analysis software needed to be repeatable. 
The final method adopted was robust enough to provide confidence in the results.  
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The biological methods adopted in this thesis were predominantly well established methods 
that were readily transferable to the investigation, for example examining the histoarchitecture 
using histology and immunohistochemical investigation of the collagen IV content. Some of 
the more novel methods used were multiphoton imaging and DSC. The multiphoton imaging 
created images based on the ability of the collagen structure to emit second harmonic light. 
When a collagenous structure is damaged or altered its ability to emit second harmonic light 
diminishes (Lin et al., 2006; Brockbank et al., 2008; Schenke-Layland, 2008) Hence, this 
method provided a good tool for visual demonstration of any effects caused by sterilisation on 
the porcine carotid arteries. DSC is a thermo-analytical technique that has been used to 
identify the denaturation temperatures of collagenous materials by measuring the heat energy 
change (Sun & Leung, 2008). This method could be used firstly to provide evidence for the 
workable temperature ranges of the arteries and whether the temperature conditions of a 
particular sterilisation process was suitable for the graft and secondly it could potentially 
identify changes caused by the sterilisation process. 
For Gamma and E-Beam irradiation the two predominant mechanisms acting on the 
biological and mechanical structure are chain-scission and cross-linking. Through 
examination of the results it was clear that for the same dose of irradiation the mechanisms 
were not consistent between the two processes.  
From a mechanics stand point, the E-Beam irradiation increased the stiffness of the elastin 
modulus and collagen modulus, with the greatest increase in stiffness on the elastin modulus. 
E-Beam irradiation also reduced the ultimate strength of the material perhaps indicating that 
while a large increase in stiffness occurred due to cross-linking, in the elastin modulus a large 
chain-scission effect could have occurred simultaneously. The increased circumferential 
elastic stiffness certainly had an impact on the compliance testing, which demonstrated a 
longitudinal expansion and a circumferential narrowing under pressure giving a negative 
percentage diameter change. The clear indication that E-Beam irradiation had a significant 
effect on the ECM was also highlighted in the biological evaluation. The collagen IV immuno-
staining intensity was greatly reduced with patches of very low intensity and the multiphoton 
imaging also showed the collagen as segmented with large areas where no second harmonic 
light was generated. These observations suggested that the collagen structure had been 
altered resulting in a loss of antibody binding to collagen IV and reduction in ability to emit 
second harmonic light as  usually seen in collagen structures.  Although short lived, the 
temperature of the E-Beam process can rapidly increase to 40 ºC above ambient temperature 
which when considering the DSC data could have raised the temperature above the 
denaturation point of collagen (~ 60 ºC), the denatured collagen content of the treated tissue 
was however not significantly different to native or acellular porcine carotid arteries. This did 
not support the hypothesis that the arteries had been over-heated and therefore it was 
unlikely that that this was the cause of the structural alterations occurring in the matrix. On a 
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whole the data presented in both chapters 5 and 6 supported the conclusion that E-Beam 
irradiation is not a compatible choice of sterilisation for acellular vascular grafts. 
Gamma irradiation sterilisation of acellular porcine carotid arteries resulted in minimal 
differences compared to untreated acellular arteries. There were indications of increased 
stiffness of both the collagen and elastin modulus but the only significant difference was a 
decrease in transition strain in the axial direction demonstrating a reduced extensibility.  As 
there was no significant reduction in UTS it might be concluded that chain-scission of the 
proteins in the matrix was not a predominant effect as seen for E-Beam irradiation. Equally 
when considering the compliance there was no significant  difference in the compliance of the 
Gamma irradiation treated acellular porcine carotid arteries compared to the untreated 
acellular arteries, demonstrating that Gamma irradiation had far less impact on the elastin 
modulus compared to E-Beam irradiation. This was not however reflected in the biological 
evaluation. The collagen IV staining showed a reduction in intensity and the multiphoton 
imaging showed some distinct changes in structure and reduction in second harmonic light 
generated compared to acellular arteries. This supports that the combined effects of chain-
scission and cross-linking on the mechanical properties of collagen in Gamma irradiated 
acellular porcine carotid arteries are in effect cancelling each other out but that the process 
itself is still changing the structure of the proteinaceous material. 
Much of the initial literature on the effects of irradiation sterilisation on collagenous materials 
was carried out at doses above 200 kGy. More recent work has been investigated the effects 
of lower doses below 50 kGy to reflect the requirements of sterilisation processes. The 
mechanisms of chain-scission and free-radical formed cross-linking can have varying effects 
based on tissue structure, process environment conditions, hydrated vs dehydrated tissue 
and, of course, irradiation dose.  Sun & Leung (2008) Gamma irradiated decellularised 
human dermis (Alloderm, LifeCell Corporation, Branchburg, NJ) at doses from 0 to 32 kGy. 
They found that the denaturation temperature determined by DSC decreased with increasing 
dose and hypothesised that chain-scission was the predominant factor at lower doses. 
Controversially the DSC results from this study suggested that for both E-Beam and Gamma 
irradiation that either the cross-linking had occurred to an extent that masked the chain-
scission or that chain-scission was having little effect on the denaturation temperature of the 
collagen. This could potentially have been due to the fact that the decellularised human 
dermis was irradiated in a freeze-dried state in a nitrogen atmosphere with low relative 
humidity. These conditions reduce the water content present during irradiation and prevent 
the formation of free radicals such as hydroxyl radicals, that promote the formation of cross-
linking (Gorham et al., 1993; Lerouge & Simmons, 2012). Gouk et al. (2008) investigated the 
mechanics of the same decellularised freeze-dried human dermis, after Gamma irradiation at 
doses of 0 to 30 kGy, after it had been rehydrated. Again, the mechanical data showed a 
reduction in UTS and Young`s modulus with increasing dose, supporting the conclusion that 
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chain-scission was the predominant mechanism. A comparison to the results found in this 
study suggested that the presence of water may have greatly impacted on the occurrence of 
free-radical induced cross-linking and masked any measurable effects from chain-scission.  
In a move away from traditional high dose Gamma irradiation of bone-patella-tendon-bone 
grafts, Hoburg et al. (2015) compared the effects of E-Beam and Gamma irradiation on bone-
patella-tendon grafts at 25 kGy and 34 kGy and found that Gamma irradiation significantly 
reduced the stiffness and failure load at both 25 kGy and 34 kGy, whereas only the failure 
load was reduced with E-Beam irradiation at 34 kGy. These findings were again contrary to 
the results found in the present study for Gamma and E-beam irradiated acellular porcine 
carotid arteries, this could be attributed to the differences in the parameters used in the 
process, including temperature and environment. In the Hoburg et al. (2015) study all the 
irradiation treatments were carried out on dry ice (~ -70 oC) and the E-Beam irradiation of the 
tendons was carried out in an inert atmosphere of CO2. Both of these conditions have the 
ability to reduce the occurrence of free-radical reactions. The differences between the 
Gamma irradiated and E-Beam irradiated tendons could also potentially be attributed to 
differences in the process parameters as the Gamma irradiation process was carried out in 
air and therefore the differences in mechanical properties of the irradiated tendons cannot 
solely be attributed to the difference in the irradiation mechanisms. The inclusion of a group 
of tendons Gamma irradiated in CO2 would have enabled conclusions about the differences 
in Gamma and E-Beam irradiation more convincingly and provided more insight on the 
mechanisms occurring. In addition, both irradiation treatments were carried out at -70 ºC 
compared to the ambient temperature used in this study. This reduction in temperature may 
have reduced the kinetic energy and therefore the incidence of free-radical reactions. The 
data from the Hoburg et al. (2015) study also suggested that free-radical reactions may have 
caused chain-scission in the collagen of the tendons, as chain-scission is associated with a 
reduction in stiffness and strength and these were the effects negated in an atmosphere of 
CO2. It is important to note the differences in structure when comparing the effects of 
sterilisation on tendons vs arteries. There is a much higher proportion of collagen in tendons 
and limited amounts of elastin compared to the elastin rich artery. 
In agreement with the literature (Gorham et al., 1993) neither Gamma or E-Beam irradiation 
of the acellular porcine carotid arteries resulted in the presence of any cytotoxic residuals in 
the tissue and on the whole, the histoarchithcure of the irradiated tissues appeared to be 
unaffected by the treatments as judged by observation of H&E stained tissue sections. .  
The main mechanism of action of EO treatment is cross-linking of proteins caused by 
alkylation. Both collagen and elastin have functional groups susceptible to this mechanism. 
The biomechanical data presented in this study showed significant increases in the collagen 
and elastin modulus and ultimate tensile stress of the acellular porcine carotid arteries post 
EO treatment. This suggested that cross-linking had occurred throughout the ECM. In 
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contrast to irradiation processes EO treatment does not cause chain-scission and hence a 
significant increase in strength of the acellular porcine carotid arteries post treatment was 
observed. This finding was reflected in the compliance data for the EO treated acellular 
porcine carotid arteries. Similar to E-Beam irradiation, EO treatment increased the elastin 
modulus to an extent that resulted in a negative percentage diameter change and expansion 
only occurred longitudinally. These effects of EO treatment of the acellular porcine carotid 
arteries were only partially reflected in the biological evaluation. Following EO treatment there 
was an absence of collagen IV immuno-staining indicating that the epitope recognised by the 
antibody had been altered or lost. Multiphoton imaging of EO treated acellular artery tissue 
however showed little difference in the treated tissue compared to untreated acellular artery 
tissue. This suggested that any cross-linking of the collagen caused by EO treatment had not 
greatly altered the overall collagen structure.. At lower resolution, using light microscopy to 
assess H&E stained sections; gross separation between the layers of the ECM of the EO 
treated tissue was observed. This had occurred mostly in the adventitial and luminal areas of 
the treated tissues where exposure to EO was greatest. There were also spherical artefacts 
found in the EO treated arteries that were perhaps separation caused by the cross-linking of 
the collagen structure.  
The EO treated acellular porcine carotid arteries also showed significantly higher levels of 
denatured collagen content compared to the native and acellular arteries. This increase in 
denatured collagen content could have been due to the fact the sterilisation process was 
carried out at 55 oC which was close to the denaturation temperature of the acellular porcine 
carotid arteries as determined by DSC. The amount of denatured collagen present was 
however, still very low and there were no observable deterioration on the mechanics as might 
be expected with denaturation of collagen. The EO treated acellular porcine carotid arteries 
showed no evidence of cellular toxicity in the contact cytotoxicity assays indicating that the 
controlled aeration of the arteries was sufficient length of time to eliminate any cytotoxic 
residuals.. In conclusion, with regard to EO sterilisation of the acellular porcine carotid 
arteries although  the collagen structure seemed to be  preserved when observed in the 
multiphoton imaging, the gross histoarchitechure was altered significantly and the 
biomechanical properties,  particularly the compliance data demonstrated that EO treatment 
is not a feasible sterilisation process for acellular vascular grafts. 
The biomechanical test results reported in this study raises the question of whether more 
attention needs to be paid to the structural changes that might occur in elastin as a result of 
sterilisation of acellular  arterial grafts. Compliance mismatch is one of the key causes of 
failure in arterial grafts and the structural component associated with this is elastin. Significant 
changes to the elastin phase in E-Beam irradiated and EO treated arteries caused a 
complete reversal of compliance.  The overall strength of the matrix, which is essential, 
remained adequate in both EO treated and E-Beam irradiated arteries. It is important for a 
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vascular graft to reach a threshold of strength to prevent rupture, typically 2000 mmHg is the 
minimum (Teebken & Haverich, 2002), but once this threshold is met the most important 
factor is matching the compliance characteristics.    
The overall aim of establishing the potential of industrial sterilisation processes for use with 
acellular vascular grafts in this study was fulfilled. Firstly, it was shown that both E-Beam 
irradiation and EO treatment were incompatible for use with acellular porcine carotid arteries 
resulting in significant stiffening of the elastin modulus and negative percentage diameter 
changes upon compliance testing.  It would not be feasible to use these sterilisation methods 
to produce acellular porcine carotid arteries for clinical use. Gamma irradiation, however, 
showed promise as a potential sterilisation method for the acellular vascular grafts. The 
process did cause some stiffening of acellular arteries but had a greater effect on the 
collagen modulus compared to the elastin modulus. This lesser effect on the elastin modulus 
compared to E-Beam irradiation and EO treatment could clearly be seen when in the 
compliance testing data.  The percentage diameter change of Gamma irradiated acellular 
porcine carotid arteries was not significantly different to acellular arteries. Indeed, Gamma 
irradiation treatment may result in a graft with more desirable characteristics by increasing the 
overall strength of the tissue without effecting the artery compliance, however further 
investigation would be required to assess this. In conclusion, it was shown that Gamma 
irradiation is a feasible sterilisation method for acellular vascular grafts and Gamma 
irradiation could be further investigated to optimise the sterilisation process.  
Future Studies.  
In oncology the use of cumulative doses of radiation to target tumours to deliver the 
therapeutic dose has been practised over many years (Gerbi et al., 2009). It is also accepted 
in irradiation sterilisation that cumulative doses (ISO, 11137-2:2012) combine to make the 
total dose. The use of fractionated doses of irradiation has also been investigated in a novel 
approach to reduce the effects of irradiation on the structure of biological tissue. The theory is 
that the use of multiple short bursts of lower dose irradiation will reduce the detrimental 
effects on the tissue. This has been successfully demonstrated using fractionated E-Beam 
irradiation compared to single dose E-Beam and Gamma irradiation (Hoburg et al., 2011). It 
would therefore be of interest to study the effects of fractionated Gamma irradiation, to reach 
the required sterilisation dose, on the biomechanical and biological properties of acellular 
porcine carotid arteries.. For example, two doses of 12.5 kGy or four doses of 6.25 kGy could 
be investigated. There are however some limitations to the potential implementation of 
fractioned Gamma irradiation. In Industrial sterilisation plants the tolerances of the dose 
mapping for both E-Beam and Gamma irradiation are not as sensitive as the research based 
facilities. This could pose a barrier to this option due to cost or availability. With reference to 
industrial irradiation sterilisation validation, VDmax methods are adopted since this reduces 
the number of samples that have to be destroyed in order to validate the process. The 
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methods used to validate irradiation sterilisation processes are dependent on the bioburden 
of the product. With regard to acellular porcine tissue products, the combination of the 
antibiotic wash and the decellularisation process itself has been shown to disinfect the tissue 
(Holmes, 2013) It is therefore anticipated that the acellular porcine carotid artery product 
would have a low bioburden. If this was robustly demonstrated to be less than 1.5 CFU then 
VDmax 15 could be adopted, reducing the required Gamma irradiation sterilisation dose.  
There could however be some contention regarding the use of low dose of Gamma irradiation 
for a graft derived from xenogeneic tissue. It would be necessary to investigate viral 
clearance in future studies once a sterilisation method has been optimised and found to be 
compatible with vascular tissues. There is disagreement within the literature regarding the 
dose of irradiation needed for viral inactivation (Spire et al., 1985; Sullivan et al., 1971; 
Fideler et al., 1994). As part of ISO 22442-3:2007 “Medical devices utilizing animal tissues 
and their derivatives”, a risk assessment for the tissue must be carried out followed by any 
validations deemed necessary as a result of the risk assessment.  A full literature review 
would be necessary to determine the best model viruses, however for a porcine derived 
tissue, potential highly irradiation resistant viruses are porcine parvoviruses (enveloped) and 
pseudorabies virus (non enveloped) (ISO, 22442-3:2007). An investigation could include 
spiking native porcine carotid arteries with a known titre of virus, subjecting the arteries to the 
decellularisation process and the sterilisation process and then measuring recovery of the 
virus before decellularisation after decellularisation and after sterilisation.  
Another method that has been adopted in other studies is the use of radio protectants to 
reduce damage caused by irradiation to the tissue. Radioprotectants have been used 
successfully to minimise the effects on mechanical parameters of tendons subjected to high 
dose (~50 kGy) Gamma irradiation (Grieb et al., 2006) and E-Beam irradiation (Seto et al., 
2009). The idea behind radioprotectants is that free-radicals that are produced during 
sterilisation have the ability to cause either cross-linking or chain-scission in the graft, a 
radioprotectant interacts with these free-radicals limiting the damage potential to the graft. It 
would be interesting to evaluate the effects one or a combination of radioprotectants might 
have on preserving the biological and mechanical parameters of acellular vascular grafts 
when irradiated. 
The methods that have been developed or adopted during the present study were adequate 
for the initial investigation of the effects of sterilisation processes on the biological and 
biomechanical properties of the acellular porcine carotid arteries; however, other techniques 
could have been used. Gouk et al. (2008) employed techniques such as scanning electron 
microscopy (SEM), swelling ratio and enzyme degradation to assess the effects of 
sterilisation on biological tissue. These techniques have advantages and disadvantages 
compared to techniques such as multiphoton imaging for example, the use of SEM would 
allow observation of the tissue structure when it has been damaged, whereas the use of 
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multiphoton imaging is limited to changes in the capacity of the tissue to emit second 
harmonic light. Enzymatic degradation is a technique employed to assess either the increase 
in stability of a biological material due to cross-linking or the decrease in stability due to chain 
scission. The theory is based on the concept that if cross-linking has occurred, the resistance 
to enzymatic digestion would increase and if polypeptide  fragmentation has occurred due to 
chain-scission then the resistance to enzymatic digestion may decrease. This method also 
may allow determination of the particular protein damaged by using enzymes specific to a 
certain sequences of amino acids in the protein. Determination of the swelling ratio has been 
used as an estimation of cross-linking density based on the equations used for a polymeric 
network (Jiang et al., 2006).  A decrease in swelling ratio can be estimated as increase in 
cross-linking density as the matrix becomes more tightly packed together, however this type 
of evaluation may not be sensitive enough to detect changes in a product with high natural 
variability but could be a simple method to assess an increase in cross-linking as a result of 
sterilisation.  
Although cross-linking mechanisms have been established in (Eyre et al., 1984) collagen and 
elastin, it would be useful to further investigate the differences in radiation induced cross-
linking. One method that could potentially highlight the structural changes due to cross-linking 
is infrared spectroscopy (Jiang et al., 2006; Zhang et al., 2014). Again, due to the natural 
variability between products when using animal tissues it may be necessary to do matched 
testing by using tissue from the same sample before and after sterilisation.  
High performance liquid chromatography (HPLC) has also been used to evaluate cross-links 
in collagen and elastin (Eyre et al., 1984). HPLC can be used to evaluate enzymatic digest 
products and with the use of reverse phase HPLC it may be possible to identify the 
mechanism of irradiation induced cross-linking collagenous materials.  
Other future studies that should be undertaken include the assessment of the thrombogenic 
potential of the acellular porcine carotid arteries before and after gamma sterilisation. 
Damage to the basement membrane and intima layer could potentially alter the thrombogenic 
potential of the graft. There are simple in vitro methods available to assess the 
thrombogenicity of a material, for example the Chandler loop method (Guilliatt RS et al., 
2011; Tatterton et al., 2012). This would involve placing the artery in-line with circular tubing 
filled with citrated sheep’s blood and after a period of incubation with rotation, the weight of 
any clot formed would then be assessed.  
Once a sterilisation process has been established the long-term shelf life and stability of the 
acellular porcine carotid arteries post-sterilisation would need to be assessed. Free-radical 
reactions can continue to occur in the final packaging post sterilisation and the extent of this 
would need to be evaluated. Real time shelf life could be assessed at intervals over the 
period of a year using the methods developed in this study to evaluate if the biological and 
mechanical properties were stable over time. In addition to the methods already developed, 
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the thrombogenicity could also be assessed and new methods for determining cross-linking 
density could be investigated.  
Another vital piece of information that could be investigated in future studies is to carry out 
mechanical and biological evaluation of human arteries at the graft site. Arteries to be 
included would be coronary arteries of the heart, femoral and popliteal arteries of the leg and 
ulnar and radial arteries of the arm. This would then provide comparative data on the desired 
biological and mechanical properties to match the acellular graft against. Limitations to this 
will be down to careful screening of cadaveric material to obtain non-diseased arteries.  
Finally in-vivo studies in an animal model would be a huge benefit. This has the potential to 
demonstrate that post sterilisation the combined biological and mechanical characteristics of 
the sterile acellular vascular graft are adequate for purpose. A comparison of the patency 
rates of sterile acellular vascular grafts vs synthetic alternatives would provide a good 
indicator as to the potential of the process. 
To conclude Gamma irradiation presents a potential method for sterilisation of acellular 
vascular grafts.  
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Appendix A 
Lists of general equipment, chemicals, reagents and consumables used throughout the 
project are presented here: 
 Equipment 
A list of general equipment and supplier used throughout this project. 
Table  A-1: General Equipment 
Equipment Model Supplier 
1L, 2L graduated bottles borosilicate 
glass 
FB33147, FB33148 Fisher Scientific Ltd. 
250 ml filter unit (0.2 μm) Nalgene 126-0020 
Adjustable spanners  x 2 N/A N/A 
Automatic pipettes Various Gilson 
Balance GR-200-EC AND 
Bench top autoclave 5 L Kuhn Rikon 
Burst pressure apparatus N/A N/A 
Cell^B Cell^B Olympus UK 
Centrifuge Harrier 15/80 Sanyo Biomedical 
Centrifuge Microcentaur MSE 
Class II safety cabinet CL2 Heraeus 
Class II safety cabinet CL2 Heraus 
Cutting tool N/A N/A 
Digital colour camera Evolution MP5 Media Cybernetics 
Digital colour camera XC50 Olympus UK 
Dissection Kit Various Thackeray 
Freeze dryer Modulo Thermo Scientific 
Glass troughs E105 Raymond A Lamb 
Histology water bath MH8515 Barnstead Electrothermal 
Hole punch 5 mm diameter N/A In-house 
Hot wax oven E18/31 Raymond A Lamb 
Hotplate E18/1 Raymond A Lamb 
Image-pro plus Version 5.1 Media Cybernetics 
Incubator Heraeus Jencons PLC 
Inverted microscope IX71 Olympus UK 
Magnetic stirrer CB161 Stuart Scientific 
Materials testing machine 3365 Instron 
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Equipment Model Supplier 
Micro plate spectrophotometer Multiskan spectrum Thermo Scientific 
Micro shaker AM69 Cooke 
Microtome RM2125 RTF Leica 
Nanodrop spectrophotometer ND-100 Labtech 
Orbital Shaker KS 130 IKA 
pH meter 3510 Jenway 
Pippette boy Integra acu Integra Bioscience 
Pressure gauge C9557 Comark 
Slide holder E102 Raymond A Lamb 
Thickness measurement gauge 7323 Mitutoyo 
Tissue processor TP11020 Leica 
Top Count C9902 NXT Perkin Elmer 
Upright microscope BX40 Olympus UK Ltd. 
Vernier callipers N48AA Maplin 
Water bath G 352 Grant 
Wax dispenser E66 Raymond A Lamb 
Whrli mixer CM-1 Thermo Fisher Scientific 
 Chemicals and Reagents 
A list of general equipment and supplier used throughout this project. 
Table  A-2 : Chemicals and Reagents  
Chemical/Reagent Cat No. Supplier 
10 % Neutral buffered formalin (NBF) RRFF4000-G Atom scientific 
3M Steri-Strip SkinClosure 3x75 mm 
R1540C Medisave 
Acetone 
LS8/1970/G European Bios 
Aprotonin (10000 KI ml-1) 
AP012 Mayfair House 
ATPLite-M assay 
6016941 Perkin-Elmer 
Bovine serum albumin (BSA) 
A7030-100G Sigma-Aldrich 
Calcium acetate (anhydrous) 
C/0920/50 Thermo Fisher Scientific Ltd. 
Calcium chloride 
ALFA12316.A1 VWR International 
Chloramine T 
C9887 Sigma-Aldrich 
Citric acid 
100814N VWR International 
Collagen IV isotype IgG1 
X0931 Dako 
Collagen IV mouse monoclonal 
antibody 
M0785 Dako 
Cyanoacrylate contact adhesive 
Z105902-1EA Sigma-Aldrich 
Dako fluorescence mounting medium 
S3023 Dako 
Dimethyl sulfoxide (DMSO) 
D26650 Sigma 
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Chemical/Reagent Cat No. Supplier 
Disodium ethylenediaminetetraacetic 
acid (EDTA) 
E/P140/53 Thermo Fisher Scientific Ltd. 
DNAse 
DN25-1 Sigma-Aldrich 
DNeasy kit 
69504 Qiagen 
DPX mountant 
M81330/C Thermo Fisher Scientific Ltd. 
Dulbecco’s minimal essential medium 
(DMEM) 
D6546 Sigma 
Dulbecco’s PBS tablets  
BR0014 Oxoid 
Dulbecco’s PBS with Ca2+ & Mg2+ 
D8662 Sigma 
Eosin 
1.09844.1000 VWR International 
Ethanol 
E/0555DF/25  Thermo Fisher Scientific Ltd. 
Foetal bovine serum (FBS) 
EU-000 Sera Lab 
Gentamycin sulphate 
345810 VWR International 
Giemsa solution 
352603R VWR International 
Glacial acetic acid 
10001 VWR International 
Glasgow’s minimal essential medium 
(GMEM) 
G5154 Sigma 
Glycerol 
BPE229-1 Thermo Fisher Scientific Ltd. 
Haematoxylin 
PS50/C Thermo Fisher Scientific Ltd. 
Histo-clear III 
HS-204 National Diagnostics 
Hydrochloric acid 6 M   
2611.5000 VWR International 
Hydrogen peroxide 
H1009 Sigma-Aldrich 
ImmEdge hydrophobic barrier pen 
H-4000 Vector Laboratories 
L-Glutamine (200 mM) 
G7513 Sigma 
Magnesium chloride  
22321-1000 Thermo Fisher Scientific Ltd. 
Molecular grade water 
W4502-1L Sigma Aldrich 
Paraffin wax 
PS138/E Thermo Fisher Scientific Ltd. 
PBS without Ca2+/Mg2+ 
D8537 Sigma 
p-dimethylaminobenzaldehyde 
S647861 Sigma-Aldrich 
Penicillin (5000 U/ml) / streptomycin 
(5 mg/ml) 
P4458 Sigma 
Perchloric acid (60 %) 
294582D Sigma-Aldrich 
Polymyxin B 
81334-5G Sigma-Aldrich 
Propan-1-ol 
103456A VWR International 
Proteinase K 
S3020 Dako 
RNAse 
123879 Sigma-Aldrich 
Scott’s tap water 
PS138/E Thermo Fisher Scientific Ltd. 
Sodium acetate 
S/2080/60 Thermo Fisher Scientific Ltd. 
Sodium azide 1% solution 
786-299 G-Biosciences 
Sodium chloride 
42429-5000 Thermo Fisher Scientific Ltd. 
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Chemical/Reagent Cat No. Supplier 
Sodium dodecyl sulphate (SDS) 
71727 Sigma-Aldrich 
Sodium hydroxide 6M 
S/4920/53 Thermo Fisher Scientific Ltd. 
Trans-4-hydroxy-L-proline 
H7279 Sigma-Aldrich 
Trigene 
CLE1312  SLS 
Trizma base 
T-1503 Sigma-Aldrich 
Trypsin/EDTA 
T3924 Sigma 
Tryptone phosphate broth (TPB) 
T8782 Sigma 
Tween 20 
P1379  Sigma-Aldrich 
Ultra Vision one detection system: 
HRP Polymer 
DAB Plus substrate 
 
TL-125-HLJ 
TA-125-HDX 
Thermo Scientific 
Vancomycin hydrochloride 
861987-1G Sigma-Aldrich 
Zinc acetate 
383317 Sigma-Aldrich 
Zinc chloride 
96470 Fluka 
α-chymotrypsin 
C4129-10 Sigma-Aldrich 
 
 Consumables 
A list of general equipment and supplier used throughout this project. 
Table  A-3 : Consumables 
Material Cat No. Supplier 
2 ml cryovials 
72.380.992 Sarstedit 
250ml sterile containers 
CON7580S Scientific Laboratory Supplies 
30 ml universal bottles 
CON9000 SLS 
75 ml tissue culture flask 
TKT-130-210-T Thermo-Fisher scientific 
Bijoux tubes 
SLS7522 SLS 
Cable ties 
Small Wilkinsons 
Culture slides tissue culture 4 wells 
734-0088 VWR International 
Fresh blood agar plates 
N/A FBS Media Services 
Glass cover slips 
MIC3228 Scientific Laboratory Supplies 
Histology moulds 
E10.8/4161 Raymond Lamb 
Mersilk sutures size 3-0 
W502H Medisave 
Micro tube I 1.5 ml, loop cap – 
Simport 
212-9573 VWR International 
Microtome blades 
SD3050835 Fisher Scientific 
Nutrient agar plates 
N/A FBS Media Services 
Plastic histology casettes 
CMB-160-030R Thermo Fisher Scientific Ltd. 
Sabauroud agar 
N/A FBS Media Services 
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Material Cat No. Supplier 
Six well tissue culture plates 
140675 Thermo Fisher Scientific Ltd. 
Stanley knife blades 
N/A N/A 
Sterile glass universal tube 
N/A FBS Media Services 
Superfrost microscope slide 
MIC3040 SLS 
Superfrost Plus microscope slide 
MIC3022 SLS 
TopSeal 96 well plate 
6005185 Perkin Elmer 
White, 96 well optiplate 
6005680 Perkin Elmer 
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Appendix B  
 Statistical Analysis 
Table  B-1 : Basic statistical analysis terms. 
Term Equation 
Sum of ∑ 
Value 𝑥  
Sample number  𝑛  
Mean (𝒙) ∑ 𝑥/𝑛  
Standard deviation (S) √∑ 𝑥2 𝑛⁄   
Standard error (SE) 𝑆 √𝑛⁄   
95 % Confidence limit (CL) 𝑆𝐸 × 𝑡 − 𝑣𝑎𝑙𝑢𝑒  
Minimum significant difference (MSD) 𝐶𝑟𝑖𝑡𝑖𝑐𝑎𝑙 𝑣𝑎𝑙𝑢𝑒 × 𝑆𝐸   
 
Table  B-2 Statistical analysis using minimum significant difference. 
Term Equation 
Minimum significant difference (MSD) 𝐶𝑟𝑖𝑡𝑖𝑐𝑎𝑙 𝑣𝑎𝑙𝑢𝑒 × 𝑆𝐸   
SE √𝑚𝑒𝑎𝑛 𝑠𝑞𝑢𝑎𝑟𝑒 𝑤𝑖𝑡ℎ𝑖𝑛 𝑔𝑟𝑜𝑢𝑝𝑠 𝑛⁄    
Critical value 𝑄0.05 [𝑘 , 𝑣] 𝑡ℎ𝑒 𝑠𝑡𝑢𝑑𝑒𝑛𝑡𝑖𝑠𝑒𝑑 𝑟𝑎𝑛𝑔𝑒  
Number of group means to be compared 𝑘  
Degrees of freedom  𝑣  
 
 
 
 
 
 
 
 
 
 
